{\rtf1 \ansi 
{\colortbl;
\red0\green0\blue0;
\red255\green255\blue255;
\red255\green0\blue0;
\red0\green255\blue0;
\red0\green0\blue255;
\red0\green255\blue255;
\red255\green0\blue255;
\red255\green255\blue0;
\red0\green0\blue128;
\red0\green128\blue128;
\red0\green128\blue0;
\red128\green0\blue128;
\red128\green0\blue0;
\red128\green128\blue0;
\red128\green128\blue128;
\red192\green192\blue192;
\red170\green170\blue170;
\red85\green85\blue85;
\red14\green86\blue140;
\red33\green33\blue33;
\red37\green37\blue37;
\red255\green255\blue102;
\red119\green119\blue119;
\red80\green80\blue80;
\red107\green107\blue106;
\red61\green61\blue61;
\red214\green214\blue214;
\red218\green218\blue218;
\red255\green248\blue96;
\red21\green137\blue21;
\red204\green204\blue204;
\red112\green112\blue112;
\red86\green86\blue86;
\red56\green124\blue43;
\red247\green247\blue247;
\red151\green151\blue151;
\red238\green238\blue238;
\red20\green93\blue164;
\red246\green246\blue246;
\red187\green187\blue187;
\red203\green203\blue203;
\red245\green245\blue245;
\red204\green255\blue255;
\red143\green34\blue26;
\red232\green233\blue232;
\red240\green240\blue240;
\red105\green105\blue105;
\red227\green227\blue227;
\red254\green254\blue0;
\red255\green255\blue174;
\red0\green114\blue54;
\red249\green249\blue249;
\red127\green127\blue127;
\red71\green120\blue194;
\red188\green41\blue30;
\red190\green237\blue228;
\red223\green223\blue223;
\red239\green239\blue239;
\red255\green255\blue198;
\red236\green236\blue236;
\red106\green144\blue39;
\red190\green190\blue252;
\red240\green191\blue187;
\red61\green61\blue60;
\red89\green89\blue89;
\red250\green250\blue250;
\red70\green70\blue70;
\red214\green78\blue69;
\red250\green222\blue100;
\red186\green186\blue186;
\red255\green204\blue153;
\red23\green94\blue146;
\red227\green232\blue250;
\red70\green70\blue68;
\red181\green79\blue104;
\red228\green231\blue232;
\red102\green0\blue102;
\red183\green242\blue206;
\red185\green185\blue185;
\red102\green102\blue102;
\red255\green255\blue204;
\red255\green204\blue0;
\red229\green243\blue255;
\red179\green218\blue255;
\red255\green210\blue183;
\red221\green195\blue236;
\red118\green118\blue118;
\red233\green233\blue233;
\red182\green231\blue243;
\red33\green74\blue204;
\red214\green9\blue9;
\red249\green250\blue251;
\red242\green242\blue242;
\red240\green248\blue255;
\red51\green51\blue51;
\red153\green153\blue153;
\red220\green220\blue220;
\red255\green194\blue211;
\red172\green172\blue172;
\red9\green56\blue84;
}
{\fonttbl {
\f0 Arial;}{
\f1 Symbol;}{
\f2 Times New Roman;}{
\f3 Georgia;}{
\f4 sans-serif;}{
\f5 serif;}{
\f6 Source Sans Pro;}{
\f7 Helvetica;}{
\f8 Courier New;}
}
{\*\generator Apache XML Graphics RTF Library;}
\fet0 \ftnbj \paperw12240 \paperh15840 \margt1080 \margb1080 \margl1080 \margr1080 \headery720 \footery720 \itap0 \cols1 
\sectd {\header {
{\trowd \ltrrow \trleft0 
\clpadb60 \clpadfb3 \clpadl400 \clpadfl3 \clbrdrt \clbrdrb \brdrcf17 \brdrw20 \brdrs \clbrdrl \trql \clvertalb \clwWidth9380 \cellx9380 
\clpadb60 \clpadfb3 \clpadl400 \clpadfl3 \clbrdrt \clbrdrb \brdrcf17 \brdrw20 \brdrs \clbrdrr \trql \clwWidth700 \cellx10080 
\intbl 
{\b0 \cf1 \f0 \ri0 \i0 \ql \fs18 \li0 
{\b0 \cf1 \f0 \ul0 \strike0 \i0 \fs18 
}
{\b1 \cf18 \f0 \i0 \fs18 
{\b1 \cf18 \f0 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
A PRODUCTS LIABILITY FRAMEWORK FOR AI, 25 Colum. Sci. & Tech. L. Rev. 240
}
}
{\b0 \cf1 \f0 \ul0 \strike0 \i0 \fs18 
}
}\b0 \cf1 \f0 \ri0 \ul0 \strike0 \i0 \ql \fs18 \li0 \sa0 \sb0 \intbl \cell \intbl 
{\qr \b0 \cf1 \f0 \ri0 \i0 \fs18 \li0 
}\qr \b0 \cf1 \f0 \ri0 \i0 \fs18 \li0 \intbl \cell \row }
{\trowd \lastrow \trleft0 
\clbrdrb \clbrdrl \trql \clwWidth10080 \cellx10080 
\intbl 
{\b0 \cf1 \f0 \ri0 \i0 \ql \fs18 \li0 
}\b0 \cf1 \f0 \ri0 \i0 \ql \fs18 \li0 \intbl \cell \row }}\par }{\footer {
{\trowd \lastrow \trleft0 
\clpadl60 \clpadfl3 \clbrdrt \brdrcf17 \brdrw20 \brdrs \clbrdrb \clbrdrl \trql \clvertalb \clwWidth9300 \cellx9300 
\clpadl60 \clpadfl3 \clbrdrt \brdrcf17 \brdrw20 \brdrs \clbrdrb \clbrdrr \trql \clwWidth700 \cellx10000 
\intbl 
{\b0 \cf17 \f0 \ri0 \i0 \ql \fs20 \li0 
{\b0 \cf17 \f0 \ul0 \strike0 \i0 \fs20 
}
{\*\shppict {\pict \pngblip \picw78 \pich10 \picwgoal1170 \pichgoal150 89504e470d0a1a0a0000000d494844520000004e0000000a08030000002dbd985500000300504c5445f8a969f6913ff68931fff9f5f69241f5852af68d38fcddc4f58326fac294f8a868fac193fcdabefab985fcdfc7fef5eef58022f8a35efef6effde5d2fac092fffaf6f9ac6ffffcfafde8d7fef7f1f9b279f6862cf8aa6af79e56f79c53f58327fef1e7fde3cefeeee2f9b076f79a4efef8f4f58123f58224f9ae72feefe4f58021f9ae71fac295fffaf7fcdabffef7f2f9af73f9b177f8ac6ef9b47cf8a15bf6872ef79648fef5edf9b278fcd9bdf9b782f9b57efbc89ffde3cffffefdf6872df8aa6bfcd6b8fac59af9b781fabc8bfffbf8fac091fac396fbceaaf8a461f68e39f6882ffabe8dfabf8ff9b884f79c52fdeadbfeede0f68c36f89f58fcdcc3fde0c9fef0e5fef3eaf68f3cfbcaa2f8a867f9b37afaba87f68b35fde7d6fabf90fffcfbfaba86fde7d5f6903efffdfcfef4ecf68f3bfde1cafcdfc6fbd1affbcea9fcd6b7f68a33f79444fbcba5f58429fcdec6f9af74f8a25df58428f7a461fef4edfdede0fde6d4fde7d4f9b680fbc69cfbc8a0f9b37bfac9a1f69240f79d54fcd4b4f9b883f68e3afef8f3fdebddfde2cbf7984cf8a35ff6882efef3ebf9bd8cfcd4b5feecdef8a562fde6d3fef9f4fcdbc1f9bc8afcd8bcf8ab6dfef8f2fcd7b9fffbf7feefe3f79546f8aa69f79f57fde1cbfcd3b3fcd2b1f8a25cfcd3b2fde2ccfac599fac397f9b379fcd8bbfbd2b0fef2e9fcd5b6fac79ef8a664f8a460f68a32fac090fffbf9fef2e8f8ab6cfde4d0f7994df6903df79749fffefcf79e55f8a766f8a059f68830f7974afde2cdfbcca6fabd8cf57f20ffffff000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000c5baaa8e000000bf74524e53ffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffffff00456e8439000002804944415478da63dcc70001fef2931866b0be0cd2085114e5ff7ef72a0357d0a3a31cc2129ebb9f492a3e4b6eb8cb20913bb5c808a2f849bf610c438bf99a9917cf2a18092c7bf1a30a6a0a13946658f6af92e15352e52386af5d677ee5ff61618c5ca7c6b58921d6ecc47383e56a52b3181955bf2e3e01513b49bae7260383be8b048376a2e34786a3853761a6b0c018892b57313c48fa38834195c1cf94c16a3a03c3edad7c5f163030a8672bcc3afcf4251343639ef3ae2cb05afe384e9390352a0c320cbdf71f19b43d6690c7302e84e11383d28bff67bcba9a6e2831acd9c6e0d990fe70b74ae7d2a90c0cbbc36fbaef6660b80f55ba68e9d2d5a9ae0cdd2f341878be8b9c64f8cb701d660a733c9451af78704effa1c6b3536708cf2c9ffde7c78fcb9b16497b8acf3e3721061812bfde8433302c8d5a190152ca93f7d26df6796bff83310dbfe504de7f7ff9ec621c7ad8ade964d5f0f8162da4257e9da18c39434955602283a37fdaefde9cb30c686005c3a4c9a6d792186c6b665d8e54f97ae7c5badd189e65307c22395565fbc43fcc010cad5b3ba781c5363184af0bfa8530481844b84e65b87efde6bcb50c67d9dc36d4f6bf7aa6e4015700771dc3fd57751f183c97ecfe7f04c8b17e9f9fdfceb0e334c3ca37c16940feb644b09ad7e1aee90cdaaa9f1ca31ef6bd6478e2b43ba29f615fc7cf550c1861c720c2699619c930d362d55a060ff68e592f7d4eacd82df9eb3bd7bd387986ff73182d18183686ba2ff9f76ec59f909c2e83a8499dbbaaa404ecf8199cb8051e79627ad6fa4799360383602cd0bdcbdeb2fc6158debec577daf1a9076ba51818e679bf05aaf85cfdeb0f8383c1ec0973801cee342386c537cdf218fecf4b70801b0200f61ff095f54de6170000000049454e44ae426082}}
{\b0 \cf17 \f0 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 \u169\'3f 2024 Thomson Reuters. No claim to original U.S. Government Works.
}
}\b0 \cf17 \f0 \ri0 \ul0 \strike0 \i0 \ql \fs20 \li0 \sa0 \sb0 \intbl \cell \intbl 
{\qr \b0 \cf17 \f0 \ri0 \i0 \fs20 \li0 
{\b0 \i0 \ul0 \fs20 \f0 \chpgn }
}\qr \b0 \cf17 \f0 \ri0 \ul0 \strike0 \i0 \fs20 \li0 \intbl \cell \row }}\par }
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 \par}\sect\sbknone\pgncont\cols1{\ids0 
{\*\bkmkstart co_document_1}{\*\bkmkend co_document_1}
{\b0 \cf1 \f2 \i0 \fs20 
{\*\bkmkstart I434c460335f011ef8921fbef1a541940_Target}{\*\bkmkend I434c460335f011ef8921fbef1a541940_Target}
\par 
}
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b1 \qc \cf1 \f3 \ri0 \i0 \fs20 \li0 
{\b1 \cf1 \f3 \ul0 \strike0 \i0 \fs20 \sa200 \sb0 
25 Colum. Sci. & Tech. L. Rev. 240
\par 
}
}
{\b0 \cf25 \f2 \ri0 \i0 \ql \fs20 \li0 
{\b0 \cf25 \f2 \ri0 \i0 \ql \fs18 \li0 
{\b1 \cf25 \f2 \ri0 \i0 \ql \fs18 \li0 
{\b1 \cf25 \f2 \ul0 \strike0 \i0 \fs18 \sa0 \sb364 
Columbia Science and Technology Law Review
\par 
}
}
}
{\b0 \cf25 \f3 \i0 \fs18 
{\b0 \cf25 \f3 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
Spring, 2024
\par 
}
}
{\b0 \cf25 \f2 \ri0 \i0 \ql \fs18 \li0 
{\b1 \cf25 \f2 \ri0 \i0 \ql \fs18 \li0 
{\b1 \cf25 \f2 \i0 \fs18 
{\b1 \cf25 \f2 \ul0 \strike0 \i0 \fs18 \sa0 \sb364 
Article
\par 
}
}
}
}
{\b0 \cf25 \f2 \ri0 \i0 \ql \fs20 \li0 
{\b0 \cf25 \f2 \i0 \fs20 
{\b0 \cf25 \f2 \ul0 \strike0 \i0 \fs20 \sa200 \sb0 
Catherine M. Sharkey
}
{\b0 \cf25 \f2 \i0 \fs16 
{\*\bkmkstart co_fnRef_Fa1546934635_ID0EZKAC_1}{\*\bkmkend co_fnRef_Fa1546934635_ID0EZKAC_1}
{\field {\*\fldinst HYPERLINK "#co_footnote_Fa1546934635_1" }{\fldrslt 
{\super \b0 \cf19 \f2 \ul0 \strike0 \i0 \fs16 \sa0 \sb0 
a1
}}}
\par 
}
}
}
{\b0 \cf25 \f2 \ri0 \i0 \ql \fs20 \li0 
{\b0 \cf25 \f2 \ul0 \strike0 \i0 \fs20 \sa200 \sb200 
Copyright \u169\'3f 2024 by Columbia Science and Technology Law Review; Catherine M. Sharkey
\par 
}
}
}
}
{\b0 \cf1 \f2 \i0 \brdrt \brdrcf1 \brdrw20 \brdrs \fs20 \brdrr \brdrcf1 \brdrw0 \brdrs \brdrl \brdrcf1 \brdrw0 \brdrs \ri0 \qj \li0 \brdrb \brdrcf1 \brdrw0 \brdrs 
}
{\b1 \cf20 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b1 \cf20 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb600 
A PRODUCTS LIABILITY FRAMEWORK FOR AI
\par 
}
}
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\*\bkmkstart co_g_ID0EPLAC_1}{\*\bkmkend co_g_ID0EPLAC_1}
{\b0 \cf1 \f2 \i1 \fs20 
{\b0 \cf1 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
A products liability framework, drawing inspiration from the regulation of FDA-approved medical products--which includes federal regulation as well as products liability--holds great promise for tackling many of the challenges AI poses. Notwithstanding the new challenges that sophisticated AI technologies pose, products liability provides a conceptual framework capable of responding to the learning and iterative aspects of these technologies. Moreover, this framework provides a robust model of the feedback loop between tort liability and regulation.
\par 
}
}
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
\u160\'3f
\par 
}
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\*\bkmkstart co_g_ID0ECMAC_1}{\*\bkmkend co_g_ID0ECMAC_1}
{\b0 \cf1 \f2 \i1 \fs20 
{\b0 \cf1 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
The regulation of medical products provides an instructive point of departure. The FDA has recognized the need to revise its traditional paradigm for medical device regulation to fit adaptive AI/ML technologies, which enable continuous improvements and modifications to devices based on information gathered during use. AI/ML technologies should hasten an even more significant regulatory paradigm shift at the FDA away from a model that puts most of its emphasis on (and resources into) ex ante premarket approval to one that highlights ongoing postmarket surveillance. As such a model takes form, products liability should continue to play a significant information-production and deterrence role, especially during the transition period before a new ex post regulatory framework is established.
\par 
}
}
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
\u160\'3f
\par 
}
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\*\bkmkstart co_anchor_tbl1_1}{\*\bkmkend co_anchor_tbl1_1}
\par 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 {
{\trowd \ltrrow \trleft0 
\clbrdrt \clbrdrl \trql \clwWidth8760 \cellx8760 
\clpadt30 \clpadft3 \clpadr30 \clpadfr3 \clbrdrt \clbrdrr \trql \clwWidth1320 \cellx10080 
\intbl 
{\ri0 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \ql \fs20 \li0 
{\field {\*\fldinst HYPERLINK "#co_g_ID0ENCAE_1" }{\fldrslt 
{\super \b0 \cf19 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
I. 
}
{\b0 \cf19 \f2 \i0 \fs20 
{\b0 \cf19 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
Introduction
}
}\super \b0 \cf19 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 }}
\par 
}
}\b0 \cf1 \f2 \ri0 \i0 \ql \li0 \fs20 \intbl \cell \intbl 
{\ri30 \li30 
{\b0 \cf1 \f2 \ri30 \i0 \ql \fs20 \li30 
{\field {\*\fldinst HYPERLINK "#co_g_ID0ENCAE_1" }{\fldrslt 
{\super \b0 \cf19 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
241
}\super \b0 \cf19 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 }}
\par 
}
}\b0 \cf1 \f2 \ri30 \i0 \ql \li30 \fs20 \intbl \cell \row }
{\trowd \ltrrow \trleft0 
\clbrdrl \trql \clwWidth8760 \cellx8760 
\clpadt30 \clpadft3 \clpadr30 \clpadfr3 \clbrdrr \trql \clwWidth1320 \cellx10080 
\intbl 
{\ri0 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \ql \fs20 \li0 
{\field {\*\fldinst HYPERLINK "#co_g_ID0EMIAE_1" }{\fldrslt 
{\super \b0 \cf19 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
II. 
}
{\b0 \cf19 \f2 \i0 \fs20 
{\b0 \cf19 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
A Products Liability Conceptual Framework
}
}\super \b0 \cf19 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 }}
\par 
}
}\b0 \cf1 \f2 \ri0 \i0 \ql \li0 \fs20 \intbl \cell \intbl 
{\ri30 \li30 
{\b0 \cf1 \f2 \ri30 \i0 \ql \fs20 \li30 
{\field {\*\fldinst HYPERLINK "#co_g_ID0EMIAE_1" }{\fldrslt 
{\super \b0 \cf19 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
244
}\super \b0 \cf19 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 }}
\par 
}
}\b0 \cf1 \f2 \ri30 \i0 \ql \li30 \fs20 \intbl \cell \row }
{\trowd \ltrrow \trleft0 
\clbrdrl \trql \clwWidth8760 \cellx8760 
\clpadt30 \clpadft3 \clpadr30 \clpadfr3 \clbrdrr \trql \clwWidth1320 \cellx10080 
\intbl 
{\ri0 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \ql \fs20 \li0 
{\field {\*\fldinst HYPERLINK "#co_g_ID0EIKAE_1" }{\fldrslt 
{\super \b0 \cf19 \f2 \ul0 \strike0 \i0 \fs20 
}
{\b0 \cf19 \f2 \i1 \fs20 
{\b0 \cf19 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
A. The Feedback Loop Between Tort Liability and Regulation
}
}\super \b0 \cf19 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 }}
\par 
}
}\b0 \cf1 \f2 \ri0 \i0 \ql \li0 \fs20 \intbl \cell \intbl 
{\ri30 \li30 
{\b0 \cf1 \f2 \ri30 \i0 \ql \fs20 \li30 
{\field {\*\fldinst HYPERLINK "#co_g_ID0EIKAE_1" }{\fldrslt 
{\super \b0 \cf19 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
244
}\super \b0 \cf19 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 }}
\par 
}
}\b0 \cf1 \f2 \ri30 \i0 \ql \li30 \fs20 \intbl \cell \row }
{\trowd \ltrrow \trleft0 
\clbrdrl \trql \clwWidth8760 \cellx8760 
\clpadt30 \clpadft3 \clpadr30 \clpadfr3 \clbrdrr \trql \clwWidth1320 \cellx10080 
\intbl 
{\ri0 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \ql \fs20 \li0 
{\field {\*\fldinst HYPERLINK "#co_g_ID0EHQAE_1" }{\fldrslt 
{\super \b0 \cf19 \f2 \ul0 \strike0 \i0 \fs20 
}
{\b0 \cf19 \f2 \i1 \fs20 
{\b0 \cf19 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
B. Products Liability as a Robust Conceptual Framework
}
}\super \b0 \cf19 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 }}
\par 
}
}\b0 \cf1 \f2 \ri0 \i0 \ql \li0 \fs20 \intbl \cell \intbl 
{\ri30 \li30 
{\b0 \cf1 \f2 \ri30 \i0 \ql \fs20 \li30 
{\field {\*\fldinst HYPERLINK "#co_g_ID0EHQAE_1" }{\fldrslt 
{\super \b0 \cf19 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
246
}\super \b0 \cf19 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 }}
\par 
}
}\b0 \cf1 \f2 \ri30 \i0 \ql \li30 \fs20 \intbl \cell \row }
{\trowd \ltrrow \trleft0 
\clbrdrl \trql \clwWidth8760 \cellx8760 
\clpadt30 \clpadft3 \clpadr30 \clpadfr3 \clbrdrr \trql \clwWidth1320 \cellx10080 
\intbl 
{\ri0 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \ql \fs20 \li0 
{\field {\*\fldinst HYPERLINK "#co_g_ID0EB5AE_1" }{\fldrslt 
{\super \b0 \cf19 \f2 \ul0 \strike0 \i0 \fs20 
}
{\b0 \cf19 \f2 \i1 \fs20 
{\b0 \cf19 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
C. Why Involve a Regulator Now?
}
}\super \b0 \cf19 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 }}
\par 
}
}\b0 \cf1 \f2 \ri0 \i0 \ql \li0 \fs20 \intbl \cell \intbl 
{\ri30 \li30 
{\b0 \cf1 \f2 \ri30 \i0 \ql \fs20 \li30 
{\field {\*\fldinst HYPERLINK "#co_g_ID0EB5AE_1" }{\fldrslt 
{\super \b0 \cf19 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
250
}\super \b0 \cf19 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 }}
\par 
}
}\b0 \cf1 \f2 \ri30 \i0 \ql \li30 \fs20 \intbl \cell \row }
{\trowd \ltrrow \trleft0 
\clbrdrl \trql \clwWidth8760 \cellx8760 
\clpadt30 \clpadft3 \clpadr30 \clpadfr3 \clbrdrr \trql \clwWidth1320 \cellx10080 
\intbl 
{\ri0 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \ql \fs20 \li0 
{\field {\*\fldinst HYPERLINK "#co_g_ID0EM6AE_1" }{\fldrslt 
{\super \b0 \cf19 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
III. 
}
{\b0 \cf19 \f2 \i0 \fs20 
{\b0 \cf19 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
A Point Of Departure: AI-Enabled Medical Products
}
}\super \b0 \cf19 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 }}
\par 
}
}\b0 \cf1 \f2 \ri0 \i0 \ql \li0 \fs20 \intbl \cell \intbl 
{\ri30 \li30 
{\b0 \cf1 \f2 \ri30 \i0 \ql \fs20 \li30 
{\field {\*\fldinst HYPERLINK "#co_g_ID0EM6AE_1" }{\fldrslt 
{\super \b0 \cf19 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
251
}\super \b0 \cf19 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 }}
\par 
}
}\b0 \cf1 \f2 \ri30 \i0 \ql \li30 \fs20 \intbl \cell \row }
{\trowd \ltrrow \trleft0 
\clbrdrl \trql \clwWidth8760 \cellx8760 
\clpadt30 \clpadft3 \clpadr30 \clpadfr3 \clbrdrr \trql \clwWidth1320 \cellx10080 
\intbl 
{\ri0 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \ql \fs20 \li0 
{\field {\*\fldinst HYPERLINK "#co_g_ID0EEBAG_1" }{\fldrslt 
{\super \b0 \cf19 \f2 \ul0 \strike0 \i0 \fs20 
}
{\b0 \cf19 \f2 \i1 \fs20 
{\b0 \cf19 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
A. The FDA\rquote s Regulation of AI-Enabled Medical Devices
}
}\super \b0 \cf19 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 }}
\par 
}
}\b0 \cf1 \f2 \ri0 \i0 \ql \li0 \fs20 \intbl \cell \intbl 
{\ri30 \li30 
{\b0 \cf1 \f2 \ri30 \i0 \ql \fs20 \li30 
{\field {\*\fldinst HYPERLINK "#co_g_ID0EEBAG_1" }{\fldrslt 
{\super \b0 \cf19 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
251
}\super \b0 \cf19 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 }}
\par 
}
}\b0 \cf1 \f2 \ri30 \i0 \ql \li30 \fs20 \intbl \cell \row }
{\trowd \ltrrow \trleft0 
\clbrdrl \trql \clwWidth8760 \cellx8760 
\clpadt30 \clpadft3 \clpadr30 \clpadfr3 \clbrdrr \trql \clwWidth1320 \cellx10080 
\intbl 
{\ri0 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \ql \fs20 \li0 
{\field {\*\fldinst HYPERLINK "#co_g_ID0EFRAG_1" }{\fldrslt 
{\super \b0 \cf19 \f2 \ul0 \strike0 \i0 \fs20 
}
{\b0 \cf19 \f2 \i1 \fs20 
{\b0 \cf19 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
B. Products Liability and Federal Preemption
}
}\super \b0 \cf19 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 }}
\par 
}
}\b0 \cf1 \f2 \ri0 \i0 \ql \li0 \fs20 \intbl \cell \intbl 
{\ri30 \li30 
{\b0 \cf1 \f2 \ri30 \i0 \ql \fs20 \li30 
{\field {\*\fldinst HYPERLINK "#co_g_ID0EFRAG_1" }{\fldrslt 
{\super \b0 \cf19 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
257
}\super \b0 \cf19 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 }}
\par 
}
}\b0 \cf1 \f2 \ri30 \i0 \ql \li30 \fs20 \intbl \cell \row }
{\trowd \ltrrow \trleft0 
\clbrdrl \trql \clwWidth8760 \cellx8760 
\clpadt30 \clpadft3 \clpadr30 \clpadfr3 \clbrdrr \trql \clwWidth1320 \cellx10080 
\intbl 
{\ri0 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \ql \fs20 \li0 
{\field {\*\fldinst HYPERLINK "#co_g_ID0EMVAG_1" }{\fldrslt 
{\super \b0 \cf19 \f2 \ul0 \strike0 \i0 \fs20 
}
{\b0 \cf19 \f2 \i1 \fs20 
{\b0 \cf19 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
C. Liability Insurance
}
}\super \b0 \cf19 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 }}
\par 
}
}\b0 \cf1 \f2 \ri0 \i0 \ql \li0 \fs20 \intbl \cell \intbl 
{\ri30 \li30 
{\b0 \cf1 \f2 \ri30 \i0 \ql \fs20 \li30 
{\field {\*\fldinst HYPERLINK "#co_g_ID0EMVAG_1" }{\fldrslt 
{\super \b0 \cf19 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
258
}\super \b0 \cf19 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 }}
\par 
}
}\b0 \cf1 \f2 \ri30 \i0 \ql \li30 \fs20 \intbl \cell \row }
{\trowd \lastrow \trleft0 
\clbrdrb \clbrdrl \trql \clwWidth8760 \cellx8760 
\clpadt30 \clpadft3 \clpadr30 \clpadfr3 \clbrdrb \clbrdrr \trql \clwWidth1320 \cellx10080 
\intbl 
{\ri0 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \ql \fs20 \li0 
{\field {\*\fldinst HYPERLINK "#co_g_ID0EQYAG_1" }{\fldrslt 
{\super \b0 \cf19 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
IV. 
}
{\b0 \cf19 \f2 \i0 \fs20 
{\b0 \cf19 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
Conclusion
}
}\super \b0 \cf19 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 }}
\par 
}
}\b0 \cf1 \f2 \ri0 \i0 \ql \li0 \fs20 \intbl \cell \intbl 
{\ri30 \li30 
{\b0 \cf1 \f2 \ri30 \i0 \ql \fs20 \li30 
{\field {\*\fldinst HYPERLINK "#co_g_ID0EQYAG_1" }{\fldrslt 
{\super \b0 \cf19 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
260
}\super \b0 \cf19 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 }}
\par 
}
}\b0 \cf1 \f2 \ri30 \i0 \ql \li30 \fs20 \intbl \cell \row }}\par 
}
}
}
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b1 \cf1 \f2 \ri0 \i0 \ql \fs20 \li0 
{\*\bkmkstart co_g_ID0ENCAE_1}{\*\bkmkend co_g_ID0ENCAE_1}
{\b1 \cf1 \f2 \ul0 \strike0 \i0 \fs20 
}
{\b1 \cf1 \f2 \i0 \fs20 
{\*\bkmkstart co_pp_sp_129177_241_1}{\*\bkmkend co_pp_sp_129177_241_1}
{\b1 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
*241
}
}
{\b1 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 I. 
}
{\b1 \cf1 \f2 \i0 \fs20 
{\b1 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa200 \sb200 
Introduction
\par 
}
}
}
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\*\bkmkstart co_g_ID0E3CAE_1}{\*\bkmkend co_g_ID0E3CAE_1}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
As a transformative technology, artificial intelligence (\u8220\'3fAI\u8221\'3f) promises revolutionary advances while simultaneously posing new risks to society.
}
{\b0 \cf1 \f2 \i0 \fs16 
{\*\bkmkstart co_fnRef_F1546934635_ID0EEDAE_1}{\*\bkmkend co_fnRef_F1546934635_ID0EEDAE_1}
{\field {\*\fldinst HYPERLINK "#co_footnote_F1546934635_1" }{\fldrslt 
{\super \b0 \cf19 \f2 \ul0 \strike0 \i0 \fs16 \sa0 \sb0 
1
}}}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 This Essay proposes a products liability conceptual framework that would tackle many of the regulatory challenges posed by AI and machine learning (\u8220\'3fML\u8221\'3f).
}
{\b0 \cf1 \f2 \i0 \fs16 
{\*\bkmkstart co_fnRef_F2546934635_ID0EKDAE_1}{\*\bkmkend co_fnRef_F2546934635_ID0EKDAE_1}
{\field {\*\fldinst HYPERLINK "#co_footnote_F2546934635_1" }{\fldrslt 
{\super \b0 \cf19 \f2 \ul0 \strike0 \i0 \fs16 \sa0 \sb0 
2
}}}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 It draws inspiration from the regulatory scheme governing medical products approved by the Food and Drug Administration (FDA), which includes both ex ante federal regulation and ex post products liability. FDA regulation of AI-enabled medical devices provides a particularly apt point of departure for consideration of a products liability framework for AI. The agency has been at the vanguard of revising its traditional paradigm for medical device regulation to fit adaptive AI/ML technologies, which continuously improve and modify devices based on data collected during use. However, this Essay further suggests that AI/ML technologies should inspire an even more significant regulatory paradigm shift away from a model that focuses on (and invests in) premarket approval to one that emphasizes ongoing postmarket surveillance.
}
{\b0 \cf1 \f2 \i0 \fs16 
{\*\bkmkstart co_fnRef_F3546934635_ID0EYDAE_1}{\*\bkmkend co_fnRef_F3546934635_ID0EYDAE_1}
{\field {\*\fldinst HYPERLINK "#co_footnote_F3546934635_1" }{\fldrslt 
{\super \b0 \cf19 \f2 \ul0 \strike0 \i0 \fs16 \sa0 \sb0 
3
}}}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 As such a model emerges, products liability should continue to play a significant role in information-forcing and deterrence, especially during the transition period before a new ex post regulatory framework for adaptive AI/ML technologies is in place.
\par 
}
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
\u160\'3f
\par 
}
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\*\bkmkstart co_g_ID0EBEAE_1}{\*\bkmkend co_g_ID0EBEAE_1}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
The turn to a products liability framework for AI is notable for (at least) two reasons. 
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
First, to date, legal commentators\rquote  focus has been elsewhere, as the 
}
{\b1 \cf1 \f2 \i0 \fs20 
{\*\bkmkstart co_pp_sp_129177_242_1}{\*\bkmkend co_pp_sp_129177_242_1}
{\b1 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
*242
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 proliferation of AI/ML has raised high-profile defamation and copyright legal issues, with products liability newly emergent on the scene.
}
{\b0 \cf1 \f2 \i0 \fs16 
{\*\bkmkstart co_fnRef_F4546934635_ID0EREAE_1}{\*\bkmkend co_fnRef_F4546934635_ID0EREAE_1}
{\field {\*\fldinst HYPERLINK "#co_footnote_F4546934635_1" }{\fldrslt 
{\super \b0 \cf19 \f2 \ul0 \strike0 \i0 \fs16 \sa0 \sb0 
4
}}}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 Second, commentators have suggested that the \u8220\'3flearning\u8221\'3f aspect of AI/ML demands an entirely new regulatory approach, without serious consideration of the extent to which products liability can adapt to face such a challenge.
\par 
}
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
\u160\'3f
\par 
}
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\*\bkmkstart co_g_ID0E1EAE_1}{\*\bkmkend co_g_ID0E1EAE_1}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
The 
}
{\b0 \cf1 \f2 \i1 \fs20 
{\b0 \cf1 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
Gonzalez v. Google
}
}
{\b0 \cf1 \f2 \i0 \fs16 
{\*\bkmkstart co_fnRef_F5546934635_ID0EJFAE_1}{\*\bkmkend co_fnRef_F5546934635_ID0EJFAE_1}
{\field {\*\fldinst HYPERLINK "#co_footnote_F5546934635_1" }{\fldrslt 
{\super \b0 \cf19 \f2 \ul0 \strike0 \i0 \fs16 \sa0 \sb0 
5
}}}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 case before the U.S. Supreme Court last Term illustrates a subtle turn in focus to products liability. The Court granted certiorari to consider whether a web service forfeits the protection of Section 230 of the Communications Decency Act,
}
{\b0 \cf1 \f2 \i0 \fs16 
{\*\bkmkstart co_fnRef_F6546934635_ID0EPFAE_1}{\*\bkmkend co_fnRef_F6546934635_ID0EPFAE_1}
{\field {\*\fldinst HYPERLINK "#co_footnote_F6546934635_1" }{\fldrslt 
{\super \b0 \cf19 \f2 \ul0 \strike0 \i0 \fs16 \sa0 \sb0 
6
}}}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 which immunizes web platforms from civil liability claims arising from third-party content, when it uses algorithmic recommendations (like the content that autoplays after YouTube videos) to organize and promote certain user-generated content.
}
{\b0 \cf1 \f2 \i0 \fs16 
{\*\bkmkstart co_fnRef_F7546934635_ID0EUFAE_1}{\*\bkmkend co_fnRef_F7546934635_ID0EUFAE_1}
{\field {\*\fldinst HYPERLINK "#co_footnote_F7546934635_1" }{\fldrslt 
{\super \b0 \cf19 \f2 \ul0 \strike0 \i0 \fs16 \sa0 \sb0 
7
}}}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 While the Court declined to decide that specific issue, it drew attention to looming defamation and copyright issues on the horizon. For example, AI-powered search engines (like Google\rquote s Bard and Microsoft\rquote s Bing) and large language models (\u8220\'3fLLMs\u8221\'3f) (like OpenAI\rquote s ChatGPT)
}
{\b0 \cf1 \f2 \i0 \fs16 
{\*\bkmkstart co_fnRef_F8546934635_ID0E1FAE_1}{\*\bkmkend co_fnRef_F8546934635_ID0E1FAE_1}
{\field {\*\fldinst HYPERLINK "#co_footnote_F8546934635_1" }{\fldrslt 
{\super \b0 \cf19 \f2 \ul0 \strike0 \i0 \fs16 \sa0 \sb0 
8
}}}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 are known to \u8220\'3fhallucinate\u8221\'3f and generate misleading or false information;
}
{\b0 \cf1 \f2 \i0 \fs16 
{\*\bkmkstart co_fnRef_F9546934635_ID0E4FAE_1}{\*\bkmkend co_fnRef_F9546934635_ID0E4FAE_1}
{\field {\*\fldinst HYPERLINK "#co_footnote_F9546934635_1" }{\fldrslt 
{\super \b0 \cf19 \f2 \ul0 \strike0 \i0 \fs16 \sa0 \sb0 
9
}}}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 if such mistakes cross the line into defamation, search providers could be at serious risk of lawsuits. Moreover, AI-generated content may expose developers to copyright infringement claims--which fall outside of Section 230\rquote s purview--as generative AI models are trained on vast swathes of copyrighted material that they sometimes reproduce without alteration or attribution.
}
{\b0 \cf1 \f2 \i0 \fs16 
{\*\bkmkstart co_fnRef_F10546934635_ID0EEGAE_1}{\*\bkmkend co_fnRef_F10546934635_ID0EEGAE_1}
{\field {\*\fldinst HYPERLINK "#co_footnote_F10546934635_1" }{\fldrslt 
{\super \b0 \cf19 \f2 \ul0 \strike0 \i0 \fs16 \sa0 \sb0 
10
}}}
\par 
}
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
\u160\'3f
\par 
}
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\*\bkmkstart co_g_ID0ELGAE_1}{\*\bkmkend co_g_ID0ELGAE_1}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
However, the most telling moment during the oral argument in 
}
{\b0 \cf1 \f2 \i1 \fs20 
{\b0 \cf1 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
Gonzalez
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
--at least to me--has received comparatively less attention than these looming 
}
{\b1 \cf1 \f2 \i0 \fs20 
{\*\bkmkstart co_pp_sp_129177_243_1}{\*\bkmkend co_pp_sp_129177_243_1}
{\b1 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
*243
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 copyright and defamation issues. At the tail end of her argument, Lisa Blatt, Google\rquote s attorney, admitted that she was far less concerned about losing Section 230 immunity for defamation claims than for products liability claims.
}
{\b0 \cf1 \f2 \i0 \fs16 
{\*\bkmkstart co_fnRef_F11546934635_ID0E4GAE_1}{\*\bkmkend co_fnRef_F11546934635_ID0E4GAE_1}
{\field {\*\fldinst HYPERLINK "#co_footnote_F11546934635_1" }{\fldrslt 
{\super \b0 \cf19 \f2 \ul0 \strike0 \i0 \fs16 \sa0 \sb0 
11
}}}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 Indeed, a host of pending cases allege that social media platforms are defectively designed, causing addiction and mental health issues among youths,
}
{\b0 \cf1 \f2 \i0 \fs16 
{\*\bkmkstart co_fnRef_F12546934635_ID0EAHAE_1}{\*\bkmkend co_fnRef_F12546934635_ID0EAHAE_1}
{\field {\*\fldinst HYPERLINK "#co_footnote_F12546934635_1" }{\fldrslt 
{\super \b0 \cf19 \f2 \ul0 \strike0 \i0 \fs16 \sa0 \sb0 
12
}}}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 and some courts have already rejected motions to dismiss such claims on the grounds that Section 230 prevents these platforms from being held liable for content created by their users.
}
{\b0 \cf1 \f2 \i0 \fs16 
{\*\bkmkstart co_fnRef_F13546934635_ID0EEHAE_1}{\*\bkmkend co_fnRef_F13546934635_ID0EEHAE_1}
{\field {\*\fldinst HYPERLINK "#co_footnote_F13546934635_1" }{\fldrslt 
{\super \b0 \cf19 \f2 \ul0 \strike0 \i0 \fs16 \sa0 \sb0 
13
}}}
\par 
}
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
\u160\'3f
\par 
}
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\*\bkmkstart co_g_ID0ELHAE_1}{\*\bkmkend co_g_ID0ELHAE_1}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
Even as the emergence of social media/AI cases pushes the boundaries of products liability, all too often critics dismiss the potential of a products liability framework for AI. They insist that society has never before faced such a seismic technological shift and that we thus need an entirely distinct approach to regulate harms generated by AI.
}
{\b0 \cf1 \f2 \i0 \fs16 
{\*\bkmkstart co_fnRef_F14546934635_ID0EWHAE_1}{\*\bkmkend co_fnRef_F14546934635_ID0EWHAE_1}
{\field {\*\fldinst HYPERLINK "#co_footnote_F14546934635_1" }{\fldrslt 
{\super \b0 \cf19 \f2 \ul0 \strike0 \i0 \fs16 \sa0 \sb0 
14
}}}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 Critics suggest that regulating AI/ML demands a unique regulatory approach because, as AI/ML technologies are sent out into the world and encounter new situations, they learn and change in real time.
}
{\b0 \cf1 \f2 \i0 \fs16 
{\*\bkmkstart co_fnRef_F15546934635_ID0E2HAE_1}{\*\bkmkend co_fnRef_F15546934635_ID0E2HAE_1}
{\field {\*\fldinst HYPERLINK "#co_footnote_F15546934635_1" }{\fldrslt 
{\super \b0 \cf19 \f2 \ul0 \strike0 \i0 \fs16 \sa0 \sb0 
15
}}}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 The implication is that this adaptive \u8220\'3flearning\u8221\'3f aspect of ML and the interactive aspect of generative AI pose challenges different in kind from those raised by any prior technology regulated by products liability. But such critics have failed to appreciate how robust 
}
{\b1 \cf1 \f2 \i0 \fs20 
{\*\bkmkstart co_pp_sp_129177_244_1}{\*\bkmkend co_pp_sp_129177_244_1}
{\b1 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
*244
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 a products liability framework (especially coupled with a regulatory framework) can be, and how it can embrace the learning and iterative aspects of AI/ML and generative AI technologies.
\par 
}
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
\u160\'3f
\par 
}
}
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b1 \cf1 \f2 \ri0 \i0 \ql \fs20 \li0 
{\*\bkmkstart co_g_ID0EMIAE_1}{\*\bkmkend co_g_ID0EMIAE_1}
{\b1 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
II. 
}
{\b1 \cf1 \f2 \i0 \fs20 
{\b1 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa200 \sb200 
A Products Liability Conceptual Framework
\par 
}
}
}
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\*\bkmkstart co_g_ID0EXIAE_1}{\*\bkmkend co_g_ID0EXIAE_1}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
Society faces new and uncertain risks from AI.
}
{\b0 \cf1 \f2 \i0 \fs16 
{\*\bkmkstart co_fnRef_F16546934635_ID0E6IAE_1}{\*\bkmkend co_fnRef_F16546934635_ID0E6IAE_1}
{\field {\*\fldinst HYPERLINK "#co_footnote_F16546934635_1" }{\fldrslt 
{\super \b0 \cf19 \f2 \ul0 \strike0 \i0 \fs16 \sa0 \sb0 
16
}}}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 Crafting a regulatory framework for AI using a products liability lens is the most promising approach to mitigate these risks. Products liability, as I have argued before,
}
{\b0 \cf1 \f2 \i0 \fs16 
{\*\bkmkstart co_fnRef_F17546934635_ID0EFJAE_1}{\*\bkmkend co_fnRef_F17546934635_ID0EFJAE_1}
{\field {\*\fldinst HYPERLINK "#co_footnote_F17546934635_1" }{\fldrslt 
{\super \b0 \cf19 \f2 \ul0 \strike0 \i0 \fs16 \sa0 \sb0 
17
}}}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 is a microcosm of how the common law evolves over time to respond to new societal risks--historically, those posed by the automobile, mass-produced goods, digital e-commerce, and now, emerging technologies like AI. At each juncture, common law judges explicitly relied on prevention and mitigation of harm, or \u8220\'3fcheapest cost avoider\u8221\'3f deterrence rationales, to expand products liability to address new risks and prevent them from materializing into harms and, in so doing, they recognized new forms of harms.
}
{\b0 \cf1 \f2 \i0 \fs16 
{\*\bkmkstart co_fnRef_F18546934635_ID0EMJAE_1}{\*\bkmkend co_fnRef_F18546934635_ID0EMJAE_1}
{\field {\*\fldinst HYPERLINK "#co_footnote_F18546934635_1" }{\fldrslt 
{\super \b0 \cf19 \f2 \ul0 \strike0 \i0 \fs16 \sa0 \sb0 
18
}}}
\par 
}
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
\u160\'3f
\par 
}
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\*\bkmkstart co_g_ID0ETJAE_1}{\*\bkmkend co_g_ID0ETJAE_1}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
Now is the right time to act to regulate AI. We can draw lessons from historical examples where society faced new and uncertain risks to demonstrate that, even when risks are uncertain or not entirely understood, tort liability can serve an information-production function during a \u8220\'3ftransitional period\u8221\'3f before an ex ante regulatory scheme is in place. This approach illustrates the essential feedback loop between tort liability and regulation, highlighting the ways in which tort liability can surface essential information on which regulators can act. Moreover, there are distinct dangers of holding off on tort liability and regulation, thereby creating a regulatory void into which private actors will race.
\par 
}
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
\u160\'3f
\par 
}
}
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b1 \cf1 \f2 \ri0 \i0 \ql \fs20 \li0 
{\*\bkmkstart co_g_ID0EIKAE_1}{\*\bkmkend co_g_ID0EIKAE_1}
{\b1 \cf1 \f2 \i1 \fs20 
{\b1 \cf1 \f2 \ul0 \strike0 \i1 \fs20 \sa200 \sb200 
A. The Feedback Loop Between Tort Liability and Regulation
\par 
}
}
}
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\*\bkmkstart co_g_ID0ESKAE_1}{\*\bkmkend co_g_ID0ESKAE_1}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
Few would gainsay that AI can pose risks to safety, but there is a great deal of uncertainty regarding the precise nature and scale of its potential risks and harms. The Office of Management and Budget\rquote s proposed guidance on President Biden\rquote s 
}
{\field {\*\fldinst HYPERLINK "https://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2077292919&pubNum=0001043&originatingDoc=I434c460335f011ef8921fbef1a541940&refType=CA&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b0 \cf19 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
Executive Order No. 14,110
}}}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
, \u8220\'3fSafe, Secure, and Trustworthy Development and Use of Artificial Intelligence,\u8221\'3f outlines uses of AI that are \u8220\'3fpresumed to be safety-impacting,\u8221\'3f which include \u8220\'3fmovements of a robotic appendage or body,\u8221\'3f \u8220\'3fmovements of vehicles,\u8221\'3f and \u8220\'3f[t]he design, construction, or testing of industrial 
}
{\b1 \cf1 \f2 \i0 \fs20 
{\*\bkmkstart co_pp_sp_129177_245_1}{\*\bkmkend co_pp_sp_129177_245_1}
{\b1 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
*245
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 equipment,\u8221\'3f among many other categories.
}
{\b0 \cf1 \f2 \i0 \fs16 
{\*\bkmkstart co_fnRef_F19546934635_ID0EFMAE_1}{\*\bkmkend co_fnRef_F19546934635_ID0EFMAE_1}
{\field {\*\fldinst HYPERLINK "#co_footnote_F19546934635_1" }{\fldrslt 
{\super \b0 \cf19 \f2 \ul0 \strike0 \i0 \fs16 \sa0 \sb0 
19
}}}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 These categories cover only the federal government\rquote s internal uses of AI. Regulating societal uses of AI would implicate AI-enabled medical (and other) products, which likewise risk causing potentially widespread physical and emotional harms, and generative AI models, which risk causing privacy and reputational harms by spreading misinformation.
\par 
}
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
\u160\'3f
\par 
}
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\*\bkmkstart co_g_ID0ERMAE_1}{\*\bkmkend co_g_ID0ERMAE_1}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
FDA Commissioner Robert Califf recently stated that LLMs are \u8220\'3fgoing to be transformative and [they\rquote ve] got to be regulated .... We\rquote ve met with the officials of the companies that are in the lead, and they want to be regulated. But even they don\rquote t really have good suggestions now on how to do it.\u8221\'3f
}
{\b0 \cf1 \f2 \i0 \fs16 
{\*\bkmkstart co_fnRef_F20546934635_ID0EINAE_1}{\*\bkmkend co_fnRef_F20546934635_ID0EINAE_1}
{\field {\*\fldinst HYPERLINK "#co_footnote_F20546934635_1" }{\fldrslt 
{\super \b0 \cf19 \f2 \ul0 \strike0 \i0 \fs16 \sa0 \sb0 
20
}}}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 This comment beautifully encapsulates the need for the common law of tort to play a \u8220\'3ftransitional\u8221\'3f role in addressing emerging risks when there is great uncertainty regarding how to regulate such risks. Emerging AI/ML technologies have \u8220\'3fgot to be regulated\u8221\'3f in some fashion and yet the most sophisticated market players \u8220\'3fdon\rquote t really have good suggestions on how to do it.\u8221\'3f
}
{\b0 \cf1 \f2 \i0 \fs16 
{\*\bkmkstart co_fnRef_F21546934635_ID0EZNAE_1}{\*\bkmkend co_fnRef_F21546934635_ID0EZNAE_1}
{\field {\*\fldinst HYPERLINK "#co_footnote_F21546934635_1" }{\fldrslt 
{\super \b0 \cf19 \f2 \ul0 \strike0 \i0 \fs16 \sa0 \sb0 
21
}}}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 As I have argued before,
}
{\b0 \cf1 \f2 \i0 \fs16 
{\*\bkmkstart co_fnRef_F22546934635_ID0E3NAE_1}{\*\bkmkend co_fnRef_F22546934635_ID0E3NAE_1}
{\field {\*\fldinst HYPERLINK "#co_footnote_F22546934635_1" }{\fldrslt 
{\super \b0 \cf19 \f2 \ul0 \strike0 \i0 \fs16 \sa0 \sb0 
22
}}}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 particularly in areas that pose emerging and incompletely understood health and safety risks, common law tort liability holds out the potential for a dynamic regulatory response, one that incentivizes gathering additional information about potential risks and means to mitigate or adapt to these risks. Tort law, in other words, could step in not only to fill the regulatory void emerging around AI/ML technologies but, even more so, to serve an essential information-production role, which is a necessary prerequisite for regulators to design an optimal policy strategy.
\par 
}
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
\u160\'3f
\par 
}
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\*\bkmkstart co_g_ID0EIOAE_1}{\*\bkmkend co_g_ID0EIOAE_1}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
Hydraulic fracturing, or fracking, provides a historical illustration of the regulatory challenge posed by a new, controversial practice with highly uncertain risks.
}
{\b0 \cf1 \f2 \i0 \fs16 
{\*\bkmkstart co_fnRef_F23546934635_ID0EQOAE_1}{\*\bkmkend co_fnRef_F23546934635_ID0EQOAE_1}
{\field {\*\fldinst HYPERLINK "#co_footnote_F23546934635_1" }{\fldrslt 
{\super \b0 \cf19 \f2 \ul0 \strike0 \i0 \fs16 \sa0 \sb0 
23
}}}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 When this technology emerged, there were many unknowns about the risks it posed to the environment, to groundwater, and to personal health.
}
{\b0 \cf1 \f2 \i0 \fs16 
{\*\bkmkstart co_fnRef_F24546934635_ID0EVOAE_1}{\*\bkmkend co_fnRef_F24546934635_ID0EVOAE_1}
{\field {\*\fldinst HYPERLINK "#co_footnote_F24546934635_1" }{\fldrslt 
{\super \b0 \cf19 \f2 \ul0 \strike0 \i0 \fs16 \sa0 \sb0 
24
}}}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 Crafting an ideal ex ante regulatory framework was nearly impossible given these uncertainties; 
}
{\b1 \cf1 \f2 \i0 \fs20 
{\*\bkmkstart co_pp_sp_129177_246_1}{\*\bkmkend co_pp_sp_129177_246_1}
{\b1 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
*246
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 moreover, overly hasty regulation might have hampered innovation or entrenched flawed incentives.
}
{\b0 \cf1 \f2 \i0 \fs16 
{\*\bkmkstart co_fnRef_F25546934635_ID0EGPAE_1}{\*\bkmkend co_fnRef_F25546934635_ID0EGPAE_1}
{\field {\*\fldinst HYPERLINK "#co_footnote_F25546934635_1" }{\fldrslt 
{\super \b0 \cf19 \f2 \ul0 \strike0 \i0 \fs16 \sa0 \sb0 
25
}}}
\par 
}
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
\u160\'3f
\par 
}
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\*\bkmkstart co_g_ID0ENPAE_1}{\*\bkmkend co_g_ID0ENPAE_1}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
Rather than settle for a potential regulatory void, tort liability can be relied on during a \u8220\'3ftransitional\u8221\'3f period, where harmed individuals come forward to sue and thereby serve an information-production function with regard to identifying and mitigating risks. Common law tort liability thereby allows for experimentation with various risk-minimization methods and remedial strategies until optimal approaches emerge, which can then be enshrined in more uniform regulations. Thus, it plays an essential role in the transition to an ex ante regulatory scheme.
\par 
}
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
\u160\'3f
\par 
}
}
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b1 \cf1 \f2 \ri0 \i0 \ql \fs20 \li0 
{\*\bkmkstart co_g_ID0EHQAE_1}{\*\bkmkend co_g_ID0EHQAE_1}
{\b1 \cf1 \f2 \i1 \fs20 
{\b1 \cf1 \f2 \ul0 \strike0 \i1 \fs20 \sa200 \sb200 
B. Products Liability as a Robust Conceptual Framework
\par 
}
}
}
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\*\bkmkstart co_g_ID0ERQAE_1}{\*\bkmkend co_g_ID0ERQAE_1}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
The affirmative case for products liability as a framework to regulate AI remains to be stated; here, I take a first stab at suggesting that such a framework is robust enough to handle both the learning and iterative aspects of AI/ML. Creative scholars have put forth competing frameworks, and, in the process, some have disparaged products liability. I thus respond to some of the naysayers.
\par 
}
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
\u160\'3f
\par 
}
}
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b1 \cf1 \f2 \ri0 \i0 \ql \fs20 \li0 
{\*\bkmkstart co_g_ID0EDRAE_1}{\*\bkmkend co_g_ID0EDRAE_1}
{\b1 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa200 \sb200 
1. Building the Affirmative Case for Products Liability
\par 
}
}
}
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b1 \cf1 \f2 \ri0 \i0 \ql \fs20 \li0 
{\*\bkmkstart co_g_ID0ENRAE_1}{\*\bkmkend co_g_ID0ENRAE_1}
{\b1 \cf1 \f2 \i1 \fs20 
{\b1 \cf1 \f2 \ul0 \strike0 \i1 \fs20 \sa200 \sb200 
a. Learning Aspect
\par 
}
}
}
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\*\bkmkstart co_g_ID0EXRAE_1}{\*\bkmkend co_g_ID0EXRAE_1}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
In developing a regulatory framework that reflects the learning aspect of AI/ML, we might draw on the lessons of regulating pharmaceutical drugs. To be sure, regulators have a considerable body of information regarding the benefits and risks of drugs before releasing them onto the market. The FDA requires manufacturers to conduct three phases of clinical trials and to submit evidence of the trials to the FDA, which engages in a stringent ex ante regulatory review for safety and efficacy.
}
{\b0 \cf1 \f2 \i0 \fs16 
{\*\bkmkstart co_fnRef_F26546934635_ID0ENSAE_1}{\*\bkmkend co_fnRef_F26546934635_ID0ENSAE_1}
{\field {\*\fldinst HYPERLINK "#co_footnote_F26546934635_1" }{\fldrslt 
{\super \b0 \cf19 \f2 \ul0 \strike0 \i0 \fs16 \sa0 \sb0 
26
}}}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 This premarket approval process is information-producing in 
}
{\b1 \cf1 \f2 \i0 \fs20 
{\*\bkmkstart co_pp_sp_129177_247_1}{\*\bkmkend co_pp_sp_129177_247_1}
{\b1 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
*247
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 the sense that it mandates that manufacturers conduct clinical testing and hand over data-driven studies to the FDA for review.
}
{\b0 \cf1 \f2 \i0 \fs16 
{\*\bkmkstart co_fnRef_F27546934635_ID0EWSAE_1}{\*\bkmkend co_fnRef_F27546934635_ID0EWSAE_1}
{\field {\*\fldinst HYPERLINK "#co_footnote_F27546934635_1" }{\fldrslt 
{\super \b0 \cf19 \f2 \ul0 \strike0 \i0 \fs16 \sa0 \sb0 
27
}}}
\par 
}
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
\u160\'3f
\par 
}
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\*\bkmkstart co_g_ID0E4SAE_1}{\*\bkmkend co_g_ID0E4SAE_1}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
But, notwithstanding this rigorous ex ante premarket review, there is still relatively little known about the properties of drugs, in particular given their interactions with the much larger and more diverse populations who will consume those drugs.
}
{\b0 \cf1 \f2 \i0 \fs16 
{\*\bkmkstart co_fnRef_F28546934635_ID0ENTAE_1}{\*\bkmkend co_fnRef_F28546934635_ID0ENTAE_1}
{\field {\*\fldinst HYPERLINK "#co_footnote_F28546934635_1" }{\fldrslt 
{\super \b0 \cf19 \f2 \ul0 \strike0 \i0 \fs16 \sa0 \sb0 
28
}}}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 Thus, once an FDA-approved drug is released onto the market, and is prescribed by doctors to a much larger population of individuals, we learn quite a lot about that drug\rquote s risks and benefits. A drug\rquote s interactions with multitudes of patients will produce new information regarding its properties and its safety and efficacy across different patient demographics.
\par 
}
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
\u160\'3f
\par 
}
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\*\bkmkstart co_g_ID0EZTAE_1}{\*\bkmkend co_g_ID0EZTAE_1}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
Given this \u8220\'3flearning,\u8221\'3f it is imperative to design a feedback loop whereby this new risk evidence, once unearthed, tweaks the regulatory framework. A manufacturer either has to go back to the FDA with this new evidence--whether it be about additional risks or a new use--and let the FDA weigh in on, for example, the addition of new warnings or the approval of new intended uses; or, if the manufacturer does not do so, then tort lawsuits should be available as a private mechanism of information-forcing and deterrence.
}
{\b0 \cf1 \f2 \i0 \fs16 
{\*\bkmkstart co_fnRef_F29546934635_ID0EDUAE_1}{\*\bkmkend co_fnRef_F29546934635_ID0EDUAE_1}
{\field {\*\fldinst HYPERLINK "#co_footnote_F29546934635_1" }{\fldrslt 
{\super \b0 \cf19 \f2 \ul0 \strike0 \i0 \fs16 \sa0 \sb0 
29
}}}
\par 
}
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
\u160\'3f
\par 
}
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\*\bkmkstart co_g_ID0EKUAE_1}{\*\bkmkend co_g_ID0EKUAE_1}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
In sum, a products liability framework can address the learning aspect of AI/ML. The regulatory framework for pharmaceutical drugs provides inspiration, as it demonstrates that tort liability can inform regulations by taking into account new risk evidence that becomes available only after a given product is released onto 
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 
}
{\b1 \cf1 \f2 \i0 \fs20 
{\*\bkmkstart co_pp_sp_129177_248_1}{\*\bkmkend co_pp_sp_129177_248_1}
{\b1 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
*248
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 the market. For this reason, notwithstanding the FDA\rquote s stringent ex ante premarket regulatory scrutiny, tort law still has an information-forcing and deterrence role, identifying new risks in the postmarket period.
\par 
}
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
\u160\'3f
\par 
}
}
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b1 \cf1 \f2 \ri0 \i0 \ql \fs20 \li0 
{\*\bkmkstart co_g_ID0EJVAE_1}{\*\bkmkend co_g_ID0EJVAE_1}
{\b1 \cf1 \f2 \i1 \fs20 
{\b1 \cf1 \f2 \ul0 \strike0 \i1 \fs20 \sa200 \sb200 
b. Interactive Aspect
\par 
}
}
}
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\*\bkmkstart co_g_ID0ETVAE_1}{\*\bkmkend co_g_ID0ETVAE_1}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
Generative AI models, such as ChatGPT, are distinct from other technologies due to their interactive nature. For example, they allow users to contribute by writing prompts. While this interactivity raises some vexing challenges, they differ more in degree than in kind from other complicated issues that products liability has tackled, such as liability for component parts manufacturers, or for manufacturers of a product to which another product is added down the line.
\par 
}
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
\u160\'3f
\par 
}
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\*\bkmkstart co_g_ID0EFWAE_1}{\*\bkmkend co_g_ID0EFWAE_1}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
To take one illustrative example--high-profile, if atypical given that it involves the U.S. Supreme Court confronting state tort law--in 2019, in 
}
{\b0 \cf1 \f2 \i1 \fs20 
{\b0 \cf1 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
Air & Liquid Systems Corp. v. DeVries
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
, the Court considered whether the manufacturer of a \u8220\'3fbare-metal\u8221\'3f product such as a turbine, blower, or pump has a duty to warn of dangers arising from the later incorporation of asbestos-laden parts into the product.
}
{\b0 \cf1 \f2 \i0 \fs16 
{\*\bkmkstart co_fnRef_F30546934635_ID0EWWAE_1}{\*\bkmkend co_fnRef_F30546934635_ID0EWWAE_1}
{\field {\*\fldinst HYPERLINK "#co_footnote_F30546934635_1" }{\fldrslt 
{\super \b0 \cf19 \f2 \ul0 \strike0 \i0 \fs16 \sa0 \sb0 
30
}}}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 To answer this question, the Justices turned to first principles from tort theory. In a 6-3 decision, Justice Brett Kavanaugh, drawing heavily from Judge Guido Calabresi\rquote s \u8220\'3fcheapest cost avoider\u8221\'3f theory, held for the majority that the bare-metal product manufacturer did have a duty to warn, reasoning that \u8220\'3fthe product manufacturer will often be in a better position than the parts manufacturer to warn of the danger from the integrated product.\u8221\'3f
}
{\b0 \cf1 \f2 \i0 \fs16 
{\*\bkmkstart co_fnRef_F31546934635_ID0EHXAE_1}{\*\bkmkend co_fnRef_F31546934635_ID0EHXAE_1}
{\field {\*\fldinst HYPERLINK "#co_footnote_F31546934635_1" }{\fldrslt 
{\super \b0 \cf19 \f2 \ul0 \strike0 \i0 \fs16 \sa0 \sb0 
31
}}}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 Justice Neil Gorsuch\rquote s dissent likewise hinged on Judge Calabresi\rquote s cheapest cost avoider theory but reasoned that the subsequent parts manufacturer is the one that \u8220\'3fis in the best position to understand and warn users about its risks; in the language of law and economics, those who make products are generally the least-cost avoiders of their risks.\u8221\'3f
}
{\b0 \cf1 \f2 \i0 \fs16 
{\*\bkmkstart co_fnRef_F32546934635_ID0EVXAE_1}{\*\bkmkend co_fnRef_F32546934635_ID0EVXAE_1}
{\field {\*\fldinst HYPERLINK "#co_footnote_F32546934635_1" }{\fldrslt 
{\super \b0 \cf19 \f2 \ul0 \strike0 \i0 \fs16 \sa0 \sb0 
32
}}}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 While the majority and the dissent disagreed as to which party--the bare-metal product manufacturer or the subsequent parts manufacturer--was in fact the cheapest cost avoider, they were unanimous in using the lens of law-and-economics, incentive-driven tort theory.
}
{\b0 \cf1 \f2 \i0 \fs16 
{\*\bkmkstart co_fnRef_F33546934635_ID0E1XAE_1}{\*\bkmkend co_fnRef_F33546934635_ID0E1XAE_1}
{\field {\*\fldinst HYPERLINK "#co_footnote_F33546934635_1" }{\fldrslt 
{\super \b0 \cf19 \f2 \ul0 \strike0 \i0 \fs16 \sa0 \sb0 
33
}}}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 So, we have a well-established framework for decision-making, even though courts may disagree about how to apply it.
\par 
}
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
\u160\'3f
\par 
}
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\*\bkmkstart co_g_ID0EDYAE_1}{\*\bkmkend co_g_ID0EDYAE_1}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
A similar approach could be applied to interactive AI/ML technologies if users are understood as contributing to the product down the line. Moreover, the cheapest cost avoider framework bypasses attribution issues created by the AI \u8220\'3fblack box\u8221\'3f because it aims to reduce the societal cost of accidents. Instead of attempting to attribute each AI output to a single party, courts would focus on whether the 
}
{\b1 \cf1 \f2 \i0 \fs20 
{\*\bkmkstart co_pp_sp_129177_249_1}{\*\bkmkend co_pp_sp_129177_249_1}
{\b1 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
*249
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 interactive user or the AI developer is in the best position to mitigate or prevent harms.
}
{\b0 \cf1 \f2 \i0 \fs16 
{\*\bkmkstart co_fnRef_F34546934635_ID0EVYAE_1}{\*\bkmkend co_fnRef_F34546934635_ID0EVYAE_1}
{\field {\*\fldinst HYPERLINK "#co_footnote_F34546934635_1" }{\fldrslt 
{\super \b0 \cf19 \f2 \ul0 \strike0 \i0 \fs16 \sa0 \sb0 
34
}}}
\par 
}
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
\u160\'3f
\par 
}
}
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b1 \cf1 \f2 \ri0 \i0 \ql \fs20 \li0 
{\*\bkmkstart co_g_ID0E3YAE_1}{\*\bkmkend co_g_ID0E3YAE_1}
{\b1 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa200 \sb200 
2. Responding to the Naysayers
\par 
}
}
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\*\bkmkstart co_g_ID0EGZAE_1}{\*\bkmkend co_g_ID0EGZAE_1}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
Two scholars have taken up the gauntlet of resisting a products liability framework for AI. An early mover in the AI space, Professor Ryan Abbott, argues that acts of \u8220\'3fautonomous computer tortfeasors\u8221\'3f should be assessed under a negligence framework where the computer is playing the role of a reasonable person and automation will increase safety.
}
{\b0 \cf1 \f2 \i0 \fs16 
{\*\bkmkstart co_fnRef_F35546934635_ID0ERZAE_1}{\*\bkmkend co_fnRef_F35546934635_ID0ERZAE_1}
{\field {\*\fldinst HYPERLINK "#co_footnote_F35546934635_1" }{\fldrslt 
{\super \b0 \cf19 \f2 \ul0 \strike0 \i0 \fs16 \sa0 \sb0 
35
}}}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 Also advocating for a negligence framework, but moving away from the nebulous \u8220\'3freasonable person\u8221\'3f standard, Professor Bryan Choi argues that we should draw on professional malpractice law to create a framework for regulating AI developers.
}
{\b0 \cf1 \f2 \i0 \fs16 
{\*\bkmkstart co_fnRef_F36546934635_ID0EVZAE_1}{\*\bkmkend co_fnRef_F36546934635_ID0EVZAE_1}
{\field {\*\fldinst HYPERLINK "#co_footnote_F36546934635_1" }{\fldrslt 
{\super \b0 \cf19 \f2 \ul0 \strike0 \i0 \fs16 \sa0 \sb0 
36
}}}
\par 
}
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
\u160\'3f
\par 
}
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\*\bkmkstart co_g_ID0E3ZAE_1}{\*\bkmkend co_g_ID0E3ZAE_1}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
Abbott rejects a products liability framework for AI on two grounds. First, he argues that we should not regulate computers as products subject to strict liability (instead of negligence) because doing so would hamper socially valuable AI innovation, as 
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
\u8220\'3f[i]t is easier to establish strict liability than negligence\u8221\'3f since the former does not require showing intent.
}
{\b0 \cf1 \f2 \i0 \fs16 
{\*\bkmkstart co_fnRef_F37546934635_ID0EQ1AE_1}{\*\bkmkend co_fnRef_F37546934635_ID0EQ1AE_1}
{\field {\*\fldinst HYPERLINK "#co_footnote_F37546934635_1" }{\fldrslt 
{\super \b0 \cf19 \f2 \ul0 \strike0 \i0 \fs16 \sa0 \sb0 
37
}}}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 While Abbott acknowledges that the promise and peril of automation is up for debate,
}
{\b0 \cf1 \f2 \i0 \fs16 
{\*\bkmkstart co_fnRef_F38546934635_ID0ET1AE_1}{\*\bkmkend co_fnRef_F38546934635_ID0ET1AE_1}
{\field {\*\fldinst HYPERLINK "#co_footnote_F38546934635_1" }{\fldrslt 
{\super \b0 \cf19 \f2 \ul0 \strike0 \i0 \fs16 \sa0 \sb0 
38
}}}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 his advocacy for negligence liability relies on it incentivizing the adoption of iteratively safer technologies, like self-driving cars that are ten- or one hundred-times safer than human drivers.
}
{\b0 \cf1 \f2 \i0 \fs16 
{\*\bkmkstart co_fnRef_F39546934635_ID0EY1AE_1}{\*\bkmkend co_fnRef_F39546934635_ID0EY1AE_1}
{\field {\*\fldinst HYPERLINK "#co_footnote_F39546934635_1" }{\fldrslt 
{\super \b0 \cf19 \f2 \ul0 \strike0 \i0 \fs16 \sa0 \sb0 
39
}}}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 Second, Abbott argues that \u8220\'3f[c]omputers are no longer just inert tools directed by individuals. Rather, in at least some instances, computers are taking over activities once performed by people and ... stepping into the shoes of a reasonable person.\u8221\'3f
}
{\b0 \cf1 \f2 \i0 \fs16 
{\*\bkmkstart co_fnRef_F40546934635_ID0EL2AE_1}{\*\bkmkend co_fnRef_F40546934635_ID0EL2AE_1}
{\field {\*\fldinst HYPERLINK "#co_footnote_F40546934635_1" }{\fldrslt 
{\super \b0 \cf19 \f2 \ul0 \strike0 \i0 \fs16 \sa0 \sb0 
40
}}}
\par 
}
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
\u160\'3f
\par 
}
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\*\bkmkstart co_g_ID0ES2AE_1}{\*\bkmkend co_g_ID0ES2AE_1}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
However, Abbott fails to appreciate how products liability fosters incentives to take care. For instance, it would enable liability if consumers came to expect self-driving cars to be inhumanly safe or if one could slightly reduce risk at scale 
}
{\b1 \cf1 \f2 \i0 \fs20 
{\*\bkmkstart co_pp_sp_129177_250_1}{\*\bkmkend co_pp_sp_129177_250_1}
{\b1 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
*250
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 through a reasonable alternative design.
}
{\b0 \cf1 \f2 \i0 \fs16 
{\*\bkmkstart co_fnRef_F41546934635_ID0EC3AE_1}{\*\bkmkend co_fnRef_F41546934635_ID0EC3AE_1}
{\field {\*\fldinst HYPERLINK "#co_footnote_F41546934635_1" }{\fldrslt 
{\super \b0 \cf19 \f2 \ul0 \strike0 \i0 \fs16 \sa0 \sb0 
41
}}}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 Moreover, the dominant test for design defects is a negligence-inflected risk-utility balancing test (whether or not the more demanding version of risk-utility, namely the reasonable alternative design formulation favored by the 
}
{\b0 \cf1 \f2 \i1 \fs20 
{\b0 \cf1 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
Restatement (Third) of Torts: Products Liability
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
, is adopted). And, as Professors Chinmayi Sharma and Benjamin Zipursky have highlighted in arguing for federal legislation to impose products liability rather than negligence for software security, \u8220\'3f[b]y focusing on the fault in the product--the potential defect--rather than the faultiness of the defendant\rquote s practices, products liability chooses forward-looking proactivity rather than backward-looking conventionalism.\u8221\'3f
}
{\b0 \cf1 \f2 \i0 \fs16 
{\*\bkmkstart co_fnRef_F42546934635_ID0EU3AE_1}{\*\bkmkend co_fnRef_F42546934635_ID0EU3AE_1}
{\field {\*\fldinst HYPERLINK "#co_footnote_F42546934635_1" }{\fldrslt 
{\super \b0 \cf19 \f2 \ul0 \strike0 \i0 \fs16 \sa0 \sb0 
42
}}}
\par 
}
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
\u160\'3f
\par 
}
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\*\bkmkstart co_g_ID0E23AE_1}{\*\bkmkend co_g_ID0E23AE_1}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
Choi criticizes the products liability framework for \u8220\'3fevaluating the AI system as a discrete entity or object, while minimizing the human processes behind the development of that AI system.\u8221\'3f
}
{\b0 \cf1 \f2 \i0 \fs16 
{\*\bkmkstart co_fnRef_F43546934635_ID0EM4AE_1}{\*\bkmkend co_fnRef_F43546934635_ID0EM4AE_1}
{\field {\*\fldinst HYPERLINK "#co_footnote_F43546934635_1" }{\fldrslt 
{\super \b0 \cf19 \f2 \ul0 \strike0 \i0 \fs16 \sa0 \sb0 
43
}}}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 But, a products liability framework in no way precludes consideration of \u8220\'3fhuman processes.\u8221\'3f For example, manufacturing defects often relate to human errors made in production. Similarly, design decisions always occur in the shadow of the law, namely, potential liability in the form of the consumer expectations and risk-utility tests, which hinge on the attitudes and product use of reasonable humans, respectively. Moreover, choices AI developers make, which range from identifying hyperparameters to cleaning training data to testing models,
}
{\b0 \cf1 \f2 \i0 \fs16 
{\*\bkmkstart co_fnRef_F44546934635_ID0EY4AE_1}{\*\bkmkend co_fnRef_F44546934635_ID0EY4AE_1}
{\field {\*\fldinst HYPERLINK "#co_footnote_F44546934635_1" }{\fldrslt 
{\super \b0 \cf19 \f2 \ul0 \strike0 \i0 \fs16 \sa0 \sb0 
44
}}}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 could be cited in support of a products liability claim.
\par 
}
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
\u160\'3f
\par 
}
}
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b1 \cf1 \f2 \ri0 \i0 \ql \fs20 \li0 
{\*\bkmkstart co_g_ID0EB5AE_1}{\*\bkmkend co_g_ID0EB5AE_1}
{\b1 \cf1 \f2 \i1 \fs20 
{\b1 \cf1 \f2 \ul0 \strike0 \i1 \fs20 \sa200 \sb200 
C. Why Involve a Regulator Now?
\par 
}
}
}
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\*\bkmkstart co_g_ID0EL5AE_1}{\*\bkmkend co_g_ID0EL5AE_1}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
There are perils in waiting too long to regulate risks posed by emerging technologies. The saga of direct-to-consumer genetic testing provides a cautionary tale. The FDA initially held off regulating these tests--considered by some to be information that falls within the category of \u8220\'3fthe practice of medicine\u8221\'3f not regulated by the FDA--and belatedly decided to regulate them as medical products, 
}
{\b1 \cf1 \f2 \i0 \fs20 
{\*\bkmkstart co_pp_sp_129177_251_1}{\*\bkmkend co_pp_sp_129177_251_1}
{\b1 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
*251
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 given the risks they posed.
}
{\b0 \cf1 \f2 \i0 \fs16 
{\*\bkmkstart co_fnRef_F45546934635_ID0E55AE_1}{\*\bkmkend co_fnRef_F45546934635_ID0E55AE_1}
{\field {\*\fldinst HYPERLINK "#co_footnote_F45546934635_1" }{\fldrslt 
{\super \b0 \cf19 \f2 \ul0 \strike0 \i0 \fs16 \sa0 \sb0 
45
}}}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 But, meanwhile, the private company 23&Me had amassed a large private database of highly sensitive genetic information, giving it an edge over new entrants to the market and potentially hampering future competition. Similarly, when it comes to regulating data-hungry AI, it is prudent to consider the role of the FDA not only as a safety regulator but also as a medical information regulator.
}
{\b0 \cf1 \f2 \i0 \fs16 
{\*\bkmkstart co_fnRef_F46546934635_ID0EF6AE_1}{\*\bkmkend co_fnRef_F46546934635_ID0EF6AE_1}
{\field {\*\fldinst HYPERLINK "#co_footnote_F46546934635_1" }{\fldrslt 
{\super \b0 \cf19 \f2 \ul0 \strike0 \i0 \fs16 \sa0 \sb0 
46
}}}
\par 
}
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
\u160\'3f
\par 
}
}
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b1 \cf1 \f2 \ri0 \i0 \ql \fs20 \li0 
{\*\bkmkstart co_g_ID0EM6AE_1}{\*\bkmkend co_g_ID0EM6AE_1}
{\b1 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
III. 
}
{\b1 \cf1 \f2 \i0 \fs20 
{\b1 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa200 \sb200 
A Point Of Departure: AI-Enabled Medical Products
\par 
}
}
}
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\*\bkmkstart co_g_ID0EX6AE_1}{\*\bkmkend co_g_ID0EX6AE_1}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
My overarching goal in this Essay is to put forward a products liability conceptual framework for the regulation of AI. The FDA\rquote s evolving regulatory landscape for AI is an auspicious starting point for thinking about the viability of a products liability framework for the regulation of AI.
\par 
}
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
\u160\'3f
\par 
}
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\*\bkmkstart co_g_ID0EHAAG_1}{\*\bkmkend co_g_ID0EHAAG_1}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
In this Part, as a jumping off point to consider potential regulation of AI, I showcase how high-risk medical products, such as medical devices that incorporate AI/ML, are subject to a nuanced regime of ex ante federal regulation by the FDA and ex post products liability. Under a products liability framework, courts would pin liability on the \u8220\'3fcheapest cost avoider\u8221\'3f to mitigate AI harms stemming from design defects and failures to warn. Courts would also need to consider the interplay between federal regulation and common law products liability. Finally, I consider the extent to which liability insurance may play a role in shaping the contours of the development of products liability in this realm.
\par 
}
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
\u160\'3f
\par 
}
}
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b1 \cf1 \f2 \ri0 \i0 \ql \fs20 \li0 
{\*\bkmkstart co_g_ID0EEBAG_1}{\*\bkmkend co_g_ID0EEBAG_1}
{\b1 \cf1 \f2 \i1 \fs20 
{\b1 \cf1 \f2 \ul0 \strike0 \i1 \fs20 \sa200 \sb200 
A. The FDA\rquote s Regulation of AI-Enabled Medical Devices
\par 
}
}
}
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\*\bkmkstart co_g_ID0EOBAG_1}{\*\bkmkend co_g_ID0EOBAG_1}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
In recent years, the FDA has made AI an area of particular focus:
}
{\b0 \cf1 \f2 \i0 \fs16 
{\*\bkmkstart co_fnRef_F47546934635_ID0EUBAG_1}{\*\bkmkend co_fnRef_F47546934635_ID0EUBAG_1}
{\field {\*\fldinst HYPERLINK "#co_footnote_F47546934635_1" }{\fldrslt 
{\super \b0 \cf19 \f2 \ul0 \strike0 \i0 \fs16 \sa0 \sb0 
47
}}}
\par 
}
}
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ri400 \i0 \qj \fs20 \li700 
{\b0 \cf1 \f2 \ri400 \i0 \qj \fs20 \li700 
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 
}
{\b1 \cf1 \f2 \i0 \fs20 
{\*\bkmkstart co_pp_sp_129177_252_1}{\*\bkmkend co_pp_sp_129177_252_1}
{\b1 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
*252
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa200 \sb400 
 As technology continues to advance every aspect of health care, software incorporating artificial intelligence (AI), and specifically the subset of AI known as machine learning (ML), has become an important part of an increasing number of medical devices. One of the greatest potential benefits of AI/ML resides in its ability to create new and important insights from the vast amount of data generated during the delivery of health care every day. Digital health technologies are playing an increasingly significant role in many facets of our health and daily lives, and AI/ML is powering important advancements in this field. Ensuring that these innovative devices are safe and effective, and that they can reach their full potential to help people, is central to the FDA\rquote s public health mission.
}
{\b0 \cf1 \f2 \i0 \fs16 
{\*\bkmkstart co_fnRef_F48546934635_ID0EMCAG_1}{\*\bkmkend co_fnRef_F48546934635_ID0EMCAG_1}
{\field {\*\fldinst HYPERLINK "#co_footnote_F48546934635_1" }{\fldrslt 
{\super \b0 \cf19 \f2 \ul0 \strike0 \i0 \fs16 \sa0 \sb0 
48
}}}
\sb200 
\par 
}
}
}
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
\u160\'3f
\par 
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
\u160\'3f
\par 
}
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\*\bkmkstart co_g_ID0ETCAG_1}{\*\bkmkend co_g_ID0ETCAG_1}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
Moreover, the FDA is by no means new to regulating AI. Going back nearly three decades, the FDA has granted marketing authorizations for roughly 700 AI/ML-enabled medical devices; the vast majority of devices are radiological or cardiovascular, and the AI/ML models underpinning them range widely in complexity.
}
{\b0 \cf1 \f2 \i0 \fs16 
{\*\bkmkstart co_fnRef_F49546934635_ID0E5CAG_1}{\*\bkmkend co_fnRef_F49546934635_ID0E5CAG_1}
{\field {\*\fldinst HYPERLINK "#co_footnote_F49546934635_1" }{\fldrslt 
{\super \b0 \cf19 \f2 \ul0 \strike0 \i0 \fs16 \sa0 \sb0 
49
}}}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 The FDA has also been active in developing action plans, engaging industry, issuing guidance documents, and devoting an increasing number of resources to oversee this growing area. For instance, the FDA extended its device 
}
{\b1 \cf1 \f2 \i0 \fs20 
{\*\bkmkstart co_pp_sp_129177_253_1}{\*\bkmkend co_pp_sp_129177_253_1}
{\b1 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
*253
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 regulations to govern software intended for medical purposes
}
{\b0 \cf1 \f2 \i0 \fs16 
{\*\bkmkstart co_fnRef_F50546934635_ID0EJDAG_1}{\*\bkmkend co_fnRef_F50546934635_ID0EJDAG_1}
{\field {\*\fldinst HYPERLINK "#co_footnote_F50546934635_1" }{\fldrslt 
{\super \b0 \cf19 \f2 \ul0 \strike0 \i0 \fs16 \sa0 \sb0 
50
}}}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 and released an action plan governing related AI/ML applications.
}
{\b0 \cf1 \f2 \i0 \fs16 
{\*\bkmkstart co_fnRef_F51546934635_ID0ENDAG_1}{\*\bkmkend co_fnRef_F51546934635_ID0ENDAG_1}
{\field {\*\fldinst HYPERLINK "#co_footnote_F51546934635_1" }{\fldrslt 
{\super \b0 \cf19 \f2 \ul0 \strike0 \i0 \fs16 \sa0 \sb0 
51
}}}
\par 
}
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
\u160\'3f
\par 
}
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\*\bkmkstart co_g_ID0EUDAG_1}{\*\bkmkend co_g_ID0EUDAG_1}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
The FDA has recognized that novel AI/ML-enabled medical devices warrant a novel regulatory approach.
}
{\b0 \cf1 \f2 \i0 \fs16 
{\*\bkmkstart co_fnRef_F52546934635_ID0E3DAG_1}{\*\bkmkend co_fnRef_F52546934635_ID0E3DAG_1}
{\field {\*\fldinst HYPERLINK "#co_footnote_F52546934635_1" }{\fldrslt 
{\super \b0 \cf19 \f2 \ul0 \strike0 \i0 \fs16 \sa0 \sb0 
52
}}}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 Perhaps most significantly, this new paradigm must be aimed at mitigating risks over the entire lifecycle of the ever-changing devices.
}
{\b0 \cf1 \f2 \i0 \fs16 
{\*\bkmkstart co_fnRef_F53546934635_ID0EBEAG_1}{\*\bkmkend co_fnRef_F53546934635_ID0EBEAG_1}
{\field {\*\fldinst HYPERLINK "#co_footnote_F53546934635_1" }{\fldrslt 
{\super \b0 \cf19 \f2 \ul0 \strike0 \i0 \fs16 \sa0 \sb0 
53
}}}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 That said, a word of caution is in order: \u8220\'3f[t]he landscape of FDA oversight of AI/ML-enabled medical devices is dynamic, and the only constant that industry should expect in the coming years is change.\u8221\'3f
}
{\b0 \cf1 \f2 \i0 \fs16 
{\*\bkmkstart co_fnRef_F54546934635_ID0EPEAG_1}{\*\bkmkend co_fnRef_F54546934635_ID0EPEAG_1}
{\field {\*\fldinst HYPERLINK "#co_footnote_F54546934635_1" }{\fldrslt 
{\super \b0 \cf19 \f2 \ul0 \strike0 \i0 \fs16 \sa0 \sb0 
54
}}}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 AI/ML regulatory principles are seemingly in greater flux and progressing at a faster rate than any other area of FDA regulatory oversight.
\par 
}
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
\u160\'3f
\par 
}
}
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b1 \cf1 \f2 \ri0 \i0 \ql \fs20 \li0 
{\*\bkmkstart co_g_ID0EYEAG_1}{\*\bkmkend co_g_ID0EYEAG_1}
{\b1 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa200 \sb200 
1. AI/ML
\par 
}
}
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\*\bkmkstart co_g_ID0ECFAG_1}{\*\bkmkend co_g_ID0ECFAG_1}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
AI/ML-enabled medical devices are products \u8220\'3fintended to treat, diagnose, cure, mitigate, or prevent disease\u8221\'3f that use algorithms to perform their intended medical purposes.
}
{\b0 \cf1 \f2 \i0 \fs16 
{\*\bkmkstart co_fnRef_F55546934635_ID0ETFAG_1}{\*\bkmkend co_fnRef_F55546934635_ID0ETFAG_1}
{\field {\*\fldinst HYPERLINK "#co_footnote_F55546934635_1" }{\fldrslt 
{\super \b0 \cf19 \f2 \ul0 \strike0 \i0 \fs16 \sa0 \sb0 
55
}}}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 The FDA grants marketing authorization for medical devices that pass one of three premarket review pathways: (1) the rigorous premarket approval (\u8220\'3fPMA\u8221\'3f) process; (2) the more streamlined premarket notification (\u8220\'3fPMN\u8221\'3f) or 510(k) clearance (for devices substantially similar to ones already on the market); and (3) de novo classification (for novel devices with low to moderate risk).
}
{\b0 \cf1 \f2 \i0 \fs16 
{\*\bkmkstart co_fnRef_F56546934635_ID0EZFAG_1}{\*\bkmkend co_fnRef_F56546934635_ID0EZFAG_1}
{\field {\*\fldinst HYPERLINK "#co_footnote_F56546934635_1" }{\fldrslt 
{\super \b0 \cf19 \f2 \ul0 \strike0 \i0 \fs16 \sa0 \sb0 
56
}}}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 Initially, the FDA only approved AI/ML-enabled devices with \u8220\'3flocked algorithms,\u8221\'3f the code and outputs of which do not change with use, as such changes would likely 
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 
}
{\b1 \cf1 \f2 \i0 \fs20 
{\*\bkmkstart co_pp_sp_129177_254_1}{\*\bkmkend co_pp_sp_129177_254_1}
{\b1 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
*254
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 require further regulatory approval.
}
{\b0 \cf1 \f2 \i0 \fs16 
{\*\bkmkstart co_fnRef_F57546934635_ID0EDGAG_1}{\*\bkmkend co_fnRef_F57546934635_ID0EDGAG_1}
{\field {\*\fldinst HYPERLINK "#co_footnote_F57546934635_1" }{\fldrslt 
{\super \b0 \cf19 \f2 \ul0 \strike0 \i0 \fs16 \sa0 \sb0 
57
}}}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 For instance, the FDA first granted PMA approval to an AI/ML-enabled medical device in 1995 when it approved the PAPNET Testing System, a semi-automated test that assists in rescreening negative cervical smears and detecting cervical epithelial abnormalities in order to support clinician decision-making.
}
{\b0 \cf1 \f2 \i0 \fs16 
{\*\bkmkstart co_fnRef_F58546934635_ID0EIGAG_1}{\*\bkmkend co_fnRef_F58546934635_ID0EIGAG_1}
{\field {\*\fldinst HYPERLINK "#co_footnote_F58546934635_1" }{\fldrslt 
{\super \b0 \cf19 \f2 \ul0 \strike0 \i0 \fs16 \sa0 \sb0 
58
}}}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 More recently, the FDA has begun approving increasingly complex and autonomous AI/ML-enabled systems that \u8220\'3flearn\u8221\'3f and adapt based on data inputs and analyses; for example, in 2018, it granted de novo classification to the first autonomous AI/ML-powered diagnostic device, the IDx-DR software, which uses AI for the early detection of diabetic retinopathy.
}
{\b0 \cf1 \f2 \i0 \fs16 
{\*\bkmkstart co_fnRef_F59546934635_ID0EMGAG_1}{\*\bkmkend co_fnRef_F59546934635_ID0EMGAG_1}
{\field {\*\fldinst HYPERLINK "#co_footnote_F59546934635_1" }{\fldrslt 
{\super \b0 \cf19 \f2 \ul0 \strike0 \i0 \fs16 \sa0 \sb0 
59
}}}
\par 
}
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
\u160\'3f
\par 
}
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\*\bkmkstart co_g_ID0ETGAG_1}{\*\bkmkend co_g_ID0ETGAG_1}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
The FDA has answered the question--long beguiling products liability law-- whether software is a product or a service: it regulates software as a medical device (i.e., a product).
}
{\b0 \cf1 \f2 \i0 \fs16 
{\*\bkmkstart co_fnRef_F60546934635_ID0E3GAG_1}{\*\bkmkend co_fnRef_F60546934635_ID0E3GAG_1}
{\field {\*\fldinst HYPERLINK "#co_footnote_F60546934635_1" }{\fldrslt 
{\super \b0 \cf19 \f2 \ul0 \strike0 \i0 \fs16 \sa0 \sb0 
60
}}}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 In April 2019, the FDA proposed regulating AI/ML-enabled software as a medical device (\u8220\'3fSaMD\u8221\'3f) and sought feedback about issues such as premarket review of AI/ML-enabled medical devices, governance frameworks for adaptive SaMD systems, and the role of lifecycle monitoring.
}
{\b0 \cf1 \f2 \i0 \fs16 
{\*\bkmkstart co_fnRef_F61546934635_ID0EBHAG_1}{\*\bkmkend co_fnRef_F61546934635_ID0EBHAG_1}
{\field {\*\fldinst HYPERLINK "#co_footnote_F61546934635_1" }{\fldrslt 
{\super \b0 \cf19 \f2 \ul0 \strike0 \i0 \fs16 \sa0 \sb0 
61
}}}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 After receiving a significant amount of feedback, the FDA published its \u8220\'3fArtificial Intelligence/Machine Learning (AI/ML)-Based Software as a Medical Device (SaMD) Action Plan\u8221\'3f in January 2021.
}
{\b0 \cf1 \f2 \i0 \fs16 
{\*\bkmkstart co_fnRef_F62546934635_ID0EPHAG_1}{\*\bkmkend co_fnRef_F62546934635_ID0EPHAG_1}
{\field {\*\fldinst HYPERLINK "#co_footnote_F62546934635_1" }{\fldrslt 
{\super \b0 \cf19 \f2 \ul0 \strike0 \i0 \fs16 \sa0 \sb0 
62
}}}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 The five-part plan sought to create a new regulatory paradigm for AI/ML-enabled SaMD that facilitates certain postmarket changes; harmonizes principles for good AI/ML design; increases patient transparency about AI/ML data sources, training methods, risks, etc.; supports technical methods that reduce AI bias; and incorporates real-world performance 
}
{\b1 \cf1 \f2 \i0 \fs20 
{\*\bkmkstart co_pp_sp_129177_255_1}{\*\bkmkend co_pp_sp_129177_255_1}
{\b1 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
*255
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 metrics into FDA monitoring.
}
{\b0 \cf1 \f2 \i0 \fs16 
{\*\bkmkstart co_fnRef_F63546934635_ID0EZHAG_1}{\*\bkmkend co_fnRef_F63546934635_ID0EZHAG_1}
{\field {\*\fldinst HYPERLINK "#co_footnote_F63546934635_1" }{\fldrslt 
{\super \b0 \cf19 \f2 \ul0 \strike0 \i0 \fs16 \sa0 \sb0 
63
}}}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 And, in September 2022, the FDA completed its Digital Health Software Precertification (Pre-Cert) Pilot Program, which aimed to inform the development of adaptive regulatory approaches, many of which are applicable to AI/ML-enabled devices, and signaled openness to further paradigm shifts.
}
{\b0 \cf1 \f2 \i0 \fs16 
{\*\bkmkstart co_fnRef_F64546934635_ID0E4HAG_1}{\*\bkmkend co_fnRef_F64546934635_ID0E4HAG_1}
{\field {\*\fldinst HYPERLINK "#co_footnote_F64546934635_1" }{\fldrslt 
{\super \b0 \cf19 \f2 \ul0 \strike0 \i0 \fs16 \sa0 \sb0 
64
}}}
\par 
}
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
\u160\'3f
\par 
}
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\*\bkmkstart co_g_ID0EEIAG_1}{\*\bkmkend co_g_ID0EEIAG_1}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
Recognizing the need to update its traditional framework for premarket review of changes to medical devices, in April 2023, the FDA outlined a \u8220\'3fPredetermined Change Control Plan for Artificial Intelligence/Machine Learning Devices\u8221\'3f (\u8220\'3fPCCP\u8221\'3f), intended to reduce regulatory hurdles for adaptive devices that can improve performance through iterative modifications.
}
{\b0 \cf1 \f2 \i0 \fs16 
{\*\bkmkstart co_fnRef_F65546934635_ID0EVIAG_1}{\*\bkmkend co_fnRef_F65546934635_ID0EVIAG_1}
{\field {\*\fldinst HYPERLINK "#co_footnote_F65546934635_1" }{\fldrslt 
{\super \b0 \cf19 \f2 \ul0 \strike0 \i0 \fs16 \sa0 \sb0 
65
}}}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 The FDA authorizes manufacturers to include a PCCP in marketing submissions to \u8220\'3fpre-specify and seek premarket authorization for intended modifications (and their method of implementation) to an [AI/ML-enabled device] without necessitating additional marketing submissions for each modification delineated and implemented in accordance with the PCCP.\u8221\'3f
}
{\b0 \cf1 \f2 \i0 \fs16 
{\*\bkmkstart co_fnRef_F66546934635_ID0EDJAG_1}{\*\bkmkend co_fnRef_F66546934635_ID0EDJAG_1}
{\field {\*\fldinst HYPERLINK "#co_footnote_F66546934635_1" }{\fldrslt 
{\super \b0 \cf19 \f2 \ul0 \strike0 \i0 \fs16 \sa0 \sb0 
66
}}}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 Central to PCCPs is the requirement that developers conduct an ex ante impact assessment: \u8220\'3f[a]n Impact Assessment, in the context of a PCCP, is the documentation of the assessment of the benefits and risks of implementing a PCCP for an [AI/ML-enabled device], as well as the mitigations of those risks.\u8221\'3f
}
{\b0 \cf1 \f2 \i0 \fs16 
{\*\bkmkstart co_fnRef_F67546934635_ID0EYJAG_1}{\*\bkmkend co_fnRef_F67546934635_ID0EYJAG_1}
{\field {\*\fldinst HYPERLINK "#co_footnote_F67546934635_1" }{\fldrslt 
{\super \b0 \cf19 \f2 \ul0 \strike0 \i0 \fs16 \sa0 \sb0 
67
}}}
\par 
}
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
\u160\'3f
\par 
}
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\*\bkmkstart co_g_ID0E6JAG_1}{\*\bkmkend co_g_ID0E6JAG_1}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
The FDA\rquote s PCCP guidance strikes a balance between allowing AI/ML-enabled medical devices to be released and to learn in the market while mitigating harm that could result from the use of unregulated AI. The PCCP framework does so by requiring a certain level of premarket review while loosening restrictions so as to allow for certain, limited adjustments to be made without requiring developers to submit new proposals too frequently.
\par 
}
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
\u160\'3f
\par 
}
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\*\bkmkstart co_g_ID0EOKAG_1}{\*\bkmkend co_g_ID0EOKAG_1}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
The FDA\rquote s PCCP framework is still primarily oriented towards ex ante premarket regulatory review. I have argued that AI/ML technologies are accelerating a paradigm shift at the FDA from a model that devotes the majority of its emphasis (and resources) to premarket approval to one that focuses on ongoing 
}
{\b1 \cf1 \f2 \i0 \fs20 
{\*\bkmkstart co_pp_sp_129177_256_1}{\*\bkmkend co_pp_sp_129177_256_1}
{\b1 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
*256
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 postmarket surveillance.
}
{\b0 \cf1 \f2 \i0 \fs16 
{\*\bkmkstart co_fnRef_F68546934635_ID0EGLAG_1}{\*\bkmkend co_fnRef_F68546934635_ID0EGLAG_1}
{\field {\*\fldinst HYPERLINK "#co_footnote_F68546934635_1" }{\fldrslt 
{\super \b0 \cf19 \f2 \ul0 \strike0 \i0 \fs16 \sa0 \sb0 
68
}}}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 Given that AI models learn from the data they gather, it is even more important to buttress this shift to ongoing postmarket scrutiny.
\par 
}
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
\u160\'3f
\par 
}
}
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b1 \cf1 \f2 \ri0 \i0 \ql \fs20 \li0 
{\*\bkmkstart co_g_ID0EPLAG_1}{\*\bkmkend co_g_ID0EPLAG_1}
{\b1 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa200 \sb200 
2. LLMs and Generative AI
\par 
}
}
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\*\bkmkstart co_g_ID0EZLAG_1}{\*\bkmkend co_g_ID0EZLAG_1}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
LLMs are AI models trained on sprawling text datasets, enabling them to recognize, summarize, translate, predict, and generate content; some prominent LLMs include ChatGPT, Llama, Claude, and PaLM. Generative AI is \u8220\'3fthe class of AI models that emulate the structure and characteristics of input data in order to generate derived synthetic content. This can include images, videos, audio, text, and other digital content.\u8221\'3f
}
{\b0 \cf1 \f2 \i0 \fs16 
{\*\bkmkstart co_fnRef_F69546934635_ID0EPMAG_1}{\*\bkmkend co_fnRef_F69546934635_ID0EPMAG_1}
{\field {\*\fldinst HYPERLINK "#co_footnote_F69546934635_1" }{\fldrslt 
{\super \b0 \cf19 \f2 \ul0 \strike0 \i0 \fs16 \sa0 \sb0 
69
}}}
\par 
}
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
\u160\'3f
\par 
}
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\*\bkmkstart co_g_ID0EWMAG_1}{\*\bkmkend co_g_ID0EWMAG_1}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
As of October 19, 2023, the FDA has not authorized any device that is powered by LLMs or that uses any form of generative AI.
}
{\b0 \cf1 \f2 \i0 \fs16 
{\*\bkmkstart co_fnRef_F70546934635_ID0E5MAG_1}{\*\bkmkend co_fnRef_F70546934635_ID0E5MAG_1}
{\field {\*\fldinst HYPERLINK "#co_footnote_F70546934635_1" }{\fldrslt 
{\super \b0 \cf19 \f2 \ul0 \strike0 \i0 \fs16 \sa0 \sb0 
70
}}}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 But, to the extent that such models are used to treat or diagnose conditions or diseases, the FDA may soon find itself regulating generative AI. For example, a ChatGPT-like product specific to clinicians would be subject to FDA oversight if a company were selling it for the purpose of providing diagnostic, treatment, or clinical decision support.
\par 
}
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
\u160\'3f
\par 
}
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\*\bkmkstart co_g_ID0EKNAG_1}{\*\bkmkend co_g_ID0EKNAG_1}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
Generative AI has the ability to increase the efficacy and safety of the medical devices and drugs put onto the market. For example, \u8220\'3f[b]y training on data related to known drugs\rquote  chemical properties, [generative AI] can generate new candidate[] [drugs] with similar properties but different structures, potentially resulting in safer and more effective drugs.\u8221\'3f
}
{\b0 \cf1 \f2 \i0 \fs16 
{\*\bkmkstart co_fnRef_F71546934635_ID0E5NAG_1}{\*\bkmkend co_fnRef_F71546934635_ID0E5NAG_1}
{\field {\*\fldinst HYPERLINK "#co_footnote_F71546934635_1" }{\fldrslt 
{\super \b0 \cf19 \f2 \ul0 \strike0 \i0 \fs16 \sa0 \sb0 
71
}}}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 It can also help doctors better understand how particular individuals will respond to a certain drug, making possible far more tailored drug design.
}
{\b0 \cf1 \f2 \i0 \fs16 
{\*\bkmkstart co_fnRef_F72546934635_ID0EDOAG_1}{\*\bkmkend co_fnRef_F72546934635_ID0EDOAG_1}
{\field {\*\fldinst HYPERLINK "#co_footnote_F72546934635_1" }{\fldrslt 
{\super \b0 \cf19 \f2 \ul0 \strike0 \i0 \fs16 \sa0 \sb0 
72
}}}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 In addition, generative AI has been found to be more effective than traditional AI/ML models in certain domains, such as diagnosing the initial stages of certain heart conditions.
}
{\b0 \cf1 \f2 \i0 \fs16 
{\*\bkmkstart co_fnRef_F73546934635_ID0EIOAG_1}{\*\bkmkend co_fnRef_F73546934635_ID0EIOAG_1}
{\field {\*\fldinst HYPERLINK "#co_footnote_F73546934635_1" }{\fldrslt 
{\super \b0 \cf19 \f2 \ul0 \strike0 \i0 \fs16 \sa0 \sb0 
73
}}}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 But, the downside risk is that individuals might rely on the information generated by generative AI models at the expense of ever consulting their physicians,
}
{\b0 \cf1 \f2 \i0 \fs16 
{\*\bkmkstart co_fnRef_F74546934635_ID0ELOAG_1}{\*\bkmkend co_fnRef_F74546934635_ID0ELOAG_1}
{\field {\*\fldinst HYPERLINK "#co_footnote_F74546934635_1" }{\fldrslt 
{\super \b0 \cf19 \f2 \ul0 \strike0 \i0 \fs16 \sa0 \sb0 
74
}}}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 as can sometimes occur with direct-to-consumer genetic testing.
}
{\b0 \cf1 \f2 \i0 \fs16 
{\*\bkmkstart co_fnRef_F75546934635_ID0EPOAG_1}{\*\bkmkend co_fnRef_F75546934635_ID0EPOAG_1}
{\field {\*\fldinst HYPERLINK "#co_footnote_F75546934635_1" }{\fldrslt 
{\super \b0 \cf19 \f2 \ul0 \strike0 \i0 \fs16 \sa0 \sb0 
75
}}}
\par 
}
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
\u160\'3f
\par 
}
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\*\bkmkstart co_g_ID0EWOAG_1}{\*\bkmkend co_g_ID0EWOAG_1}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 
}
{\b1 \cf1 \f2 \i0 \fs20 
{\*\bkmkstart co_pp_sp_129177_257_1}{\*\bkmkend co_pp_sp_129177_257_1}
{\b1 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
*257
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 Experts disagree about whether generative AI poses a challenge different in kind or merely in degree from other technologies. One view places perhaps undue emphasis on what it deems categorical differences: \u8220\'3f[i]f you take, for example, the 100 or 150 or so software as a medical device approvals that have gone through the FDA, what\rquote s going on with many of them is a supervised learning algorithm,\u8221\'3f whereas, \u8220\'3f[w]hen it comes to large language models, they\rquote re quite different.\u8221\'3f
}
{\b0 \cf1 \f2 \i0 \fs16 
{\*\bkmkstart co_fnRef_F76546934635_ID0EXPAG_1}{\*\bkmkend co_fnRef_F76546934635_ID0EXPAG_1}
{\field {\*\fldinst HYPERLINK "#co_footnote_F76546934635_1" }{\fldrslt 
{\super \b0 \cf19 \f2 \ul0 \strike0 \i0 \fs16 \sa0 \sb0 
76
}}}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 \u8220\'3f\u8216\'3fThese models are more flexible, maybe than some of those supervised learning classifiers, in that they can do a number of different things,\u8217\'3f such as answering questions about how well certain therapies worked or summarizing [medical research] papers in conversational language.\u8221\'3f
}
{\b0 \cf1 \f2 \i0 \fs16 
{\*\bkmkstart co_fnRef_F77546934635_ID0EOQAG_1}{\*\bkmkend co_fnRef_F77546934635_ID0EOQAG_1}
{\field {\*\fldinst HYPERLINK "#co_footnote_F77546934635_1" }{\fldrslt 
{\super \b0 \cf19 \f2 \ul0 \strike0 \i0 \fs16 \sa0 \sb0 
77
}}}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 The contrary view--which seems to better reflect the reality of the evolution of AI technologies to date--holds that the principles embedded in the FDA\rquote s SaMD framework would transfer readily to ChatGPT: \u8220\'3f[a]s we become more familiar with the technology, there might be changes that are made specifically for this. But it strikes me that a lot of it is going to be following on the principles that already exist.\u8221\'3f
}
{\b0 \cf1 \f2 \i0 \fs16 
{\*\bkmkstart co_fnRef_F78546934635_ID0E5QAG_1}{\*\bkmkend co_fnRef_F78546934635_ID0E5QAG_1}
{\field {\*\fldinst HYPERLINK "#co_footnote_F78546934635_1" }{\fldrslt 
{\super \b0 \cf19 \f2 \ul0 \strike0 \i0 \fs16 \sa0 \sb0 
78
}}}
\par 
}
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
\u160\'3f
\par 
}
}
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b1 \cf1 \f2 \ri0 \i0 \ql \fs20 \li0 
{\*\bkmkstart co_g_ID0EFRAG_1}{\*\bkmkend co_g_ID0EFRAG_1}
{\b1 \cf1 \f2 \i1 \fs20 
{\b1 \cf1 \f2 \ul0 \strike0 \i1 \fs20 \sa200 \sb200 
B. Products Liability and Federal Preemption
\par 
}
}
}
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\*\bkmkstart co_g_ID0EPRAG_1}{\*\bkmkend co_g_ID0EPRAG_1}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
Federal preemption is an affirmative defense to a state products liability action, whereby the defendant claims that a federal statute and regulatory scheme reigns supreme and ousts conflicting state law. The courts\rquote  preemption determinations--namely the extent to which federal regulation ousts conflicting state tort actions--are not only a matter of conventional statutory interpretation, but are also highly dependent upon the stringency of the ex ante review by the relevant regulator (in this case the FDA).
\par 
}
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
\u160\'3f
\par 
}
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\*\bkmkstart co_g_ID0EGSAG_1}{\*\bkmkend co_g_ID0EGSAG_1}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
With regard to products liability actions involving prescription medical products, the courts\rquote  starting point is the Federal Food, Drug and Cosmetic Act (\u8220\'3fFDCA\u8221\'3f), enacted by Congress, which includes an express preemption provision governing medical devices, but not drugs. But, even when faced with preemption decisions pertaining to medical devices, courts have looked beyond the statutory language of the FDCA--and the preemption provision enacted as part of the Medical Device Amendment Act of 1976--to consider the stringency of the regulatory review conducted by the FDA. Thus, in 
}
{\b0 \cf1 \f2 \i1 \fs20 
{\b0 \cf1 \f2 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
Riegel v. Medtronic
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
, the U.S. Supreme Court decided that the vast majority of products liability claims arising from high-risk medical devices that were approved by the FDA via the PMA pathway--which entails rigorous scrutiny of empirical evidence resulting in a determination of safety and efficacy--are preempted.
}
{\b0 \cf1 \f2 \i0 \fs16 
{\*\bkmkstart co_fnRef_F79546934635_ID0EWSAG_1}{\*\bkmkend co_fnRef_F79546934635_ID0EWSAG_1}
{\field {\*\fldinst HYPERLINK "#co_footnote_F79546934635_1" }{\fldrslt 
{\super \b0 \cf19 \f2 \ul0 \strike0 \i0 \fs16 \sa0 \sb0 
79
}}}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 On the other hand, claims 
}
{\b1 \cf1 \f2 \i0 \fs20 
{\*\bkmkstart co_pp_sp_129177_258_1}{\*\bkmkend co_pp_sp_129177_258_1}
{\b1 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
*258
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 arising from medical devices that are approved via the more lax PMN pathway--whereby the FDA gives a more streamlined review, resulting in a decision that the medical device is \u8220\'3fsubstantially similar\u8221\'3f to one existing on the market--are not preempted.
}
{\b0 \cf1 \f2 \i0 \fs16 
{\*\bkmkstart co_fnRef_F80546934635_ID0E6SAG_1}{\*\bkmkend co_fnRef_F80546934635_ID0E6SAG_1}
{\field {\*\fldinst HYPERLINK "#co_footnote_F80546934635_1" }{\fldrslt 
{\super \b0 \cf19 \f2 \ul0 \strike0 \i0 \fs16 \sa0 \sb0 
80
}}}
\par 
}
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
\u160\'3f
\par 
}
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\*\bkmkstart co_g_ID0EGTAG_1}{\*\bkmkend co_g_ID0EGTAG_1}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
In prior work, I have explored at length the interplay between federal regulation and products liability for mitigating risks posed by pharmaceutical drugs and medical devices.
}
{\b0 \cf1 \f2 \i0 \fs16 
{\*\bkmkstart co_fnRef_F81546934635_ID0EOTAG_1}{\*\bkmkend co_fnRef_F81546934635_ID0EOTAG_1}
{\field {\*\fldinst HYPERLINK "#co_footnote_F81546934635_1" }{\fldrslt 
{\super \b0 \cf19 \f2 \ul0 \strike0 \i0 \fs16 \sa0 \sb0 
81
}}}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 I have set forth a proposed \u8220\'3fagency reference\u8221\'3f model, whereby courts look to and scrutinize input from the FDA regarding the extent to which a products liability design defect or failure-to-warn action revisits the risk-benefit calculus the FDA made in either its approval decision or subsequent actions: if the action raises new risk evidence not yet considered by the FDA, the products liability action should proceed, and, if it does not, the action should be preempted.
}
{\b0 \cf1 \f2 \i0 \fs16 
{\*\bkmkstart co_fnRef_F82546934635_ID0ETTAG_1}{\*\bkmkend co_fnRef_F82546934635_ID0ETTAG_1}
{\field {\*\fldinst HYPERLINK "#co_footnote_F82546934635_1" }{\fldrslt 
{\super \b0 \cf19 \f2 \ul0 \strike0 \i0 \fs16 \sa0 \sb0 
82
}}}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 In this way, state tort actions serve an information-forcing role, surfacing evidence of new risks that have come to light post-approval, after a drug or medical device has been used by patients.
\par 
}
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
\u160\'3f
\par 
}
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\*\bkmkstart co_g_ID0E3TAG_1}{\*\bkmkend co_g_ID0E3TAG_1}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
The agency reference model can be applied to the realm of AI-enabled medical devices. The stringent ex ante PMA regulatory pathway, by which the FDA would approve high-risk (i.e., Class III) AI-enabled devices, would preempt products liability claims. But the evolution of SaMD and PCCP guidelines (discussed above)
}
{\b0 \cf1 \f2 \i0 \fs16 
{\*\bkmkstart co_fnRef_F83546934635_ID0EQUAG_1}{\*\bkmkend co_fnRef_F83546934635_ID0EQUAG_1}
{\field {\*\fldinst HYPERLINK "#co_footnote_F83546934635_1" }{\fldrslt 
{\super \b0 \cf19 \f2 \ul0 \strike0 \i0 \fs16 \sa0 \sb0 
83
}}}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 suggests that the FDA is moving towards a minimally burdensome ex ante regulatory approach. Under the agency reference model, this relatively light-touch ex ante review should leave ample room for products liability claims to survive.
\par 
}
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
\u160\'3f
\par 
}
}
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b1 \cf1 \f2 \ri0 \i0 \ql \fs20 \li0 
{\*\bkmkstart co_g_ID0EMVAG_1}{\*\bkmkend co_g_ID0EMVAG_1}
{\b1 \cf1 \f2 \i1 \fs20 
{\b1 \cf1 \f2 \ul0 \strike0 \i1 \fs20 \sa200 \sb200 
C. Liability Insurance
\par 
}
}
}
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\*\bkmkstart co_g_ID0EWVAG_1}{\*\bkmkend co_g_ID0EWVAG_1}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
Finally, by invoking a products liability framework for AI, I mean also to invoke the potential role to be played by liability insurance. The availability of liability insurance has figured prominently in the development and expansion of products liability for three-quarters of a century and has been expressly stated to be a relevant consideration in numerous significant decisions.
}
{\b0 \cf1 \f2 \i0 \fs16 
{\*\bkmkstart co_fnRef_F84546934635_ID0EAWAG_1}{\*\bkmkend co_fnRef_F84546934635_ID0EAWAG_1}
{\field {\*\fldinst HYPERLINK "#co_footnote_F84546934635_1" }{\fldrslt 
{\super \b0 \cf19 \f2 \ul0 \strike0 \i0 \fs16 \sa0 \sb0 
84
}}}
\par 
}
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
\u160\'3f
\par 
}
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\*\bkmkstart co_g_ID0EHWAG_1}{\*\bkmkend co_g_ID0EHWAG_1}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 
}
{\b1 \cf1 \f2 \i0 \fs20 
{\*\bkmkstart co_pp_sp_129177_259_1}{\*\bkmkend co_pp_sp_129177_259_1}
{\b1 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
*259
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 Liability insurance, moreover, can play a critical role in terms of fostering the development of standards that can be deployed to mitigate or prevent harms, including in this brave new world of AI harms. Liability insurers can aggregate risk-related information obtained about the expanding universe of policyholders as part of the process of underwriting and premium-setting.
}
{\b0 \cf1 \f2 \i0 \fs16 
{\*\bkmkstart co_fnRef_F85546934635_ID0EWWAG_1}{\*\bkmkend co_fnRef_F85546934635_ID0EWWAG_1}
{\field {\*\fldinst HYPERLINK "#co_footnote_F85546934635_1" }{\fldrslt 
{\super \b0 \cf19 \f2 \ul0 \strike0 \i0 \fs16 \sa0 \sb0 
85
}}}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 As I have explored with Professor Kenneth Abraham in depth,
}
{\b0 \cf1 \f2 \i0 \fs16 
{\*\bkmkstart co_fnRef_F86546934635_ID0EZWAG_1}{\*\bkmkend co_fnRef_F86546934635_ID0EZWAG_1}
{\field {\*\fldinst HYPERLINK "#co_footnote_F86546934635_1" }{\fldrslt 
{\super \b0 \cf19 \f2 \ul0 \strike0 \i0 \fs16 \sa0 \sb0 
86
}}}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 when liability insurers have more information than policyholders regarding certain methods of reducing risk, those insurers have an incentive to communicate that information to policyholders through \u8220\'3fcoaching\u8221\'3f policyholders, either as part of their interactions over premiums or on an ongoing basis.
}
{\b0 \cf1 \f2 \i0 \fs16 
{\*\bkmkstart co_fnRef_F87546934635_ID0E4WAG_1}{\*\bkmkend co_fnRef_F87546934635_ID0E4WAG_1}
{\field {\*\fldinst HYPERLINK "#co_footnote_F87546934635_1" }{\fldrslt 
{\super \b0 \cf19 \f2 \ul0 \strike0 \i0 \fs16 \sa0 \sb0 
87
}}}
\par 
}
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
\u160\'3f
\par 
}
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\*\bkmkstart co_g_ID0EEXAG_1}{\*\bkmkend co_g_ID0EEXAG_1}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
As mentioned above, the IDx-DR software, which uses AI for the early detection of diabetic retinopathy, was the first autonomous AI/ML-powered diagnostic device to receive FDA approval.
}
{\b0 \cf1 \f2 \i0 \fs16 
{\*\bkmkstart co_fnRef_F88546934635_ID0EMXAG_1}{\*\bkmkend co_fnRef_F88546934635_ID0EMXAG_1}
{\field {\*\fldinst HYPERLINK "#co_footnote_F88546934635_1" }{\fldrslt 
{\super \b0 \cf19 \f2 \ul0 \strike0 \i0 \fs16 \sa0 \sb0 
88
}}}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 Digital Diagnostic, the designer of IDx-DR, carries malpractice insurance and indemnifies physicians using its devices.
}
{\b0 \cf1 \f2 \i0 \fs16 
{\*\bkmkstart co_fnRef_F89546934635_ID0ERXAG_1}{\*\bkmkend co_fnRef_F89546934635_ID0ERXAG_1}
{\field {\*\fldinst HYPERLINK "#co_footnote_F89546934635_1" }{\fldrslt 
{\super \b0 \cf19 \f2 \ul0 \strike0 \i0 \fs16 \sa0 \sb0 
89
}}}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 It is curious that the form of liability insurance is malpractice insurance, as distinct from products liability insurance.
}
{\b0 \cf1 \f2 \i0 \fs16 
{\*\bkmkstart co_fnRef_F90546934635_ID0EWXAG_1}{\*\bkmkend co_fnRef_F90546934635_ID0EWXAG_1}
{\field {\*\fldinst HYPERLINK "#co_footnote_F90546934635_1" }{\fldrslt 
{\super \b0 \cf19 \f2 \ul0 \strike0 \i0 \fs16 \sa0 \sb0 
90
}}}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 But it does nonetheless suggest that AI-enabled software designers are anticipating potential tort liability.
\par 
}
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
\u160\'3f
\par 
}
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\*\bkmkstart co_g_ID0E6XAG_1}{\*\bkmkend co_g_ID0E6XAG_1}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
It remains to be seen whether a third-party liability insurance market will emerge in response to the threat of products liability actions for AI/ML harms, in which case insurers would engage in further risk management and exert more potent regulatory control.
}
{\b0 \cf1 \f2 \i0 \fs16 
{\*\bkmkstart co_fnRef_F91546934635_ID0EHYAG_1}{\*\bkmkend co_fnRef_F91546934635_ID0EHYAG_1}
{\field {\*\fldinst HYPERLINK "#co_footnote_F91546934635_1" }{\fldrslt 
{\super \b0 \cf19 \f2 \ul0 \strike0 \i0 \fs16 \sa0 \sb0 
91
}}}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 In this way, liability insurance joins in as part of the tort liability-regulatory feedback loop.
\par 
}
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
\u160\'3f
\par 
}
}
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b1 \cf1 \f2 \ri0 \i0 \ql \fs20 \li0 
{\*\bkmkstart co_g_ID0EQYAG_1}{\*\bkmkend co_g_ID0EQYAG_1}
{\b1 \cf1 \f2 \ul0 \strike0 \i0 \fs20 
}
{\b1 \cf1 \f2 \i0 \fs20 
{\*\bkmkstart co_pp_sp_129177_260_1}{\*\bkmkend co_pp_sp_129177_260_1}
{\b1 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
*260
}
}
{\b1 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
 IV. 
}
{\b1 \cf1 \f2 \i0 \fs20 
{\b1 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa200 \sb200 
Conclusion
\par 
}
}
}
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 
{\*\bkmkstart co_g_ID0E6YAG_1}{\*\bkmkend co_g_ID0E6YAG_1}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
A products liability framework provides an auspicious model for regulating AI harms. Such a framework is robust enough to tackle the challenges posed by the adaptive learning aspect of ML as well as the interactive aspects of AI and generative AI technologies. Chief among the advantages of products liability is capturing the feedback loop between tort liability and regulation, which is well illustrated by the evolving regulatory framework for FDA-approved, AI-enabled medical devices. The feedback loop of an agency regulator and products liability allows for experimenting with standards before the agency regulator settles on an optimal one, which in turn will preempt certain tort actions under something like the agency reference model. Finally, liability insurance is a key ingredient of any form of tort liability, and, here too, it offers promise in terms of risk management and the development of safety standards.
\par 
}
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
\u160\'3f
\par 
}
}
}
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 {
{\trowd \ltrrow \trleft0 
\clpadl200 \clpadfl3 \clbrdrt \clbrdrl \trql \clwWidth10080 \cellx10080 
\intbl 
{\ri0 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \ql \fs20 \li0 
{\b0 \cf1 \f2 \i0 \fs20 
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
Footnotes
\par 
}
}
}
}\b0 \cf1 \f2 \ri0 \ul0 \strike0 \i0 \ql \li0 \fs20 \sa0 \sb0 \intbl \cell \row }
{\trowd \ltrrow \trleft0 
\clbrdrl \trql \clvertalt \clwWidth600 \cellx600 
\clpadb90 \clpadfb3 \clpadl90 \clpadfl3 \clbrdrr \trql \clwWidth9480 \cellx10080 
\intbl 
{\ri0 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \ql \fs18 \li0 
{\b0 \cf1 \f2 \i0 \fs18 
{\*\bkmkstart co_footnote_Fa1546934635_1}{\*\bkmkend co_footnote_Fa1546934635_1}
{\field {\*\fldinst HYPERLINK "#co_fnRef_Fa1546934635_ID0EZKAC_1" }{\fldrslt 
{\super \b0 \cf19 \f2 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
a1
}\super \b0 \cf19 \f2 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 }}
\par 
}
}
}\b0 \cf1 \f2 \ri0 \i0 \ql \li0 \fs18 \intbl \cell \intbl 
{\ri0 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs18 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs18 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs18 \li0 
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs18 \sa200 \sb0 
Segal Family Professor of Regulatory Law and Policy, New York University School of Law. Callen DiGiovanni (NYU 2024) and Nicholas Tilmes (NYU 2025) provided excellent research assistance. I am grateful to Thomas Merrill for insights he provided as a commentator at the symposium and to Ryan Abbott, Bryan Choi, Chinmayi Sharma, and Benjamin Zipursky for feedback. I also appreciate input from my fabulous Artificial Intelligence seminar students, who inspired this Essay.
\par 
}
}
}
}
}\b0 \cf1 \f2 \ri0 \ul0 \strike0 \i0 \qj \li0 \fs18 \sa200 \sb0 \intbl \cell \row }
{\trowd \ltrrow \trleft0 
\clbrdrl \trql \clvertalt \clwWidth600 \cellx600 
\clpadb90 \clpadfb3 \clpadl90 \clpadfl3 \clbrdrr \trql \clwWidth9480 \cellx10080 
\intbl 
{\ri0 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \ql \fs18 \li0 
{\b0 \cf1 \f2 \i0 \fs18 
{\*\bkmkstart co_footnote_F1546934635_1}{\*\bkmkend co_footnote_F1546934635_1}
{\field {\*\fldinst HYPERLINK "#co_fnRef_F1546934635_ID0EEDAE_1" }{\fldrslt 
{\super \b0 \cf19 \f2 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
1
}\super \b0 \cf19 \f2 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 }}
\par 
}
}
}\b0 \cf1 \f2 \ri0 \i0 \ql \li0 \fs18 \intbl \cell \intbl 
{\ri0 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs18 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs18 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs18 \li0 
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
President Biden\rquote s Executive Order on Safe, Secure, and Trustworthy Development and Use of Artificial Intelligence repeatedly sounds the theme of AI\rquote s \u8220\'3fextraordinary potential for both promise and peril.\u8221\'3f 
}
{\field {\*\fldinst HYPERLINK "https://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2077292919&pubNum=0001043&originatingDoc=I434c460335f011ef8921fbef1a541940&refType=CA&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b0 \cf19 \f2 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
Exec. Order No. 14,110, 88 Fed. Reg. 75191, 75191 (Oct. 30, 2023)
}\b0 \cf19 \f2 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 }}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs18 \sa200 \sb0 
.
\par 
}
}
}
}
}\b0 \cf1 \f2 \ri0 \ul0 \strike0 \i0 \qj \li0 \fs18 \sa200 \sb0 \intbl \cell \row }
{\trowd \ltrrow \trleft0 
\clbrdrl \trql \clvertalt \clwWidth600 \cellx600 
\clpadb90 \clpadfb3 \clpadl90 \clpadfl3 \clbrdrr \trql \clwWidth9480 \cellx10080 
\intbl 
{\ri0 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \ql \fs18 \li0 
{\b0 \cf1 \f2 \i0 \fs18 
{\*\bkmkstart co_footnote_F2546934635_1}{\*\bkmkend co_footnote_F2546934635_1}
{\field {\*\fldinst HYPERLINK "#co_fnRef_F2546934635_ID0EKDAE_1" }{\fldrslt 
{\super \b0 \cf19 \f2 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
2
}\super \b0 \cf19 \f2 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 }}
\par 
}
}
}\b0 \cf1 \f2 \ri0 \i0 \ql \li0 \fs18 \intbl \cell \intbl 
{\ri0 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs18 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs18 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs18 \li0 
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
AI is \u8220\'3fa branch of computer science, statistics, and engineering that uses algorithms or models to perform tasks and exhibit behaviors such as learning, making decisions, and making predictions.\u8221\'3f Shawn Forrest, 
}
{\b0 \cf1 \f2 \i1 \fs18 
{\b0 \cf1 \f2 \ul0 \strike0 \i1 \fs18 \sa0 \sb0 
Artificial Intelligence/ Machine Learning (AI/ML)-Enabled Medical Devices: Tailoring a Regulatory Framework to Encourage Responsible Innovation in AI/ML
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
, 
}
{\b0 \cf1 \f2 \i0 \fs18 
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
Food & Drug Admin.
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
 (2023), https://www.fda.gov/media/160125/download [https://perma.cc/L8BH-5GHB] (adapted from 
}
{\b0 \cf1 \f2 \i1 \fs18 
{\b0 \cf1 \f2 \ul0 \strike0 \i1 \fs18 \sa0 \sb0 
Machine Learning-Enabled Medical Devices: Key Terms and Definitions
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
, 
}
{\b0 \cf1 \f2 \i0 \fs18 
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
Int\rquote l Med. Device Regul. F.
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
 (Mar. 9, 2022), https://www.imdrf.org/documents/machine-learning-enabled-medical-devices-key-terms-and-definitions [https://perma.cc/PKR8-VF99]). ML is \u8220\'3fa subset of AI that allows ML models to be developed by ML training algorithms through analysis of data, without models being explicitly programmed.\u8221\'3f 
}
{\b0 \cf1 \f2 \i1 \fs18 
{\b0 \cf1 \f2 \ul0 \strike0 \i1 \fs18 \sa200 \sb0 
Id.
\par 
}
}
}
}
}
}\b0 \cf1 \f2 \ri0 \ul0 \strike0 \i1 \qj \li0 \fs18 \sa200 \sb0 \intbl \cell \row }
{\trowd \ltrrow \trleft0 
\clbrdrl \trql \clvertalt \clwWidth600 \cellx600 
\clpadb90 \clpadfb3 \clpadl90 \clpadfl3 \clbrdrr \trql \clwWidth9480 \cellx10080 
\intbl 
{\ri0 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \ql \fs18 \li0 
{\b0 \cf1 \f2 \i0 \fs18 
{\*\bkmkstart co_footnote_F3546934635_1}{\*\bkmkend co_footnote_F3546934635_1}
{\field {\*\fldinst HYPERLINK "#co_fnRef_F3546934635_ID0EYDAE_1" }{\fldrslt 
{\super \b0 \cf19 \f2 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
3
}\super \b0 \cf19 \f2 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 }}
\par 
}
}
}\b0 \cf1 \f2 \ri0 \i0 \ql \li0 \fs18 \intbl \cell \intbl 
{\ri0 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs18 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs18 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs18 \li0 
{\b0 \cf1 \f2 \i1 \fs18 
{\b0 \cf1 \f2 \ul0 \strike0 \i1 \fs18 \sa0 \sb0 
See
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
 Catherine M. Sharkey & Kevin M.K. Fodouop, 
}
{\field {\*\fldinst HYPERLINK "https://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=0528905061&pubNum=0224882&originatingDoc=I434c460335f011ef8921fbef1a541940&refType=LR&fi=co_pp_sp_224882_97&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)#co_pp_sp_224882_97" }{\fldrslt 
{\b0 \cf19 \f2 \i1 \fs18 
{\b0 \cf19 \f2 \ul0 \strike0 \i1 \fs18 \sa0 \sb0 
AI and the Regulatory Paradigm Shift at the FDA
}
}
{\b0 \cf19 \f2 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
, 72 
}
{\b0 \cf19 \f2 \i0 \fs18 
{\b0 \cf19 \f2 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
Duke L. J. Online
}
}
{\b0 \cf19 \f2 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
 86, 97-103 (2022)
}\b0 \cf19 \f2 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 }}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs18 \sa200 \sb0 
.
\par 
}
}
}
}
}\b0 \cf1 \f2 \ri0 \ul0 \strike0 \i0 \qj \li0 \fs18 \sa200 \sb0 \intbl \cell \row }
{\trowd \ltrrow \trleft0 
\clbrdrl \trql \clvertalt \clwWidth600 \cellx600 
\clpadb90 \clpadfb3 \clpadl90 \clpadfl3 \clbrdrr \trql \clwWidth9480 \cellx10080 
\intbl 
{\ri0 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \ql \fs18 \li0 
{\b0 \cf1 \f2 \i0 \fs18 
{\*\bkmkstart co_footnote_F4546934635_1}{\*\bkmkend co_footnote_F4546934635_1}
{\field {\*\fldinst HYPERLINK "#co_fnRef_F4546934635_ID0EREAE_1" }{\fldrslt 
{\super \b0 \cf19 \f2 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
4
}\super \b0 \cf19 \f2 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 }}
\par 
}
}
}\b0 \cf1 \f2 \ri0 \i0 \ql \li0 \fs18 \intbl \cell \intbl 
{\ri0 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs18 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs18 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs18 \li0 
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
Moreover, the canonical types of algorithmic harms that received the most attention at the symposium--reputational, representational, etc.--are not classic products liability harms, which typically involve discrete physical injuries. 
}
{\b0 \cf1 \f2 \i1 \fs18 
{\b0 \cf1 \f2 \ul0 \strike0 \i1 \fs18 \sa0 \sb0 
See
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
 Symposium, 
}
{\b0 \cf1 \f2 \i1 \fs18 
{\b0 \cf1 \f2 \ul0 \strike0 \i1 \fs18 \sa0 \sb0 
Accountability & Liability in 
}
}
{\field {\*\fldinst HYPERLINK "https://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=0546934633&pubNum=0129177&originatingDoc=I434c460335f011ef8921fbef1a541940&refType=LR&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b0 \cf19 \f2 \i1 \fs18 
{\b0 \cf19 \f2 \ul0 \strike0 \i1 \fs18 \sa0 \sb0 
Generative AI: Challenges & Perspectives
}
}
{\b0 \cf19 \f2 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
, 25 
}
{\b0 \cf19 \f2 \i0 \fs18 
{\b0 \cf19 \f2 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
Colum. Sci. & Tech. L. Rev.
}
}
{\b0 \cf19 \f2 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
 190 (2023)
}\b0 \cf19 \f2 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 }}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs18 \sa200 \sb0 
.
\par 
}
}
}
}
}\b0 \cf1 \f2 \ri0 \ul0 \strike0 \i0 \qj \li0 \fs18 \sa200 \sb0 \intbl \cell \row }
{\trowd \ltrrow \trleft0 
\clbrdrl \trql \clvertalt \clwWidth600 \cellx600 
\clpadb90 \clpadfb3 \clpadl90 \clpadfl3 \clbrdrr \trql \clwWidth9480 \cellx10080 
\intbl 
{\ri0 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \ql \fs18 \li0 
{\b0 \cf1 \f2 \i0 \fs18 
{\*\bkmkstart co_footnote_F5546934635_1}{\*\bkmkend co_footnote_F5546934635_1}
{\field {\*\fldinst HYPERLINK "#co_fnRef_F5546934635_ID0EJFAE_1" }{\fldrslt 
{\super \b0 \cf19 \f2 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
5
}\super \b0 \cf19 \f2 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 }}
\par 
}
}
}\b0 \cf1 \f2 \ri0 \i0 \ql \li0 \fs18 \intbl \cell \intbl 
{\ri0 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs18 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs18 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs18 \li0 
{\field {\*\fldinst HYPERLINK "https://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2074754241&pubNum=0000780&originatingDoc=I434c460335f011ef8921fbef1a541940&refType=RP&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b0 \cf19 \f2 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
Gonzalez v. Google LLC, 598 U.S. 617 (2023)
}\b0 \cf19 \f2 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 }}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
. The suit stemmed from a 2015 Islamic State shooting in Paris that killed student Nohemi Gonzalez. 
}
{\field {\*\fldinst HYPERLINK "https://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2074754241&pubNum=0000780&originatingDoc=I434c460335f011ef8921fbef1a541940&refType=RP&fi=co_pp_sp_780_619&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)#co_pp_sp_780_619" }{\fldrslt 
{\b0 \cf19 \f2 \i1 \fs18 
{\b0 \cf19 \f2 \ul0 \strike0 \i1 \fs18 \sa0 \sb0 
Id.
}
}
{\b0 \cf19 \f2 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
 at 619-20
}\b0 \cf19 \f2 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 }}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
. Her family argued that YouTube had recommended videos by terrorists and therefore violated laws against aiding and abetting foreign terrorist groups. 
}
{\b0 \cf1 \f2 \i1 \fs18 
{\b0 \cf1 \f2 \ul0 \strike0 \i1 \fs18 \sa0 \sb0 
See
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
 
}
{\field {\*\fldinst HYPERLINK "https://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2053869040&pubNum=0008173&originatingDoc=I434c460335f011ef8921fbef1a541940&refType=RP&fi=co_pp_sp_8173_881&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)#co_pp_sp_8173_881" }{\fldrslt 
{\b0 \cf19 \f2 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
Gonzalez v. Google LLC, 2 F.4th 871, 881 (9th Cir. 2021)
}\b0 \cf19 \f2 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 }}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
, 
}
{\b0 \cf1 \f2 \i1 \fs18 
{\b0 \cf1 \f2 \ul0 \strike0 \i1 \fs18 \sa0 \sb0 
vacated and remanded
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
, 
}
{\field {\*\fldinst HYPERLINK "https://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2074754241&pubNum=0000780&originatingDoc=I434c460335f011ef8921fbef1a541940&refType=RP&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b0 \cf19 \f2 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
598 U.S. 617 (2023)
}\b0 \cf19 \f2 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 }}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
, and 
}
{\b0 \cf1 \f2 \i1 \fs18 
{\b0 \cf1 \f2 \ul0 \strike0 \i1 \fs18 \sa0 \sb0 
rev\rquote d sub nom.
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
 
}
{\field {\*\fldinst HYPERLINK "https://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2074754243&pubNum=0000780&originatingDoc=I434c460335f011ef8921fbef1a541940&refType=RP&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b0 \cf19 \f2 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
Twitter, Inc. v. Taamneh, 598 U.S. 471 (2023)
}\b0 \cf19 \f2 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 }}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
. While Section 230 of the Communications Decency Act typically protects sites from liability over user-generated content, the complaint argued that YouTube created its own speech with its recommendation algorithm. 
}
{\b0 \cf1 \f2 \i1 \fs18 
{\b0 \cf1 \f2 \ul0 \strike0 \i1 \fs18 \sa200 \sb0 
Id.
\par 
}
}
}
}
}
}\b0 \cf1 \f2 \ri0 \ul0 \strike0 \i1 \qj \li0 \fs18 \sa200 \sb0 \intbl \cell \row }
{\trowd \ltrrow \trleft0 
\clbrdrl \trql \clvertalt \clwWidth600 \cellx600 
\clpadb90 \clpadfb3 \clpadl90 \clpadfl3 \clbrdrr \trql \clwWidth9480 \cellx10080 
\intbl 
{\ri0 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \ql \fs18 \li0 
{\b0 \cf1 \f2 \i0 \fs18 
{\*\bkmkstart co_footnote_F6546934635_1}{\*\bkmkend co_footnote_F6546934635_1}
{\field {\*\fldinst HYPERLINK "#co_fnRef_F6546934635_ID0EPFAE_1" }{\fldrslt 
{\super \b0 \cf19 \f2 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
6
}\super \b0 \cf19 \f2 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 }}
\par 
}
}
}\b0 \cf1 \f2 \ri0 \i0 \ql \li0 \fs18 \intbl \cell \intbl 
{\ri0 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs18 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs18 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs18 \li0 
{\field {\*\fldinst HYPERLINK "https://www.westlaw.com/Link/Document/FullText?findType=L&pubNum=1000546&cite=47USCAS230&originatingDoc=I434c460335f011ef8921fbef1a541940&refType=LQ&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b0 \cf19 \f2 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
47 U.S.C. \u167\'3f 230
}\b0 \cf19 \f2 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 }}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs18 \sa200 \sb0 
.
\par 
}
}
}
}
}\b0 \cf1 \f2 \ri0 \ul0 \strike0 \i0 \qj \li0 \fs18 \sa200 \sb0 \intbl \cell \row }
{\trowd \ltrrow \trleft0 
\clbrdrl \trql \clvertalt \clwWidth600 \cellx600 
\clpadb90 \clpadfb3 \clpadl90 \clpadfl3 \clbrdrr \trql \clwWidth9480 \cellx10080 
\intbl 
{\ri0 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \ql \fs18 \li0 
{\b0 \cf1 \f2 \i0 \fs18 
{\*\bkmkstart co_footnote_F7546934635_1}{\*\bkmkend co_footnote_F7546934635_1}
{\field {\*\fldinst HYPERLINK "#co_fnRef_F7546934635_ID0EUFAE_1" }{\fldrslt 
{\super \b0 \cf19 \f2 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
7
}\super \b0 \cf19 \f2 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 }}
\par 
}
}
}\b0 \cf1 \f2 \ri0 \i0 \ql \li0 \fs18 \intbl \cell \intbl 
{\ri0 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs18 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs18 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs18 \li0 
{\b0 \cf1 \f2 \i1 \fs18 
{\b0 \cf1 \f2 \ul0 \strike0 \i1 \fs18 \sa0 \sb0 
See 
}
}
{\field {\*\fldinst HYPERLINK "https://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2074754241&pubNum=0000780&originatingDoc=I434c460335f011ef8921fbef1a541940&refType=RP&fi=co_pp_sp_780_622&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)#co_pp_sp_780_622" }{\fldrslt 
{\b0 \cf19 \f2 \i1 \fs18 
{\b0 \cf19 \f2 \ul0 \strike0 \i1 \fs18 \sa0 \sb0 
Gonzalez
}
}
{\b0 \cf19 \f2 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
, 598 U.S. at 622
}\b0 \cf19 \f2 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 }}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs18 \sa200 \sb0 
.
\par 
}
}
}
}
}\b0 \cf1 \f2 \ri0 \ul0 \strike0 \i0 \qj \li0 \fs18 \sa200 \sb0 \intbl \cell \row }
{\trowd \ltrrow \trleft0 
\clbrdrl \trql \clvertalt \clwWidth600 \cellx600 
\clpadb90 \clpadfb3 \clpadl90 \clpadfl3 \clbrdrr \trql \clwWidth9480 \cellx10080 
\intbl 
{\ri0 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \ql \fs18 \li0 
{\b0 \cf1 \f2 \i0 \fs18 
{\*\bkmkstart co_footnote_F8546934635_1}{\*\bkmkend co_footnote_F8546934635_1}
{\field {\*\fldinst HYPERLINK "#co_fnRef_F8546934635_ID0E1FAE_1" }{\fldrslt 
{\super \b0 \cf19 \f2 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
8
}\super \b0 \cf19 \f2 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 }}
\par 
}
}
}\b0 \cf1 \f2 \ri0 \i0 \ql \li0 \fs18 \intbl \cell \intbl 
{\ri0 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs18 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs18 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs18 \li0 
{\b0 \cf1 \f2 \i1 \fs18 
{\b0 \cf1 \f2 \ul0 \strike0 \i1 \fs18 \sa0 \sb0 
See
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
 Tu Vu, 
}
{\b0 \cf1 \f2 \i1 \fs18 
{\b0 \cf1 \f2 \ul0 \strike0 \i1 \fs18 \sa0 \sb0 
FreshLLMs: Refreshing Large Language Models with Search Engine Augmentation
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
, 
}
{\b0 \cf1 \f2 \i0 \fs18 
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
arXiv
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs18 \sa200 \sb0 
 (Nov. 22, 2023) (preprint), https://arxiv.org/pdf/2310.03214.pdf [https://perma.cc/K5WX-YFU2] (comparing LLMs (two generative pre-trained transformer (\u8220\'3fGPT\u8221\'3f) models and Perplexity) with Google search and finding that, while the models struggled to answer questions that contained false information, they were as, or in some cases more, accurate than Google).
\par 
}
}
}
}
}\b0 \cf1 \f2 \ri0 \ul0 \strike0 \i0 \qj \li0 \fs18 \sa200 \sb0 \intbl \cell \row }
{\trowd \ltrrow \trleft0 
\clbrdrl \trql \clvertalt \clwWidth600 \cellx600 
\clpadb90 \clpadfb3 \clpadl90 \clpadfl3 \clbrdrr \trql \clwWidth9480 \cellx10080 
\intbl 
{\ri0 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \ql \fs18 \li0 
{\b0 \cf1 \f2 \i0 \fs18 
{\*\bkmkstart co_footnote_F9546934635_1}{\*\bkmkend co_footnote_F9546934635_1}
{\field {\*\fldinst HYPERLINK "#co_fnRef_F9546934635_ID0E4FAE_1" }{\fldrslt 
{\super \b0 \cf19 \f2 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
9
}\super \b0 \cf19 \f2 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 }}
\par 
}
}
}\b0 \cf1 \f2 \ri0 \i0 \ql \li0 \fs18 \intbl \cell \intbl 
{\ri0 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs18 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs18 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs18 \li0 
{\b0 \cf1 \f2 \i1 \fs18 
{\b0 \cf1 \f2 \ul0 \strike0 \i1 \fs18 \sa0 \sb0 
See
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
 Yue Zhang et al., 
}
{\b0 \cf1 \f2 \i1 \fs18 
{\b0 \cf1 \f2 \ul0 \strike0 \i1 \fs18 \sa0 \sb0 
Siren\rquote s Song in the AI Ocean: A Survey on Hallucination in Large Language Models
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
, 
}
{\b0 \cf1 \f2 \i0 \fs18 
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
arXiv
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs18 \sa200 \sb0 
 (Sept. 24, 2023) (preprint), https://arxiv.org/pdf/2309.01219.pdf [https://perma.cc/Y894-3D35].
\par 
}
}
}
}
}\b0 \cf1 \f2 \ri0 \ul0 \strike0 \i0 \qj \li0 \fs18 \sa200 \sb0 \intbl \cell \row }
{\trowd \ltrrow \trleft0 
\clbrdrl \trql \clvertalt \clwWidth600 \cellx600 
\clpadb90 \clpadfb3 \clpadl90 \clpadfl3 \clbrdrr \trql \clwWidth9480 \cellx10080 
\intbl 
{\ri0 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \ql \fs18 \li0 
{\b0 \cf1 \f2 \i0 \fs18 
{\*\bkmkstart co_footnote_F10546934635_1}{\*\bkmkend co_footnote_F10546934635_1}
{\field {\*\fldinst HYPERLINK "#co_fnRef_F10546934635_ID0EEGAE_1" }{\fldrslt 
{\super \b0 \cf19 \f2 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
10
}\super \b0 \cf19 \f2 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 }}
\par 
}
}
}\b0 \cf1 \f2 \ri0 \i0 \ql \li0 \fs18 \intbl \cell \intbl 
{\ri0 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs18 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs18 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs18 \li0 
{\b0 \cf1 \f2 \i1 \fs18 
{\b0 \cf1 \f2 \ul0 \strike0 \i1 \fs18 \sa0 \sb0 
See, e.g.
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs18 \sa200 \sb0 
, Complaint at 2, New York Times Co. v. Microsoft Corp., No. 1:23-cv-11195 (S.D.N.Y. Dec. 27, 2023).
\par 
}
}
}
}
}\b0 \cf1 \f2 \ri0 \ul0 \strike0 \i0 \qj \li0 \fs18 \sa200 \sb0 \intbl \cell \row }
{\trowd \ltrrow \trleft0 
\clbrdrl \trql \clvertalt \clwWidth600 \cellx600 
\clpadb90 \clpadfb3 \clpadl90 \clpadfl3 \clbrdrr \trql \clwWidth9480 \cellx10080 
\intbl 
{\ri0 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \ql \fs18 \li0 
{\b0 \cf1 \f2 \i0 \fs18 
{\*\bkmkstart co_footnote_F11546934635_1}{\*\bkmkend co_footnote_F11546934635_1}
{\field {\*\fldinst HYPERLINK "#co_fnRef_F11546934635_ID0E4GAE_1" }{\fldrslt 
{\super \b0 \cf19 \f2 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
11
}\super \b0 \cf19 \f2 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 }}
\par 
}
}
}\b0 \cf1 \f2 \ri0 \i0 \ql \li0 \fs18 \intbl \cell \intbl 
{\ri0 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs18 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs18 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs18 \li0 
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs18 \sa200 \sb0 
Blatt responded to a question about defamation liability, saying:
\par 
}
}
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs18 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs18 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs18 \li0 
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
No, I\rquote m not worried about the defamation claim. 
}
{\b0 \cf1 \f2 \i1 \fs18 
{\b0 \cf1 \f2 \ul0 \strike0 \i1 \fs18 \sa0 \sb0 
I\rquote m worried for a products liability claim
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs18 \sa200 \sb0 
 or what the government kept saying, your design choices. Those could just be a product liability claim or a negligence claim. You negligently went alphabetical or you negligently featured whatever you featured that made my, you know, kid addicted to whatever it was. And that--those kind of claims happen because they\rquote re publishing. And the whole point of getting this statute was to protect against publishing. So whatever is publishing, inherent to publishing, yeah, has to be covered.
\par 
}
}
}
}
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs18 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs18 \li0 
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
Transcript of Oral Argument at 161, 
}
{\field {\*\fldinst HYPERLINK "https://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2074754241&pubNum=0000780&originatingDoc=I434c460335f011ef8921fbef1a541940&refType=RP&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b0 \cf19 \f2 \i1 \fs18 
{\b0 \cf19 \f2 \ul0 \strike0 \i1 \fs18 \sa0 \sb0 
Gonzalez
}
}
{\b0 \cf19 \f2 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
, 598 U.S. 617
}\b0 \cf19 \f2 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 }}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs18 \sa200 \sb0 
 (emphasis added).
\par 
}
}
}
}
}
}\b0 \cf1 \f2 \ri0 \ul0 \strike0 \i0 \qj \li0 \fs18 \sa200 \sb0 \intbl \cell \row }
{\trowd \ltrrow \trleft0 
\clbrdrl \trql \clvertalt \clwWidth600 \cellx600 
\clpadb90 \clpadfb3 \clpadl90 \clpadfl3 \clbrdrr \trql \clwWidth9480 \cellx10080 
\intbl 
{\ri0 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \ql \fs18 \li0 
{\b0 \cf1 \f2 \i0 \fs18 
{\*\bkmkstart co_footnote_F12546934635_1}{\*\bkmkend co_footnote_F12546934635_1}
{\field {\*\fldinst HYPERLINK "#co_fnRef_F12546934635_ID0EAHAE_1" }{\fldrslt 
{\super \b0 \cf19 \f2 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
12
}\super \b0 \cf19 \f2 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 }}
\par 
}
}
}\b0 \cf1 \f2 \ri0 \i0 \ql \li0 \fs18 \intbl \cell \intbl 
{\ri0 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs18 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs18 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs18 \li0 
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
The number of social media-related products liability complaints has dramatically increased. \u8220\'3fOf the 186 federal complaints involving major social media platforms since 2016, 179 of them were filed in the last 12 months. Notably, 100 of those complaints have been filed since October 3, when the Supreme Court granted certiorari in 
}
{\b0 \cf1 \f2 \i1 \fs18 
{\b0 \cf1 \f2 \ul0 \strike0 \i1 \fs18 \sa0 \sb0 
Gonzalez
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
.\u8221\'3f Peter Karalis & Golriz Chrostowski, 
}
{\b0 \cf1 \f2 \i1 \fs18 
{\b0 \cf1 \f2 \ul0 \strike0 \i1 \fs18 \sa0 \sb0 
ANALYSIS: Product Claims Spike as SCOTUS Ponders 
}
{\field {\*\fldinst HYPERLINK "https://www.westlaw.com/Link/Document/FullText?findType=L&pubNum=1000546&cite=47USCAS230&originatingDoc=I434c460335f011ef8921fbef1a541940&refType=LQ&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b0 \cf19 \f2 \ul0 \strike0 \i1 \fs18 \sa0 \sb0 
Section 230
}\b0 \cf19 \f2 \ul0 \strike0 \i1 \fs18 \sa0 \sb0 }}
{\b0 \cf1 \f2 \ul0 \strike0 \i1 \fs18 \sa0 \sb0 
 Fix
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
, 
}
{\b0 \cf1 \f2 \i0 \fs18 
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
Bloomberg L.
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs18 \sa200 \sb0 
 (Mar. 2, 2023, 1:01 PM), https://news.bloomberglaw.com/bloomberg-law-analysis/analysis-product-claims-spike-as-scotus-ponders-section-230-fix [https://perma.cc/6MAV-7ER5].
\par 
}
}
}
}
}\b0 \cf1 \f2 \ri0 \ul0 \strike0 \i0 \qj \li0 \fs18 \sa200 \sb0 \intbl \cell \row }
{\trowd \ltrrow \trleft0 
\clbrdrl \trql \clvertalt \clwWidth600 \cellx600 
\clpadb90 \clpadfb3 \clpadl90 \clpadfl3 \clbrdrr \trql \clwWidth9480 \cellx10080 
\intbl 
{\ri0 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \ql \fs18 \li0 
{\b0 \cf1 \f2 \i0 \fs18 
{\*\bkmkstart co_footnote_F13546934635_1}{\*\bkmkend co_footnote_F13546934635_1}
{\field {\*\fldinst HYPERLINK "#co_fnRef_F13546934635_ID0EEHAE_1" }{\fldrslt 
{\super \b0 \cf19 \f2 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
13
}\super \b0 \cf19 \f2 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 }}
\par 
}
}
}\b0 \cf1 \f2 \ri0 \i0 \ql \li0 \fs18 \intbl \cell \intbl 
{\ri0 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs18 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs18 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs18 \li0 
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
A California federal district court in an ongoing multidistrict litigation rejected social media companies\rquote  motions to dismiss products liability claims. 
}
{\b0 \cf1 \f2 \i1 \fs18 
{\b0 \cf1 \f2 \ul0 \strike0 \i1 \fs18 \sa0 \sb0 
See
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
 In re Soc. Media Adolescent Addiction/Pers. Inj. 
}
{\field {\*\fldinst HYPERLINK "https://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2077442454&pubNum=0000999&originatingDoc=I434c460335f011ef8921fbef1a541940&refType=RP&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b0 \cf19 \f2 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
Prod. Liab. Litig., No. 4:22-MD-3047, 2023 WL 7524912 (N.D. Cal. Mar. 10, 2023)
}\b0 \cf19 \f2 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 }}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
. The court crafted a test to determine when platforms are subject to products liability. 
}
{\b0 \cf1 \f2 \i1 \fs18 
{\b0 \cf1 \f2 \ul0 \strike0 \i1 \fs18 \sa0 \sb0 
Id.
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
 at *24. Evaluating whether specific \u8220\'3ffunctionalities\u8221\'3f of platforms are analogous to physical products, Judge Rogers allowed design defect claims for platforms\rquote  omissions of parental and screen-time controls, among others, to survive the motion to dismiss. 
}
{\b0 \cf1 \f2 \i1 \fs18 
{\b0 \cf1 \f2 \ul0 \strike0 \i1 \fs18 \sa0 \sb0 
Id.
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs18 \sa200 \sb0 
 at *29-31.
\par 
}
}
}
}
}\b0 \cf1 \f2 \ri0 \ul0 \strike0 \i0 \qj \li0 \fs18 \sa200 \sb0 \intbl \cell \row }
{\trowd \ltrrow \trleft0 
\clbrdrl \trql \clvertalt \clwWidth600 \cellx600 
\clpadb90 \clpadfb3 \clpadl90 \clpadfl3 \clbrdrr \trql \clwWidth9480 \cellx10080 
\intbl 
{\ri0 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \ql \fs18 \li0 
{\b0 \cf1 \f2 \i0 \fs18 
{\*\bkmkstart co_footnote_F14546934635_1}{\*\bkmkend co_footnote_F14546934635_1}
{\field {\*\fldinst HYPERLINK "#co_fnRef_F14546934635_ID0EWHAE_1" }{\fldrslt 
{\super \b0 \cf19 \f2 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
14
}\super \b0 \cf19 \f2 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 }}
\par 
}
}
}\b0 \cf1 \f2 \ri0 \i0 \ql \li0 \fs18 \intbl \cell \intbl 
{\ri0 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs18 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs18 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs18 \li0 
{\b0 \cf1 \f2 \i1 \fs18 
{\b0 \cf1 \f2 \ul0 \strike0 \i1 \fs18 \sa0 \sb0 
See, e.g.
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
, Andrew D. Selbst, 
}
{\field {\*\fldinst HYPERLINK "https://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=0501688872&pubNum=0003197&originatingDoc=I434c460335f011ef8921fbef1a541940&refType=LR&fi=co_pp_sp_3197_1375&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)#co_pp_sp_3197_1375" }{\fldrslt 
{\b0 \cf19 \f2 \i1 \fs18 
{\b0 \cf19 \f2 \ul0 \strike0 \i1 \fs18 \sa0 \sb0 
Negligence and AI\rquote s Human Users
}
}
{\b0 \cf19 \f2 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
, 100 
}
{\b0 \cf19 \f2 \i0 \fs18 
{\b0 \cf19 \f2 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
B.U. L. Rev.
}
}
{\b0 \cf19 \f2 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
 1315, 1375 (2019)
}\b0 \cf19 \f2 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 }}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs18 \sa200 \sb0 
 (\u8220\'3fWhere society decides that AI is too beneficial to set aside, we will likely need a new regulatory paradigm to compensate the victims of AI\rquote s use ....\u8221\'3f).
\par 
}
}
}
}
}\b0 \cf1 \f2 \ri0 \ul0 \strike0 \i0 \qj \li0 \fs18 \sa200 \sb0 \intbl \cell \row }
{\trowd \ltrrow \trleft0 
\clbrdrl \trql \clvertalt \clwWidth600 \cellx600 
\clpadb90 \clpadfb3 \clpadl90 \clpadfl3 \clbrdrr \trql \clwWidth9480 \cellx10080 
\intbl 
{\ri0 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \ql \fs18 \li0 
{\b0 \cf1 \f2 \i0 \fs18 
{\*\bkmkstart co_footnote_F15546934635_1}{\*\bkmkend co_footnote_F15546934635_1}
{\field {\*\fldinst HYPERLINK "#co_fnRef_F15546934635_ID0E2HAE_1" }{\fldrslt 
{\super \b0 \cf19 \f2 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
15
}\super \b0 \cf19 \f2 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 }}
\par 
}
}
}\b0 \cf1 \f2 \ri0 \i0 \ql \li0 \fs18 \intbl \cell \intbl 
{\ri0 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs18 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs18 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs18 \li0 
{\b0 \cf1 \f2 \i1 \fs18 
{\b0 \cf1 \f2 \ul0 \strike0 \i1 \fs18 \sa0 \sb0 
See, e.g.
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
, Jeannie Baumann, 
}
{\b0 \cf1 \f2 \i1 \fs18 
{\b0 \cf1 \f2 \ul0 \strike0 \i1 \fs18 \sa0 \sb0 
ChatGPT Poses New Regulatory Questions for FDA, Medical Industry
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
, 
}
{\b0 \cf1 \f2 \i0 \fs18 
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
Bloomberg L.
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs18 \sa200 \sb0 
 (June 21, 2023), https://www.bloomberglaw.com/bloomberglawnews/health-law-and-business/X9ISGPPG000000 [https://perma.cc/Q5GL-XEL8] (\u8220\'3fModels that update and learn, potentially could veer off from their original tasks and learn in the wrong direction if we\rquote re not keeping track .... [S]oftware needs to be monitored to make sure it\rquote s continuing to perform like expected.\u8221\'3f).
\par 
}
}
}
}
}\b0 \cf1 \f2 \ri0 \ul0 \strike0 \i0 \qj \li0 \fs18 \sa200 \sb0 \intbl \cell \row }
{\trowd \ltrrow \trleft0 
\clbrdrl \trql \clvertalt \clwWidth600 \cellx600 
\clpadb90 \clpadfb3 \clpadl90 \clpadfl3 \clbrdrr \trql \clwWidth9480 \cellx10080 
\intbl 
{\ri0 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \ql \fs18 \li0 
{\b0 \cf1 \f2 \i0 \fs18 
{\*\bkmkstart co_footnote_F16546934635_1}{\*\bkmkend co_footnote_F16546934635_1}
{\field {\*\fldinst HYPERLINK "#co_fnRef_F16546934635_ID0E6IAE_1" }{\fldrslt 
{\super \b0 \cf19 \f2 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
16
}\super \b0 \cf19 \f2 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 }}
\par 
}
}
}\b0 \cf1 \f2 \ri0 \i0 \ql \li0 \fs18 \intbl \cell \intbl 
{\ri0 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs18 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs18 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs18 \li0 
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
President Biden\rquote s Executive Order on Safe, Secure, and Trustworthy Development and Use of Artificial Intelligence recognizes that \u8220\'3f[h]arnessing AI for good and realizing its myriad benefits requires mitigating its substantial risks.\u8221\'3f 
}
{\field {\*\fldinst HYPERLINK "https://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2077292919&pubNum=0001043&originatingDoc=I434c460335f011ef8921fbef1a541940&refType=CA&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b0 \cf19 \f2 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
Exec. Order No. 14,110, 
}
{\b0 \cf19 \f2 \i1 \fs18 
{\b0 \cf19 \f2 \ul0 \strike0 \i1 \fs18 \sa0 \sb0 
supra
}
}
{\b0 \cf19 \f2 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
 note 1
}\b0 \cf19 \f2 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 }}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
, at 75191. It proceeds to lay out \u8220\'3fa coordinated, Federal Government-wide approach\u8221\'3f to \u8220\'3fgoverning the development and use of AI safely and responsibly.\u8221\'3f 
}
{\b0 \cf1 \f2 \i1 \fs18 
{\b0 \cf1 \f2 \ul0 \strike0 \i1 \fs18 \sa200 \sb0 
Id.
\par 
}
}
}
}
}
}\b0 \cf1 \f2 \ri0 \ul0 \strike0 \i1 \qj \li0 \fs18 \sa200 \sb0 \intbl \cell \row }
{\trowd \ltrrow \trleft0 
\clbrdrl \trql \clvertalt \clwWidth600 \cellx600 
\clpadb90 \clpadfb3 \clpadl90 \clpadfl3 \clbrdrr \trql \clwWidth9480 \cellx10080 
\intbl 
{\ri0 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \ql \fs18 \li0 
{\b0 \cf1 \f2 \i0 \fs18 
{\*\bkmkstart co_footnote_F17546934635_1}{\*\bkmkend co_footnote_F17546934635_1}
{\field {\*\fldinst HYPERLINK "#co_fnRef_F17546934635_ID0EFJAE_1" }{\fldrslt 
{\super \b0 \cf19 \f2 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
17
}\super \b0 \cf19 \f2 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 }}
\par 
}
}
}\b0 \cf1 \f2 \ri0 \i0 \ql \li0 \fs18 \intbl \cell \intbl 
{\ri0 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs18 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs18 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs18 \li0 
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
Catherine M. Sharkey, 
}
{\field {\*\fldinst HYPERLINK "https://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=0526946439&pubNum=0001159&originatingDoc=I434c460335f011ef8921fbef1a541940&refType=LR&fi=co_pp_sp_1159_1333&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)#co_pp_sp_1159_1333" }{\fldrslt 
{\b0 \cf19 \f2 \i1 \fs18 
{\b0 \cf19 \f2 \ul0 \strike0 \i1 \fs18 \sa0 \sb0 
Products Liability in the Digital Age: Online Platforms as \u8220\'3fCheapest Cost Avoiders\u8221\'3f
}
}
{\b0 \cf19 \f2 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
, 73 
}
{\b0 \cf19 \f2 \i0 \fs18 
{\b0 \cf19 \f2 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
Hastings L.J.
}
}
{\b0 \cf19 \f2 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
 1327, 1333-34 (2022)
}\b0 \cf19 \f2 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 }}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs18 \sa200 \sb0 
 (\u8220\'3f[P]roducts liability is a microcosm of how the common law evolves over times, specifically, here, to respond to new societal risks--posed by the automobile, mass-produced goods, and now, digital e-commerce.\u8221\'3f).
\par 
}
}
}
}
}\b0 \cf1 \f2 \ri0 \ul0 \strike0 \i0 \qj \li0 \fs18 \sa200 \sb0 \intbl \cell \row }
{\trowd \ltrrow \trleft0 
\clbrdrl \trql \clvertalt \clwWidth600 \cellx600 
\clpadb90 \clpadfb3 \clpadl90 \clpadfl3 \clbrdrr \trql \clwWidth9480 \cellx10080 
\intbl 
{\ri0 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \ql \fs18 \li0 
{\b0 \cf1 \f2 \i0 \fs18 
{\*\bkmkstart co_footnote_F18546934635_1}{\*\bkmkend co_footnote_F18546934635_1}
{\field {\*\fldinst HYPERLINK "#co_fnRef_F18546934635_ID0EMJAE_1" }{\fldrslt 
{\super \b0 \cf19 \f2 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
18
}\super \b0 \cf19 \f2 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 }}
\par 
}
}
}\b0 \cf1 \f2 \ri0 \i0 \ql \li0 \fs18 \intbl \cell \intbl 
{\ri0 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs18 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs18 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs18 \li0 
{\b0 \cf1 \f2 \i1 \fs18 
{\b0 \cf1 \f2 \ul0 \strike0 \i1 \fs18 \sa200 \sb0 
Id.
\par 
}
}
}
}
}
}\b0 \cf1 \f2 \ri0 \ul0 \strike0 \i1 \qj \li0 \fs18 \sa200 \sb0 \intbl \cell \row }
{\trowd \ltrrow \trleft0 
\clbrdrl \trql \clvertalt \clwWidth600 \cellx600 
\clpadb90 \clpadfb3 \clpadl90 \clpadfl3 \clbrdrr \trql \clwWidth9480 \cellx10080 
\intbl 
{\ri0 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \ql \fs18 \li0 
{\b0 \cf1 \f2 \i0 \fs18 
{\*\bkmkstart co_footnote_F19546934635_1}{\*\bkmkend co_footnote_F19546934635_1}
{\field {\*\fldinst HYPERLINK "#co_fnRef_F19546934635_ID0EFMAE_1" }{\fldrslt 
{\super \b0 \cf19 \f2 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
19
}\super \b0 \cf19 \f2 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 }}
\par 
}
}
}\b0 \cf1 \f2 \ri0 \i0 \ql \li0 \fs18 \intbl \cell \intbl 
{\ri0 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs18 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs18 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs18 \li0 
{\b0 \cf1 \f2 \i0 \fs18 
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
Off. of Mgmt. & Budget, Exec. Off. of the President, Advancing Governance, Innovation, and Risk Management for Agency Use of Artificial Intelligence
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs18 \sa200 \sb0 
 (Oct. 30, 2023), https://www.whitehouse.gov/wp-content/uploads/2023/11/AI-in-Government-Memo-draft-for-public-review.pdf [https://perma.cc/9L4Z-5M7U].
\par 
}
}
}
}
}\b0 \cf1 \f2 \ri0 \ul0 \strike0 \i0 \qj \li0 \fs18 \sa200 \sb0 \intbl \cell \row }
{\trowd \ltrrow \trleft0 
\clbrdrl \trql \clvertalt \clwWidth600 \cellx600 
\clpadb90 \clpadfb3 \clpadl90 \clpadfl3 \clbrdrr \trql \clwWidth9480 \cellx10080 
\intbl 
{\ri0 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \ql \fs18 \li0 
{\b0 \cf1 \f2 \i0 \fs18 
{\*\bkmkstart co_footnote_F20546934635_1}{\*\bkmkend co_footnote_F20546934635_1}
{\field {\*\fldinst HYPERLINK "#co_fnRef_F20546934635_ID0EINAE_1" }{\fldrslt 
{\super \b0 \cf19 \f2 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
20
}\super \b0 \cf19 \f2 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 }}
\par 
}
}
}\b0 \cf1 \f2 \ri0 \i0 \ql \li0 \fs18 \intbl \cell \intbl 
{\ri0 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs18 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs18 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs18 \li0 
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
Baumann, 
}
{\b0 \cf1 \f2 \i1 \fs18 
{\b0 \cf1 \f2 \ul0 \strike0 \i1 \fs18 \sa0 \sb0 
supra
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs18 \sa200 \sb0 
 note 15.
\par 
}
}
}
}
}\b0 \cf1 \f2 \ri0 \ul0 \strike0 \i0 \qj \li0 \fs18 \sa200 \sb0 \intbl \cell \row }
{\trowd \ltrrow \trleft0 
\clbrdrl \trql \clvertalt \clwWidth600 \cellx600 
\clpadb90 \clpadfb3 \clpadl90 \clpadfl3 \clbrdrr \trql \clwWidth9480 \cellx10080 
\intbl 
{\ri0 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \ql \fs18 \li0 
{\b0 \cf1 \f2 \i0 \fs18 
{\*\bkmkstart co_footnote_F21546934635_1}{\*\bkmkend co_footnote_F21546934635_1}
{\field {\*\fldinst HYPERLINK "#co_fnRef_F21546934635_ID0EZNAE_1" }{\fldrslt 
{\super \b0 \cf19 \f2 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
21
}\super \b0 \cf19 \f2 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 }}
\par 
}
}
}\b0 \cf1 \f2 \ri0 \i0 \ql \li0 \fs18 \intbl \cell \intbl 
{\ri0 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs18 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs18 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs18 \li0 
{\b0 \cf1 \f2 \i1 \fs18 
{\b0 \cf1 \f2 \ul0 \strike0 \i1 \fs18 \sa200 \sb0 
Id.
\par 
}
}
}
}
}
}\b0 \cf1 \f2 \ri0 \ul0 \strike0 \i1 \qj \li0 \fs18 \sa200 \sb0 \intbl \cell \row }
{\trowd \ltrrow \trleft0 
\clbrdrl \trql \clvertalt \clwWidth600 \cellx600 
\clpadb90 \clpadfb3 \clpadl90 \clpadfl3 \clbrdrr \trql \clwWidth9480 \cellx10080 
\intbl 
{\ri0 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \ql \fs18 \li0 
{\b0 \cf1 \f2 \i0 \fs18 
{\*\bkmkstart co_footnote_F22546934635_1}{\*\bkmkend co_footnote_F22546934635_1}
{\field {\*\fldinst HYPERLINK "#co_fnRef_F22546934635_ID0E3NAE_1" }{\fldrslt 
{\super \b0 \cf19 \f2 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
22
}\super \b0 \cf19 \f2 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 }}
\par 
}
}
}\b0 \cf1 \f2 \ri0 \i0 \ql \li0 \fs18 \intbl \cell \intbl 
{\ri0 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs18 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs18 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs18 \li0 
{\b0 \cf1 \f2 \i1 \fs18 
{\b0 \cf1 \f2 \ul0 \strike0 \i1 \fs18 \sa0 \sb0 
See
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
 Catherine M. Sharkey, 
}
{\b0 \cf1 \f2 \i1 \fs18 
{\b0 \cf1 \f2 \ul0 \strike0 \i1 \fs18 \sa0 \sb0 
Common Law Tort as a Transitional Regulatory Regime: A New Perspective on Climate Change Litigation
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
, 
}
{\b0 \cf1 \f2 \i1 \fs18 
{\b0 \cf1 \f2 \ul0 \strike0 \i1 \fs18 \sa0 \sb0 
in
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
 
}
{\b0 \cf1 \f2 \i0 \fs18 
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
Climate Liberalism: Perspectives on Liberty, Property and Pollution
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
 103 (Jonathan H. Adler ed., 2023); 
}
{\b0 \cf1 \f2 \i1 \fs18 
{\b0 \cf1 \f2 \ul0 \strike0 \i1 \fs18 \sa0 \sb0 
see also
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
 Catherine M. Sharkey, 
}
{\b0 \cf1 \f2 \i1 \fs18 
{\b0 \cf1 \f2 \ul0 \strike0 \i1 \fs18 \sa0 \sb0 
Tort as Backstop to Regulation in the Face of Uncertainty
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
, 
}
{\b0 \cf1 \f2 \i0 \fs18 
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
Jotwell
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
 (Nov. 26, 2013) (reviewing Thomas Merrill & David Schizer, 
}
{\field {\*\fldinst HYPERLINK "https://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=0394127843&pubNum=0001193&originatingDoc=I434c460335f011ef8921fbef1a541940&refType=LR&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b0 \cf19 \f2 \i1 \fs18 
{\b0 \cf19 \f2 \ul0 \strike0 \i1 \fs18 \sa0 \sb0 
The Shale Oil and Gas Revolution, Hydraulic Fracturing, and Water Contamination: A Regulatory Strategy
}
}
{\b0 \cf19 \f2 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
, 98 
}
{\b0 \cf19 \f2 \i0 \fs18 
{\b0 \cf19 \f2 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
Minn. L. Rev.
}
}
{\b0 \cf19 \f2 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
 145 (2013)
}\b0 \cf19 \f2 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 }}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
) (\u8220\'3fAt the core is the need for a dynamic regulatory response, one that generates additional information about potential risks and stimulates innovation to reduce these risks.\u8221\'3f
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs18 \sa200 \sb0 
).
\par 
}
}
}
}
}\b0 \cf1 \f2 \ri0 \ul0 \strike0 \i0 \qj \li0 \fs18 \sa200 \sb0 \intbl \cell \row }
{\trowd \ltrrow \trleft0 
\clbrdrl \trql \clvertalt \clwWidth600 \cellx600 
\clpadb90 \clpadfb3 \clpadl90 \clpadfl3 \clbrdrr \trql \clwWidth9480 \cellx10080 
\intbl 
{\ri0 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \ql \fs18 \li0 
{\b0 \cf1 \f2 \i0 \fs18 
{\*\bkmkstart co_footnote_F23546934635_1}{\*\bkmkend co_footnote_F23546934635_1}
{\field {\*\fldinst HYPERLINK "#co_fnRef_F23546934635_ID0EQOAE_1" }{\fldrslt 
{\super \b0 \cf19 \f2 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
23
}\super \b0 \cf19 \f2 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 }}
\par 
}
}
}\b0 \cf1 \f2 \ri0 \i0 \ql \li0 \fs18 \intbl \cell \intbl 
{\ri0 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs18 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs18 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs18 \li0 
{\b0 \cf1 \f2 \i1 \fs18 
{\b0 \cf1 \f2 \ul0 \strike0 \i1 \fs18 \sa0 \sb0 
See
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
 Sharkey, 
}
{\b0 \cf1 \f2 \i1 \fs18 
{\b0 \cf1 \f2 \ul0 \strike0 \i1 \fs18 \sa0 \sb0 
Tort as Backstop to Regulation in the Face of Uncertainty
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
, 
}
{\b0 \cf1 \f2 \i1 \fs18 
{\b0 \cf1 \f2 \ul0 \strike0 \i1 \fs18 \sa0 \sb0 
supra
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs18 \sa200 \sb0 
 note 22 (\u8220\'3fHydraulic fracturing is a controversial process whereby energy companies pump fluid into shale formations at high pressure to crack the rock and release the gas and oil trapped inside.\u8221\'3f).
\par 
}
}
}
}
}\b0 \cf1 \f2 \ri0 \ul0 \strike0 \i0 \qj \li0 \fs18 \sa200 \sb0 \intbl \cell \row }
{\trowd \ltrrow \trleft0 
\clbrdrl \trql \clvertalt \clwWidth600 \cellx600 
\clpadb90 \clpadfb3 \clpadl90 \clpadfl3 \clbrdrr \trql \clwWidth9480 \cellx10080 
\intbl 
{\ri0 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \ql \fs18 \li0 
{\b0 \cf1 \f2 \i0 \fs18 
{\*\bkmkstart co_footnote_F24546934635_1}{\*\bkmkend co_footnote_F24546934635_1}
{\field {\*\fldinst HYPERLINK "#co_fnRef_F24546934635_ID0EVOAE_1" }{\fldrslt 
{\super \b0 \cf19 \f2 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
24
}\super \b0 \cf19 \f2 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 }}
\par 
}
}
}\b0 \cf1 \f2 \ri0 \i0 \ql \li0 \fs18 \intbl \cell \intbl 
{\ri0 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs18 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs18 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs18 \li0 
{\b0 \cf1 \f2 \i1 \fs18 
{\b0 \cf1 \f2 \ul0 \strike0 \i1 \fs18 \sa0 \sb0 
Id.
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs18 \sa200 \sb0 
 (summarizing risks, including \u8220\'3fincreased air pollution, traffic and congestion (all risks associated with conventional oil and gas drilling) and, most significantly, potential contamination of groundwater (a unique risk associated with fracturing)\u8221\'3f).
\par 
}
}
}
}
}\b0 \cf1 \f2 \ri0 \ul0 \strike0 \i0 \qj \li0 \fs18 \sa200 \sb0 \intbl \cell \row }
{\trowd \ltrrow \trleft0 
\clbrdrl \trql \clvertalt \clwWidth600 \cellx600 
\clpadb90 \clpadfb3 \clpadl90 \clpadfl3 \clbrdrr \trql \clwWidth9480 \cellx10080 
\intbl 
{\ri0 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \ql \fs18 \li0 
{\b0 \cf1 \f2 \i0 \fs18 
{\*\bkmkstart co_footnote_F25546934635_1}{\*\bkmkend co_footnote_F25546934635_1}
{\field {\*\fldinst HYPERLINK "#co_fnRef_F25546934635_ID0EGPAE_1" }{\fldrslt 
{\super \b0 \cf19 \f2 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
25
}\super \b0 \cf19 \f2 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 }}
\par 
}
}
}\b0 \cf1 \f2 \ri0 \i0 \ql \li0 \fs18 \intbl \cell \intbl 
{\ri0 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs18 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs18 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs18 \li0 
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
Professor Thomas Merrill, commenting at the symposium, contrasted the U.S. approach to new technology of \u8220\'3ftry first, apologize later\u8221\'3f with the European approach of \u8220\'3fregulate first\u8221\'3f in order to understand the consequences of the technology before releasing it. Symposium, 
}
{\b0 \cf1 \f2 \i1 \fs18 
{\b0 \cf1 \f2 \ul0 \strike0 \i1 \fs18 \sa0 \sb0 
Accountability & Liability in Generative AI: Challenges & Perspectives
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
, 
}
{\b0 \cf1 \f2 \i1 \fs18 
{\b0 \cf1 \f2 \ul0 \strike0 \i1 \fs18 \sa0 \sb0 
supra
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
 note 4. According to Professor Merrill, worries stopped Europe from pursuing fracking, whereas the U.S. pursued fracking despite its risks--many of which never materialized. 
}
{\b0 \cf1 \f2 \i1 \fs18 
{\b0 \cf1 \f2 \ul0 \strike0 \i1 \fs18 \sa0 \sb0 
Id.
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
 The U.S. approach--which also encourages innovation--thus proved superior to the European one. 
}
{\b0 \cf1 \f2 \i1 \fs18 
{\b0 \cf1 \f2 \ul0 \strike0 \i1 \fs18 \sa0 \sb0 
See id.
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
; 
}
{\b0 \cf1 \f2 \i1 \fs18 
{\b0 \cf1 \f2 \ul0 \strike0 \i1 \fs18 \sa0 \sb0 
see also
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
 Thomas Merrill & David Schizer, 
}
{\field {\*\fldinst HYPERLINK "https://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=0394127843&pubNum=0001193&originatingDoc=I434c460335f011ef8921fbef1a541940&refType=LR&fi=co_pp_sp_1193_215&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)#co_pp_sp_1193_215" }{\fldrslt 
{\b0 \cf19 \f2 \i1 \fs18 
{\b0 \cf19 \f2 \ul0 \strike0 \i1 \fs18 \sa0 \sb0 
The Shale Oil and Gas Revolution, Hydraulic Fracturing, and Water Contamination: A Regulatory Strategy
}
}
{\b0 \cf19 \f2 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
, 98 
}
{\b0 \cf19 \f2 \i0 \fs18 
{\b0 \cf19 \f2 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
Minn. L. Rev.
}
}
{\b0 \cf19 \f2 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
 145, 215 (2013)
}\b0 \cf19 \f2 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 }}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
 (\u8220\'3fWhen technology is new, we can predict some harm that it could cause, but not all of them, and not always with confidence about their magnitude and severity. Also, it is especially difficult to devise solutions for these harms. Effective predictions and solutions--and, thus, effective 
}
{\b0 \cf1 \f2 \i1 \fs18 
{\b0 \cf1 \f2 \ul0 \strike0 \i1 \fs18 \sa0 \sb0 
ex ante
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
 regulation--require experience. Without experience, we generally will be better off with some form of 
}
{\b0 \cf1 \f2 \i1 \fs18 
{\b0 \cf1 \f2 \ul0 \strike0 \i1 \fs18 \sa0 \sb0 
ex post
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs18 \sa200 \sb0 
 regulation.\u8221\'3f).
\par 
}
}
}
}
}\b0 \cf1 \f2 \ri0 \ul0 \strike0 \i0 \qj \li0 \fs18 \sa200 \sb0 \intbl \cell \row }
{\trowd \ltrrow \trleft0 
\clbrdrl \trql \clvertalt \clwWidth600 \cellx600 
\clpadb90 \clpadfb3 \clpadl90 \clpadfl3 \clbrdrr \trql \clwWidth9480 \cellx10080 
\intbl 
{\ri0 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \ql \fs18 \li0 
{\b0 \cf1 \f2 \i0 \fs18 
{\*\bkmkstart co_footnote_F26546934635_1}{\*\bkmkend co_footnote_F26546934635_1}
{\field {\*\fldinst HYPERLINK "#co_fnRef_F26546934635_ID0ENSAE_1" }{\fldrslt 
{\super \b0 \cf19 \f2 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
26
}\super \b0 \cf19 \f2 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 }}
\par 
}
}
}\b0 \cf1 \f2 \ri0 \i0 \ql \li0 \fs18 \intbl \cell \intbl 
{\ri0 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs18 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs18 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs18 \li0 
{\b0 \cf1 \f2 \i1 \fs18 
{\b0 \cf1 \f2 \ul0 \strike0 \i1 \fs18 \sa0 \sb0 
See
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
 
}
{\b0 \cf1 \f2 \i0 \fs18 
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
Food & Drug Admin., How to Study and Market Your Device
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs18 \sa200 \sb0 
 (Oct. 12, 2022), https://www.fda.gov/medical-devices/device-advice-comprehensive-regulatory-assistance/how-study-and-market-your-device [https://perma.cc/TP3L-HQ5H].
\par 
}
}
}
}
}\b0 \cf1 \f2 \ri0 \ul0 \strike0 \i0 \qj \li0 \fs18 \sa200 \sb0 \intbl \cell \row }
{\trowd \ltrrow \trleft0 
\clbrdrl \trql \clvertalt \clwWidth600 \cellx600 
\clpadb90 \clpadfb3 \clpadl90 \clpadfl3 \clbrdrr \trql \clwWidth9480 \cellx10080 
\intbl 
{\ri0 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \ql \fs18 \li0 
{\b0 \cf1 \f2 \i0 \fs18 
{\*\bkmkstart co_footnote_F27546934635_1}{\*\bkmkend co_footnote_F27546934635_1}
{\field {\*\fldinst HYPERLINK "#co_fnRef_F27546934635_ID0EWSAE_1" }{\fldrslt 
{\super \b0 \cf19 \f2 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
27
}\super \b0 \cf19 \f2 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 }}
\par 
}
}
}\b0 \cf1 \f2 \ri0 \i0 \ql \li0 \fs18 \intbl \cell \intbl 
{\ri0 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs18 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs18 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs18 \li0 
{\b0 \cf1 \f2 \i1 \fs18 
{\b0 \cf1 \f2 \ul0 \strike0 \i1 \fs18 \sa0 \sb0 
See
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
 Rebecca S. Eisenberg, 
}
{\field {\*\fldinst HYPERLINK "https://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=0332064816&pubNum=0129180&originatingDoc=I434c460335f011ef8921fbef1a541940&refType=LR&fi=co_pp_sp_129180_347&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)#co_pp_sp_129180_347" }{\fldrslt 
{\b0 \cf19 \f2 \i1 \fs18 
{\b0 \cf19 \f2 \ul0 \strike0 \i1 \fs18 \sa0 \sb0 
The Role of the FDA in Innovation Policy
}
}
{\b0 \cf19 \f2 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
, 13 
}
{\b0 \cf19 \f2 \i0 \fs18 
{\b0 \cf19 \f2 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
Mich. Telecomm. Tech. L. Rev.
}
}
{\b0 \cf19 \f2 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
 345, 347 (2007)
}\b0 \cf19 \f2 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 }}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
 (claiming, contrary to the common criticism that FDA regulation of drugs stifles innovation, that it \u8220\'3fpromot[es] a valuable form of pharmaceutical innovation--the development of credible information about the effects of drugs\u8221\'3f); 
}
{\b0 \cf1 \f2 \i1 \fs18 
{\b0 \cf1 \f2 \ul0 \strike0 \i1 \fs18 \sa0 \sb0 
see also
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
 Catherine M. Sharkey & Daniel J. Kenny, 
}
{\b0 \cf1 \f2 \i1 \fs18 
{\b0 \cf1 \f2 \ul0 \strike0 \i1 \fs18 \sa0 \sb0 
FDA Leads, States Must Follow
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
, 102 
}
{\b0 \cf1 \f2 \i0 \fs18 
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
Wash. U. L. Rev.
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs18 \sa200 \sb0 
 (forthcoming 2024), https://papers.ssrn.com/sol3/papers.cfm?abstract_id=4753170 [https://perma.cc/KMU8-VQ2R] (highlighting the extent to which the FDA approval process generates high-quality data about medical products).
\par 
}
}
}
}
}\b0 \cf1 \f2 \ri0 \ul0 \strike0 \i0 \qj \li0 \fs18 \sa200 \sb0 \intbl \cell \row }
{\trowd \ltrrow \trleft0 
\clbrdrl \trql \clvertalt \clwWidth600 \cellx600 
\clpadb90 \clpadfb3 \clpadl90 \clpadfl3 \clbrdrr \trql \clwWidth9480 \cellx10080 
\intbl 
{\ri0 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \ql \fs18 \li0 
{\b0 \cf1 \f2 \i0 \fs18 
{\*\bkmkstart co_footnote_F28546934635_1}{\*\bkmkend co_footnote_F28546934635_1}
{\field {\*\fldinst HYPERLINK "#co_fnRef_F28546934635_ID0ENTAE_1" }{\fldrslt 
{\super \b0 \cf19 \f2 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
28
}\super \b0 \cf19 \f2 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 }}
\par 
}
}
}\b0 \cf1 \f2 \ri0 \i0 \ql \li0 \fs18 \intbl \cell \intbl 
{\ri0 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs18 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs18 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs18 \li0 
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
One aspect of this is racial diversity. Despite the FDA\rquote s 2015 action plan to increase diversity in clinical drug trials, researchers found that it failed to improve representation of Black patients. 
}
{\b0 \cf1 \f2 \i1 \fs18 
{\b0 \cf1 \f2 \ul0 \strike0 \i1 \fs18 \sa0 \sb0 
See
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
 Angela K. Green et al., 
}
{\b0 \cf1 \f2 \i1 \fs18 
{\b0 \cf1 \f2 \ul0 \strike0 \i1 \fs18 \sa0 \sb0 
Despite the FDA\rquote s Five-Year Plan, Black Patients Remain Inadequately Represented in Clinical Trials for Drugs
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
, 41 
}
{\b0 \cf1 \f2 \i0 \fs18 
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
Health Affairs
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
 368, 368 (Mar. 2022). The FDA has made improving clinical trial diversity a priority. 
}
{\b0 \cf1 \f2 \i1 \fs18 
{\b0 \cf1 \f2 \ul0 \strike0 \i1 \fs18 \sa0 \sb0 
See
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
 
}
{\b0 \cf1 \f2 \i0 \fs18 
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
Food & Drug Admin., Diversity Plans to Improve Enrollment of Participants From Underrepresented Racial and Ethnic Populations in Clinical Trials; Draft Guidance for Industry; Availability
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs18 \sa200 \sb0 
 (Apr. 13, 2022), https://www.fda.gov/regulatory-information/search-fda-guidance-documents/diversity-plans-improve-enrollment-participants-underrepresented-racial-and-ethnic-populations [https://perma.cc/Y48V-RBYW].
\par 
}
}
}
}
}\b0 \cf1 \f2 \ri0 \ul0 \strike0 \i0 \qj \li0 \fs18 \sa200 \sb0 \intbl \cell \row }
{\trowd \ltrrow \trleft0 
\clbrdrl \trql \clvertalt \clwWidth600 \cellx600 
\clpadb90 \clpadfb3 \clpadl90 \clpadfl3 \clbrdrr \trql \clwWidth9480 \cellx10080 
\intbl 
{\ri0 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \ql \fs18 \li0 
{\b0 \cf1 \f2 \i0 \fs18 
{\*\bkmkstart co_footnote_F29546934635_1}{\*\bkmkend co_footnote_F29546934635_1}
{\field {\*\fldinst HYPERLINK "#co_fnRef_F29546934635_ID0EDUAE_1" }{\fldrslt 
{\super \b0 \cf19 \f2 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
29
}\super \b0 \cf19 \f2 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 }}
\par 
}
}
}\b0 \cf1 \f2 \ri0 \i0 \ql \li0 \fs18 \intbl \cell \intbl 
{\ri0 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs18 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs18 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs18 \li0 
{\b0 \cf1 \f2 \i1 \fs18 
{\b0 \cf1 \f2 \ul0 \strike0 \i1 \fs18 \sa0 \sb0 
See
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
 Catherine M. Sharkey, 
}
{\field {\*\fldinst HYPERLINK "https://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=0337656152&pubNum=0001147&originatingDoc=I434c460335f011ef8921fbef1a541940&refType=LR&fi=co_pp_sp_1147_519&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)#co_pp_sp_1147_519" }{\fldrslt 
{\b0 \cf19 \f2 \i1 \fs18 
{\b0 \cf19 \f2 \ul0 \strike0 \i1 \fs18 \sa0 \sb0 
Products Liability Preemption: An Institutional Approach
}
}
{\b0 \cf19 \f2 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
, 76 
}
{\b0 \cf19 \f2 \i0 \fs18 
{\b0 \cf19 \f2 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
Geo. Wash. L. Rev.
}
}
{\b0 \cf19 \f2 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
 449, 519 (2008)
}\b0 \cf19 \f2 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 }}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
 (setting forth the \u8220\'3fagency reference\u8221\'3f model for preemption that \u8220\'3ftakes into account the dynamic nature of FDA regulation of drugs by providing manufacturers with incentives to go to the FDA upon discovery of new risks\u8221\'3f); Catherine M. Sharkey, 
}
{\field {\*\fldinst HYPERLINK "https://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=0345917850&pubNum=0001133&originatingDoc=I434c460335f011ef8921fbef1a541940&refType=LR&fi=co_pp_sp_1133_2129&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)#co_pp_sp_1133_2129" }{\fldrslt 
{\b0 \cf19 \f2 \i1 \fs18 
{\b0 \cf19 \f2 \ul0 \strike0 \i1 \fs18 \sa0 \sb0 
Federalism Accountability: \u8220\'3fAgency-Forcing\u8221\'3f Measures
}
}
{\b0 \cf19 \f2 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
, 58 
}
{\b0 \cf19 \f2 \i0 \fs18 
{\b0 \cf19 \f2 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
Duke L.J.
}
}
{\b0 \cf19 \f2 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
, 2125, 2129 (2009)
}\b0 \cf19 \f2 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 }}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs18 \sa200 \sb0 
 (\u8220\'3fThe \u8216\'3fagency reference model\u8217\'3f that I have proposed would be \u8216\'3finformation-forcing\u8217\'3f in the sense that it would require product manufacturers to come forward to the FDA with new safety risk information, including clinical studies, adverse event reports and the like, as a precondition for court determinations of preemption.\u8221\'3f).
\par 
}
}
}
}
}\b0 \cf1 \f2 \ri0 \ul0 \strike0 \i0 \qj \li0 \fs18 \sa200 \sb0 \intbl \cell \row }
{\trowd \ltrrow \trleft0 
\clbrdrl \trql \clvertalt \clwWidth600 \cellx600 
\clpadb90 \clpadfb3 \clpadl90 \clpadfl3 \clbrdrr \trql \clwWidth9480 \cellx10080 
\intbl 
{\ri0 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \ql \fs18 \li0 
{\b0 \cf1 \f2 \i0 \fs18 
{\*\bkmkstart co_footnote_F30546934635_1}{\*\bkmkend co_footnote_F30546934635_1}
{\field {\*\fldinst HYPERLINK "#co_fnRef_F30546934635_ID0EWWAE_1" }{\fldrslt 
{\super \b0 \cf19 \f2 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
30
}\super \b0 \cf19 \f2 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 }}
\par 
}
}
}\b0 \cf1 \f2 \ri0 \i0 \ql \li0 \fs18 \intbl \cell \intbl 
{\ri0 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs18 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs18 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs18 \li0 
{\b0 \cf1 \f2 \i1 \fs18 
{\b0 \cf1 \f2 \ul0 \strike0 \i1 \fs18 \sa0 \sb0 
See
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
 
}
{\field {\*\fldinst HYPERLINK "https://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2047793960&pubNum=0000780&originatingDoc=I434c460335f011ef8921fbef1a541940&refType=RP&fi=co_pp_sp_780_451&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)#co_pp_sp_780_451" }{\fldrslt 
{\b0 \cf19 \f2 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
Air & Liquid Sys. Corp. v. DeVries, 586 U.S. 446, 451 (2019)
}\b0 \cf19 \f2 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 }}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs18 \sa200 \sb0 
.
\par 
}
}
}
}
}\b0 \cf1 \f2 \ri0 \ul0 \strike0 \i0 \qj \li0 \fs18 \sa200 \sb0 \intbl \cell \row }
{\trowd \ltrrow \trleft0 
\clbrdrl \trql \clvertalt \clwWidth600 \cellx600 
\clpadb90 \clpadfb3 \clpadl90 \clpadfl3 \clbrdrr \trql \clwWidth9480 \cellx10080 
\intbl 
{\ri0 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \ql \fs18 \li0 
{\b0 \cf1 \f2 \i0 \fs18 
{\*\bkmkstart co_footnote_F31546934635_1}{\*\bkmkend co_footnote_F31546934635_1}
{\field {\*\fldinst HYPERLINK "#co_fnRef_F31546934635_ID0EHXAE_1" }{\fldrslt 
{\super \b0 \cf19 \f2 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
31
}\super \b0 \cf19 \f2 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 }}
\par 
}
}
}\b0 \cf1 \f2 \ri0 \i0 \ql \li0 \fs18 \intbl \cell \intbl 
{\ri0 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs18 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs18 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs18 \li0 
{\field {\*\fldinst HYPERLINK "https://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2047793960&pubNum=0000780&originatingDoc=I434c460335f011ef8921fbef1a541940&refType=RP&fi=co_pp_sp_780_455&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)#co_pp_sp_780_455" }{\fldrslt 
{\b0 \cf19 \f2 \i1 \fs18 
{\b0 \cf19 \f2 \ul0 \strike0 \i1 \fs18 \sa0 \sb0 
Id.
}
}
{\b0 \cf19 \f2 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
 at 455
}\b0 \cf19 \f2 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 }}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs18 \sa200 \sb0 
.
\par 
}
}
}
}
}\b0 \cf1 \f2 \ri0 \ul0 \strike0 \i0 \qj \li0 \fs18 \sa200 \sb0 \intbl \cell \row }
{\trowd \ltrrow \trleft0 
\clbrdrl \trql \clvertalt \clwWidth600 \cellx600 
\clpadb90 \clpadfb3 \clpadl90 \clpadfl3 \clbrdrr \trql \clwWidth9480 \cellx10080 
\intbl 
{\ri0 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \ql \fs18 \li0 
{\b0 \cf1 \f2 \i0 \fs18 
{\*\bkmkstart co_footnote_F32546934635_1}{\*\bkmkend co_footnote_F32546934635_1}
{\field {\*\fldinst HYPERLINK "#co_fnRef_F32546934635_ID0EVXAE_1" }{\fldrslt 
{\super \b0 \cf19 \f2 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
32
}\super \b0 \cf19 \f2 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 }}
\par 
}
}
}\b0 \cf1 \f2 \ri0 \i0 \ql \li0 \fs18 \intbl \cell \intbl 
{\ri0 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs18 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs18 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs18 \li0 
{\field {\*\fldinst HYPERLINK "https://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2047793960&pubNum=0000780&originatingDoc=I434c460335f011ef8921fbef1a541940&refType=RP&fi=co_pp_sp_780_460&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)#co_pp_sp_780_460" }{\fldrslt 
{\b0 \cf19 \f2 \i1 \fs18 
{\b0 \cf19 \f2 \ul0 \strike0 \i1 \fs18 \sa0 \sb0 
Id.
}
}
{\b0 \cf19 \f2 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
 at 460
}\b0 \cf19 \f2 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 }}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs18 \sa200 \sb0 
 (Gorsuch, J., dissenting).
\par 
}
}
}
}
}\b0 \cf1 \f2 \ri0 \ul0 \strike0 \i0 \qj \li0 \fs18 \sa200 \sb0 \intbl \cell \row }
{\trowd \ltrrow \trleft0 
\clbrdrl \trql \clvertalt \clwWidth600 \cellx600 
\clpadb90 \clpadfb3 \clpadl90 \clpadfl3 \clbrdrr \trql \clwWidth9480 \cellx10080 
\intbl 
{\ri0 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \ql \fs18 \li0 
{\b0 \cf1 \f2 \i0 \fs18 
{\*\bkmkstart co_footnote_F33546934635_1}{\*\bkmkend co_footnote_F33546934635_1}
{\field {\*\fldinst HYPERLINK "#co_fnRef_F33546934635_ID0E1XAE_1" }{\fldrslt 
{\super \b0 \cf19 \f2 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
33
}\super \b0 \cf19 \f2 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 }}
\par 
}
}
}\b0 \cf1 \f2 \ri0 \i0 \ql \li0 \fs18 \intbl \cell \intbl 
{\ri0 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs18 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs18 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs18 \li0 
{\b0 \cf1 \f2 \i1 \fs18 
{\b0 \cf1 \f2 \ul0 \strike0 \i1 \fs18 \sa0 \sb0 
See
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
 
}
{\field {\*\fldinst HYPERLINK "https://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=0505609128&pubNum=0003084&originatingDoc=I434c460335f011ef8921fbef1a541940&refType=LR&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b0 \cf19 \f2 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
Catherine M. Sharkey, 
}
{\b0 \cf19 \f2 \i1 \fs18 
{\b0 \cf19 \f2 \ul0 \strike0 \i1 \fs18 \sa0 \sb0 
Modern Tort Theory: Preventing Harms, Not Recognizing Wrongs
}
}
{\b0 \cf19 \f2 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
, 134 
}
{\b0 \cf19 \f2 \i0 \fs18 
{\b0 \cf19 \f2 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
Harv. L. Rev.
}
}
{\b0 \cf19 \f2 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
 1423, 1423-24 (2021)
}\b0 \cf19 \f2 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 }}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
 (describing 
}
{\b0 \cf1 \f2 \i1 \fs18 
{\b0 \cf1 \f2 \ul0 \strike0 \i1 \fs18 \sa0 \sb0 
DeVries
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs18 \sa200 \sb0 
 and arguing that \u8220\'3f[t]he law and economics-inspired view of tort law is ascendant, not only in the legal academy but also in the decisions of influential state and federal courts, including the U.S. Supreme Court\u8221\'3f).
\par 
}
}
}
}
}\b0 \cf1 \f2 \ri0 \ul0 \strike0 \i0 \qj \li0 \fs18 \sa200 \sb0 \intbl \cell \row }
{\trowd \ltrrow \trleft0 
\clbrdrl \trql \clvertalt \clwWidth600 \cellx600 
\clpadb90 \clpadfb3 \clpadl90 \clpadfl3 \clbrdrr \trql \clwWidth9480 \cellx10080 
\intbl 
{\ri0 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \ql \fs18 \li0 
{\b0 \cf1 \f2 \i0 \fs18 
{\*\bkmkstart co_footnote_F34546934635_1}{\*\bkmkend co_footnote_F34546934635_1}
{\field {\*\fldinst HYPERLINK "#co_fnRef_F34546934635_ID0EVYAE_1" }{\fldrslt 
{\super \b0 \cf19 \f2 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
34
}\super \b0 \cf19 \f2 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 }}
\par 
}
}
}\b0 \cf1 \f2 \ri0 \i0 \ql \li0 \fs18 \intbl \cell \intbl 
{\ri0 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs18 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs18 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs18 \li0 
{\b0 \cf1 \f2 \i1 \fs18 
{\b0 \cf1 \f2 \ul0 \strike0 \i1 \fs18 \sa0 \sb0 
Cf.
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
 Presidential Strategy, National Cybersecurity Strategy, 21 (Mar. 2023), https://www.whitehouse.gov/wp-content/uploads/2023/03/National-Cybersecurity-Strategy-2023.pdf [https://perma.cc/B59W-4PUH] (
}
{\b0 \cf1 \f2 \i1 \fs18 
{\b0 \cf1 \f2 \ul0 \strike0 \i1 \fs18 \sa0 \sb0 
\u8220\'3f
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs18 \sa200 \sb0 
Responsibility must be placed on the stakeholders most capable of taking action to prevent bad outcomes, not on the end-users that often bear the consequences of insecure software nor on the open-source developer of a component that is integrated into a commercial product.\u8221\'3f).
\par 
}
}
}
}
}\b0 \cf1 \f2 \ri0 \ul0 \strike0 \i0 \qj \li0 \fs18 \sa200 \sb0 \intbl \cell \row }
{\trowd \ltrrow \trleft0 
\clbrdrl \trql \clvertalt \clwWidth600 \cellx600 
\clpadb90 \clpadfb3 \clpadl90 \clpadfl3 \clbrdrr \trql \clwWidth9480 \cellx10080 
\intbl 
{\ri0 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \ql \fs18 \li0 
{\b0 \cf1 \f2 \i0 \fs18 
{\*\bkmkstart co_footnote_F35546934635_1}{\*\bkmkend co_footnote_F35546934635_1}
{\field {\*\fldinst HYPERLINK "#co_fnRef_F35546934635_ID0ERZAE_1" }{\fldrslt 
{\super \b0 \cf19 \f2 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
35
}\super \b0 \cf19 \f2 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 }}
\par 
}
}
}\b0 \cf1 \f2 \ri0 \i0 \ql \li0 \fs18 \intbl \cell \intbl 
{\ri0 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs18 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs18 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs18 \li0 
{\b0 \cf1 \f2 \i1 \fs18 
{\b0 \cf1 \f2 \ul0 \strike0 \i1 \fs18 \sa0 \sb0 
See
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
 Ryan Abbott, 
}
{\field {\*\fldinst HYPERLINK "https://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=0469550394&pubNum=0001147&originatingDoc=I434c460335f011ef8921fbef1a541940&refType=LR&fi=co_pp_sp_1147_4&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)#co_pp_sp_1147_4" }{\fldrslt 
{\b0 \cf19 \f2 \i1 \fs18 
{\b0 \cf19 \f2 \ul0 \strike0 \i1 \fs18 \sa0 \sb0 
The Reasonable Computer: Disrupting the Paradigm of Tort Liability
}
}
{\b0 \cf19 \f2 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
, 86 
}
{\b0 \cf19 \f2 \i0 \fs18 
{\b0 \cf19 \f2 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
Geo. Wash. L. Rev.
}
}
{\b0 \cf19 \f2 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
 1, 4 (2018)
}\b0 \cf19 \f2 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 }}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs18 \sa200 \sb0 
.
\par 
}
}
}
}
}\b0 \cf1 \f2 \ri0 \ul0 \strike0 \i0 \qj \li0 \fs18 \sa200 \sb0 \intbl \cell \row }
{\trowd \ltrrow \trleft0 
\clbrdrl \trql \clvertalt \clwWidth600 \cellx600 
\clpadb90 \clpadfb3 \clpadl90 \clpadfl3 \clbrdrr \trql \clwWidth9480 \cellx10080 
\intbl 
{\ri0 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \ql \fs18 \li0 
{\b0 \cf1 \f2 \i0 \fs18 
{\*\bkmkstart co_footnote_F36546934635_1}{\*\bkmkend co_footnote_F36546934635_1}
{\field {\*\fldinst HYPERLINK "#co_fnRef_F36546934635_ID0EVZAE_1" }{\fldrslt 
{\super \b0 \cf19 \f2 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
36
}\super \b0 \cf19 \f2 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 }}
\par 
}
}
}\b0 \cf1 \f2 \ri0 \i0 \ql \li0 \fs18 \intbl \cell \intbl 
{\ri0 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs18 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs18 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs18 \li0 
{\b0 \cf1 \f2 \i1 \fs18 
{\b0 \cf1 \f2 \ul0 \strike0 \i1 \fs18 \sa0 \sb0 
See
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
 Bryan H. Choi, 
}
{\field {\*\fldinst HYPERLINK "https://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=0546087656&pubNum=0001126&originatingDoc=I434c460335f011ef8921fbef1a541940&refType=LR&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b0 \cf19 \f2 \i1 \fs18 
{\b0 \cf19 \f2 \ul0 \strike0 \i1 \fs18 \sa0 \sb0 
AI Malpractice
}
}
{\b0 \cf19 \f2 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
, 73 
}
{\b0 \cf19 \f2 \i0 \fs18 
{\b0 \cf19 \f2 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
DePaul L. Rev.
}
}
{\b0 \cf19 \f2 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
 301, 301 (2024)
}\b0 \cf19 \f2 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 }}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
. Building on his work about \u8220\'3fsoftware as a profession,\u8221\'3f Choi argues that AI design should be governed by professional malpractice law because: (a) it necessarily involves subjective judgments; (b) those subjective judgments risk harmful outcomes; and (c) AI design is socially productive. 
}
{\field {\*\fldinst HYPERLINK "https://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=0546087656&pubNum=0001126&originatingDoc=I434c460335f011ef8921fbef1a541940&refType=LR&fi=co_pp_sp_1126_306&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)#co_pp_sp_1126_306" }{\fldrslt 
{\b0 \cf19 \f2 \i1 \fs18 
{\b0 \cf19 \f2 \ul0 \strike0 \i1 \fs18 \sa0 \sb0 
Id.
}
}
{\b0 \cf19 \f2 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
 at 306
}\b0 \cf19 \f2 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 }}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs18 \sa200 \sb0 
.
\par 
}
}
}
}
}\b0 \cf1 \f2 \ri0 \ul0 \strike0 \i0 \qj \li0 \fs18 \sa200 \sb0 \intbl \cell \row }
{\trowd \ltrrow \trleft0 
\clbrdrl \trql \clvertalt \clwWidth600 \cellx600 
\clpadb90 \clpadfb3 \clpadl90 \clpadfl3 \clbrdrr \trql \clwWidth9480 \cellx10080 
\intbl 
{\ri0 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \ql \fs18 \li0 
{\b0 \cf1 \f2 \i0 \fs18 
{\*\bkmkstart co_footnote_F37546934635_1}{\*\bkmkend co_footnote_F37546934635_1}
{\field {\*\fldinst HYPERLINK "#co_fnRef_F37546934635_ID0EQ1AE_1" }{\fldrslt 
{\super \b0 \cf19 \f2 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
37
}\super \b0 \cf19 \f2 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 }}
\par 
}
}
}\b0 \cf1 \f2 \ri0 \i0 \ql \li0 \fs18 \intbl \cell \intbl 
{\ri0 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs18 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs18 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs18 \li0 
{\b0 \cf1 \f2 \i1 \fs18 
{\b0 \cf1 \f2 \ul0 \strike0 \i1 \fs18 \sa0 \sb0 
See
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
 Abbott, 
}
{\b0 \cf1 \f2 \i1 \fs18 
{\b0 \cf1 \f2 \ul0 \strike0 \i1 \fs18 \sa0 \sb0 
supra
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs18 \sa200 \sb0 
 note 35, at 20-22.
\par 
}
}
}
}
}\b0 \cf1 \f2 \ri0 \ul0 \strike0 \i0 \qj \li0 \fs18 \sa200 \sb0 \intbl \cell \row }
{\trowd \ltrrow \trleft0 
\clbrdrl \trql \clvertalt \clwWidth600 \cellx600 
\clpadb90 \clpadfb3 \clpadl90 \clpadfl3 \clbrdrr \trql \clwWidth9480 \cellx10080 
\intbl 
{\ri0 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \ql \fs18 \li0 
{\b0 \cf1 \f2 \i0 \fs18 
{\*\bkmkstart co_footnote_F38546934635_1}{\*\bkmkend co_footnote_F38546934635_1}
{\field {\*\fldinst HYPERLINK "#co_fnRef_F38546934635_ID0ET1AE_1" }{\fldrslt 
{\super \b0 \cf19 \f2 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
38
}\super \b0 \cf19 \f2 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 }}
\par 
}
}
}\b0 \cf1 \f2 \ri0 \i0 \ql \li0 \fs18 \intbl \cell \intbl 
{\ri0 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs18 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs18 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs18 \li0 
{\b0 \cf1 \f2 \i1 \fs18 
{\b0 \cf1 \f2 \ul0 \strike0 \i1 \fs18 \sa0 \sb0 
See 
}
}
{\b0 \cf1 \f2 \i1 \fs18 
{\b0 \cf1 \f2 \ul0 \strike0 \i1 \fs18 \sa0 \sb0 
id.
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs18 \sa200 \sb0 
 at 42-43.
\par 
}
}
}
}
}\b0 \cf1 \f2 \ri0 \ul0 \strike0 \i0 \qj \li0 \fs18 \sa200 \sb0 \intbl \cell \row }
{\trowd \ltrrow \trleft0 
\clbrdrl \trql \clvertalt \clwWidth600 \cellx600 
\clpadb90 \clpadfb3 \clpadl90 \clpadfl3 \clbrdrr \trql \clwWidth9480 \cellx10080 
\intbl 
{\ri0 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \ql \fs18 \li0 
{\b0 \cf1 \f2 \i0 \fs18 
{\*\bkmkstart co_footnote_F39546934635_1}{\*\bkmkend co_footnote_F39546934635_1}
{\field {\*\fldinst HYPERLINK "#co_fnRef_F39546934635_ID0EY1AE_1" }{\fldrslt 
{\super \b0 \cf19 \f2 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
39
}\super \b0 \cf19 \f2 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 }}
\par 
}
}
}\b0 \cf1 \f2 \ri0 \i0 \ql \li0 \fs18 \intbl \cell \intbl 
{\ri0 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs18 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs18 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs18 \li0 
{\b0 \cf1 \f2 \i1 \fs18 
{\b0 \cf1 \f2 \ul0 \strike0 \i1 \fs18 \sa0 \sb0 
See 
}
}
{\b0 \cf1 \f2 \i1 \fs18 
{\b0 \cf1 \f2 \ul0 \strike0 \i1 \fs18 \sa0 \sb0 
id.
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
 at 22. Other advocates of a negligence model for AI liability have expanded on this argument. 
}
{\b0 \cf1 \f2 \i1 \fs18 
{\b0 \cf1 \f2 \ul0 \strike0 \i1 \fs18 \sa0 \sb0 
See, e.g.
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
, Karni A. Chagal-Feferkorn, 
}
{\field {\*\fldinst HYPERLINK "https://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=0509883538&pubNum=0234527&originatingDoc=I434c460335f011ef8921fbef1a541940&refType=LR&fi=co_pp_sp_234527_251&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)#co_pp_sp_234527_251" }{\fldrslt 
{\b0 \cf19 \f2 \i1 \fs18 
{\b0 \cf19 \f2 \ul0 \strike0 \i1 \fs18 \sa0 \sb0 
How Can I Tell If My Algorithm Was Reasonable?
}
}
{\b0 \cf19 \f2 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
, 27 
}
{\b0 \cf19 \f2 \i0 \fs18 
{\b0 \cf19 \f2 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
Mich. Tech. L. Rev.
}
}
{\b0 \cf19 \f2 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
 213, 251 (2021)
}\b0 \cf19 \f2 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 }}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs18 \sa200 \sb0 
 (\u8220\'3fIn the context of rapidly evolving technology, the neutrality of the reasonableness assessment has great value. When law is said to chase technological improvements, the neutral reasonableness assessment may be counted on without the expensive--and often futile--need to constantly reshape the legal framework when the technology advances.\u8221\'3f).
\par 
}
}
}
}
}\b0 \cf1 \f2 \ri0 \ul0 \strike0 \i0 \qj \li0 \fs18 \sa200 \sb0 \intbl \cell \row }
{\trowd \ltrrow \trleft0 
\clbrdrl \trql \clvertalt \clwWidth600 \cellx600 
\clpadb90 \clpadfb3 \clpadl90 \clpadfl3 \clbrdrr \trql \clwWidth9480 \cellx10080 
\intbl 
{\ri0 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \ql \fs18 \li0 
{\b0 \cf1 \f2 \i0 \fs18 
{\*\bkmkstart co_footnote_F40546934635_1}{\*\bkmkend co_footnote_F40546934635_1}
{\field {\*\fldinst HYPERLINK "#co_fnRef_F40546934635_ID0EL2AE_1" }{\fldrslt 
{\super \b0 \cf19 \f2 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
40
}\super \b0 \cf19 \f2 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 }}
\par 
}
}
}\b0 \cf1 \f2 \ri0 \i0 \ql \li0 \fs18 \intbl \cell \intbl 
{\ri0 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs18 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs18 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs18 \li0 
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
Abbott, 
}
{\b0 \cf1 \f2 \i1 \fs18 
{\b0 \cf1 \f2 \ul0 \strike0 \i1 \fs18 \sa0 \sb0 
supra
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs18 \sa200 \sb0 
 note 35, at 23.
\par 
}
}
}
}
}\b0 \cf1 \f2 \ri0 \ul0 \strike0 \i0 \qj \li0 \fs18 \sa200 \sb0 \intbl \cell \row }
{\trowd \ltrrow \trleft0 
\clbrdrl \trql \clvertalt \clwWidth600 \cellx600 
\clpadb90 \clpadfb3 \clpadl90 \clpadfl3 \clbrdrr \trql \clwWidth9480 \cellx10080 
\intbl 
{\ri0 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \ql \fs18 \li0 
{\b0 \cf1 \f2 \i0 \fs18 
{\*\bkmkstart co_footnote_F41546934635_1}{\*\bkmkend co_footnote_F41546934635_1}
{\field {\*\fldinst HYPERLINK "#co_fnRef_F41546934635_ID0EC3AE_1" }{\fldrslt 
{\super \b0 \cf19 \f2 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
41
}\super \b0 \cf19 \f2 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 }}
\par 
}
}
}\b0 \cf1 \f2 \ri0 \i0 \ql \li0 \fs18 \intbl \cell \intbl 
{\ri0 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs18 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs18 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs18 \li0 
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
Abbott does nonetheless suggest that manufacturers should weigh the cost of improvements to reduce accident risk. 
}
{\b0 \cf1 \f2 \i1 \fs18 
{\b0 \cf1 \f2 \ul0 \strike0 \i1 \fs18 \sa0 \sb0 
See 
}
}
{\b0 \cf1 \f2 \i1 \fs18 
{\b0 \cf1 \f2 \ul0 \strike0 \i1 \fs18 \sa0 \sb0 
id.
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs18 \sa200 \sb0 
 at 23.
\par 
}
}
}
}
}\b0 \cf1 \f2 \ri0 \ul0 \strike0 \i0 \qj \li0 \fs18 \sa200 \sb0 \intbl \cell \row }
{\trowd \ltrrow \trleft0 
\clbrdrl \trql \clvertalt \clwWidth600 \cellx600 
\clpadb90 \clpadfb3 \clpadl90 \clpadfl3 \clbrdrr \trql \clwWidth9480 \cellx10080 
\intbl 
{\ri0 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \ql \fs18 \li0 
{\b0 \cf1 \f2 \i0 \fs18 
{\*\bkmkstart co_footnote_F42546934635_1}{\*\bkmkend co_footnote_F42546934635_1}
{\field {\*\fldinst HYPERLINK "#co_fnRef_F42546934635_ID0EU3AE_1" }{\fldrslt 
{\super \b0 \cf19 \f2 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
42
}\super \b0 \cf19 \f2 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 }}
\par 
}
}
}\b0 \cf1 \f2 \ri0 \i0 \ql \li0 \fs18 \intbl \cell \intbl 
{\ri0 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs18 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs18 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs18 \li0 
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
Chinmayi Sharma & Benjamin Zipursky, 
}
{\b0 \cf1 \f2 \i1 \fs18 
{\b0 \cf1 \f2 \ul0 \strike0 \i1 \fs18 \sa0 \sb0 
Who\rquote s Afraid of Products Liability? Cybersecurity and the Defect Model
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
, 
}
{\b0 \cf1 \f2 \i0 \fs18 
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
Lawfare
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs18 \sa200 \sb0 
 (Oct. 19, 2023), https://www.lawfaremedia.org/article/who-s-afraid-of-products-liability-cybersecurity-and-the-defect-model [https://perma.cc/A2SG-HY75]. However, Jim Dempsey has criticized the products liability model in this context:
\par 
}
}
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs18 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs18 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs18 \li0 
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
If developers of software are to be held responsible for the harm caused by defects in their products, we cannot risk the impact on innovation that would result from a lack of clarity as to the standard of care. 
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs18 \sa200 \sb0 
Nor, given the urgency of the cybersecurity threat, can we afford to proceed at the pace of common law, with its incremental and often inconsistent articulation by judges across many cases over many years.
\par 
}
}
}
}
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs18 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs18 \li0 
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
Jim Dempsey, 
}
{\b0 \cf1 \f2 \i1 \fs18 
{\b0 \cf1 \f2 \ul0 \strike0 \i1 \fs18 \sa0 \sb0 
Standards for Software Liability: Focus on the Product for Liability, Focus on the Process for Safe Harbor
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
, 
}
{\b0 \cf1 \f2 \i0 \fs18 
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
Lawfare
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs18 \sa200 \sb0 
 (Jan. 23, 2024), https://www.lawfaremedia.org/article/standards-for-software-liability-focus-on-the-product-for-liability-focus-on-the-process-for-safe-harbor [https://perma.cc/AVQ8-DRLW]. Neither Dempsey nor Sharma and Zipursky contend with the information-forcing role of common law liability, which I highlight above.
\par 
}
}
}
}
}
}\b0 \cf1 \f2 \ri0 \ul0 \strike0 \i0 \qj \li0 \fs18 \sa200 \sb0 \intbl \cell \row }
{\trowd \ltrrow \trleft0 
\clbrdrl \trql \clvertalt \clwWidth600 \cellx600 
\clpadb90 \clpadfb3 \clpadl90 \clpadfl3 \clbrdrr \trql \clwWidth9480 \cellx10080 
\intbl 
{\ri0 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \ql \fs18 \li0 
{\b0 \cf1 \f2 \i0 \fs18 
{\*\bkmkstart co_footnote_F43546934635_1}{\*\bkmkend co_footnote_F43546934635_1}
{\field {\*\fldinst HYPERLINK "#co_fnRef_F43546934635_ID0EM4AE_1" }{\fldrslt 
{\super \b0 \cf19 \f2 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
43
}\super \b0 \cf19 \f2 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 }}
\par 
}
}
}\b0 \cf1 \f2 \ri0 \i0 \ql \li0 \fs18 \intbl \cell \intbl 
{\ri0 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs18 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs18 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs18 \li0 
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
Choi, 
}
{\b0 \cf1 \f2 \i1 \fs18 
{\b0 \cf1 \f2 \ul0 \strike0 \i1 \fs18 \sa0 \sb0 
supra
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs18 \sa200 \sb0 
 note 36, at 305.
\par 
}
}
}
}
}\b0 \cf1 \f2 \ri0 \ul0 \strike0 \i0 \qj \li0 \fs18 \sa200 \sb0 \intbl \cell \row }
{\trowd \ltrrow \trleft0 
\clbrdrl \trql \clvertalt \clwWidth600 \cellx600 
\clpadb90 \clpadfb3 \clpadl90 \clpadfl3 \clbrdrr \trql \clwWidth9480 \cellx10080 
\intbl 
{\ri0 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \ql \fs18 \li0 
{\b0 \cf1 \f2 \i0 \fs18 
{\*\bkmkstart co_footnote_F44546934635_1}{\*\bkmkend co_footnote_F44546934635_1}
{\field {\*\fldinst HYPERLINK "#co_fnRef_F44546934635_ID0EY4AE_1" }{\fldrslt 
{\super \b0 \cf19 \f2 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
44
}\super \b0 \cf19 \f2 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 }}
\par 
}
}
}\b0 \cf1 \f2 \ri0 \i0 \ql \li0 \fs18 \intbl \cell \intbl 
{\ri0 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs18 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs18 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs18 \li0 
{\b0 \cf1 \f2 \i1 \fs18 
{\b0 \cf1 \f2 \ul0 \strike0 \i1 \fs18 \sa0 \sb0 
See 
}
}
{\b0 \cf1 \f2 \i1 \fs18 
{\b0 \cf1 \f2 \ul0 \strike0 \i1 \fs18 \sa0 \sb0 
id.
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs18 \sa200 \sb0 
 at 314-15.
\par 
}
}
}
}
}\b0 \cf1 \f2 \ri0 \ul0 \strike0 \i0 \qj \li0 \fs18 \sa200 \sb0 \intbl \cell \row }
{\trowd \ltrrow \trleft0 
\clbrdrl \trql \clvertalt \clwWidth600 \cellx600 
\clpadb90 \clpadfb3 \clpadl90 \clpadfl3 \clbrdrr \trql \clwWidth9480 \cellx10080 
\intbl 
{\ri0 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \ql \fs18 \li0 
{\b0 \cf1 \f2 \i0 \fs18 
{\*\bkmkstart co_footnote_F45546934635_1}{\*\bkmkend co_footnote_F45546934635_1}
{\field {\*\fldinst HYPERLINK "#co_fnRef_F45546934635_ID0E55AE_1" }{\fldrslt 
{\super \b0 \cf19 \f2 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
45
}\super \b0 \cf19 \f2 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 }}
\par 
}
}
}\b0 \cf1 \f2 \ri0 \i0 \ql \li0 \fs18 \intbl \cell \intbl 
{\ri0 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs18 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs18 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs18 \li0 
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
While 23&Me claims to have begun its dialogue with the FDA in 2008, the FDA took until 2010 to notify it that direct-to-consumer genetic tests were medical devices that required approval. 
}
{\b0 \cf1 \f2 \i1 \fs18 
{\b0 \cf1 \f2 \ul0 \strike0 \i1 \fs18 \sa0 \sb0 
See An Update Regarding The FDA\rquote s Letter to 23andMe
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
, 
}
{\b0 \cf1 \f2 \i0 \fs18 
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
23&Me
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
 (Nov. 26, 2013), https://blog.23andme.com/articles/update-on-fda-letter [https://perma.cc/D9TT-KJGT]; Andrew Pollack, 
}
{\b0 \cf1 \f2 \i1 \fs18 
{\b0 \cf1 \f2 \ul0 \strike0 \i1 \fs18 \sa0 \sb0 
F.D.A. Faults Companies on Unapproved Genetic Tests
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
, 
}
{\b0 \cf1 \f2 \i0 \fs18 
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
N.Y. Times
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
 (June 11, 2010), https://www.nytimes.com/2010/06/12/health/12genome.html [https://perma.cc/8MAB-DVJH]. 23&Me was slow in communicating with the FDA, and, in 2013, the FDA ordered it to stop marketing its tests. 
}
{\b0 \cf1 \f2 \i1 \fs18 
{\b0 \cf1 \f2 \ul0 \strike0 \i1 \fs18 \sa0 \sb0 
See
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
 Andrew Pollack, 
}
{\b0 \cf1 \f2 \i1 \fs18 
{\b0 \cf1 \f2 \ul0 \strike0 \i1 \fs18 \sa0 \sb0 
F.D.A. Orders Genetic Testing Firm to Stop Selling DNA Analysis Service
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
, 
}
{\b0 \cf1 \f2 \i0 \fs18 
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
N.Y. Times
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
 (Nov. 26, 2013), https://www.nytimes.com/2013/11/26/business/fda-demands-a-halt-to-a-dna-test-kits-marketing.html [https://perma.cc/665T-ZQWU]. 23&Me\rquote s tests secured FDA approval in 2017. 
}
{\b0 \cf1 \f2 \i1 \fs18 
{\b0 \cf1 \f2 \ul0 \strike0 \i1 \fs18 \sa0 \sb0 
See
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
 
}
{\b0 \cf1 \f2 \i0 \fs18 
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
Food & Drug Admin., FDA Allows Marketing of First Direct-to-Consumer Tests That Provide Genetic Risk Information for Certain Conditions
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
 (Apr. 6, 2017), https://www.fda.gov/news-events/press-announcements/fda-allows-marketing-first-direct-consumer-tests-provide-genetic-risk-information-certain-conditions [https://perma.cc/UB6F-6MLK]. 
}
{\b0 \cf1 \f2 \i1 \fs18 
{\b0 \cf1 \f2 \ul0 \strike0 \i1 \fs18 \sa0 \sb0 
See generally
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
 Catherine M. Sharkey et al., 
}
{\b0 \cf1 \f2 \i1 \fs18 
{\b0 \cf1 \f2 \ul0 \strike0 \i1 \fs18 \sa0 \sb0 
Regulatory and Medical Aspects of DTC Genetic Testing
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
, 
}
{\b0 \cf1 \f2 \i1 \fs18 
{\b0 \cf1 \f2 \ul0 \strike0 \i1 \fs18 \sa0 \sb0 
in
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
 
}
{\b0 \cf1 \f2 \i0 \fs18 
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
Consumer Genetic Technologies: Ethical and Legal Considerations
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
 277 (I. Glenn Cohen et al. eds., 2021); Kenneth Offit et al., 
}
{\b0 \cf1 \f2 \i1 \fs18 
{\b0 \cf1 \f2 \ul0 \strike0 \i1 \fs18 \sa0 \sb0 
Regulation of Laboratory-Developed Tests in Preventive Oncology: Emerging Needs and Opportunities
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
, 41 
}
{\b0 \cf1 \f2 \i0 \fs18 
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
J. Clinical Oncology
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs18 \sa200 \sb0 
 11 (2023).
\par 
}
}
}
}
}\b0 \cf1 \f2 \ri0 \ul0 \strike0 \i0 \qj \li0 \fs18 \sa200 \sb0 \intbl \cell \row }
{\trowd \ltrrow \trleft0 
\clbrdrl \trql \clvertalt \clwWidth600 \cellx600 
\clpadb90 \clpadfb3 \clpadl90 \clpadfl3 \clbrdrr \trql \clwWidth9480 \cellx10080 
\intbl 
{\ri0 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \ql \fs18 \li0 
{\b0 \cf1 \f2 \i0 \fs18 
{\*\bkmkstart co_footnote_F46546934635_1}{\*\bkmkend co_footnote_F46546934635_1}
{\field {\*\fldinst HYPERLINK "#co_fnRef_F46546934635_ID0EF6AE_1" }{\fldrslt 
{\super \b0 \cf19 \f2 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
46
}\super \b0 \cf19 \f2 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 }}
\par 
}
}
}\b0 \cf1 \f2 \ri0 \i0 \ql \li0 \fs18 \intbl \cell \intbl 
{\ri0 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs18 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs18 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs18 \li0 
{\b0 \cf1 \f2 \i1 \fs18 
{\b0 \cf1 \f2 \ul0 \strike0 \i1 \fs18 \sa0 \sb0 
See
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
 Catherine M. Sharkey, 
}
{\field {\*\fldinst HYPERLINK "https://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=0480941619&pubNum=0001126&originatingDoc=I434c460335f011ef8921fbef1a541940&refType=LR&fi=co_pp_sp_1126_377&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)#co_pp_sp_1126_377" }{\fldrslt 
{\b0 \cf19 \f2 \i1 \fs18 
{\b0 \cf19 \f2 \ul0 \strike0 \i1 \fs18 \sa0 \sb0 
Direct-to-Consumer Genetic Testing: The FDA\rquote s Dual Role as Safety and Health Information Regulator
}
}
{\b0 \cf19 \f2 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
, 68 
}
{\b0 \cf19 \f2 \i0 \fs18 
{\b0 \cf19 \f2 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
DePaul L. Rev.
}
}
{\b0 \cf19 \f2 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
 343, 377-79 (2019)
}\b0 \cf19 \f2 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 }}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs18 \sa200 \sb0 
.
\par 
}
}
}
}
}\b0 \cf1 \f2 \ri0 \ul0 \strike0 \i0 \qj \li0 \fs18 \sa200 \sb0 \intbl \cell \row }
{\trowd \ltrrow \trleft0 
\clbrdrl \trql \clvertalt \clwWidth600 \cellx600 
\clpadb90 \clpadfb3 \clpadl90 \clpadfl3 \clbrdrr \trql \clwWidth9480 \cellx10080 
\intbl 
{\ri0 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \ql \fs18 \li0 
{\b0 \cf1 \f2 \i0 \fs18 
{\*\bkmkstart co_footnote_F47546934635_1}{\*\bkmkend co_footnote_F47546934635_1}
{\field {\*\fldinst HYPERLINK "#co_fnRef_F47546934635_ID0EUBAG_1" }{\fldrslt 
{\super \b0 \cf19 \f2 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
47
}\super \b0 \cf19 \f2 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 }}
\par 
}
}
}\b0 \cf1 \f2 \ri0 \i0 \ql \li0 \fs18 \intbl \cell \intbl 
{\ri0 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs18 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs18 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs18 \li0 
{\b0 \cf1 \f2 \i1 \fs18 
{\b0 \cf1 \f2 \ul0 \strike0 \i1 \fs18 \sa0 \sb0 
See
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
 
}
{\b0 \cf1 \f2 \i0 \fs18 
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
Food & Drug Admin., Focus Area: Artificial Intelligence
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs18 \sa200 \sb0 
 (Sept. 6, 2022), https://www.fda.gov/science-research/focus-areas-regulatory-science-report/focus-area-artificial-intelligence. Whether AI/ML is embedded in Software as a Medical Device (\u8220\'3fSaMD\u8221\'3f), or whether it is used in the development, clinical investigation, postmarket data analysis, or quality control of medical products and their quality management systems, the proliferation of AI/ML in the healthcare industry shows no signs of slowing down.
\par 
}
}
}
}
}\b0 \cf1 \f2 \ri0 \ul0 \strike0 \i0 \qj \li0 \fs18 \sa200 \sb0 \intbl \cell \row }
{\trowd \ltrrow \trleft0 
\clbrdrl \trql \clvertalt \clwWidth600 \cellx600 
\clpadb90 \clpadfb3 \clpadl90 \clpadfl3 \clbrdrr \trql \clwWidth9480 \cellx10080 
\intbl 
{\ri0 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \ql \fs18 \li0 
{\b0 \cf1 \f2 \i0 \fs18 
{\*\bkmkstart co_footnote_F48546934635_1}{\*\bkmkend co_footnote_F48546934635_1}
{\field {\*\fldinst HYPERLINK "#co_fnRef_F48546934635_ID0EMCAG_1" }{\fldrslt 
{\super \b0 \cf19 \f2 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
48
}\super \b0 \cf19 \f2 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 }}
\par 
}
}
}\b0 \cf1 \f2 \ri0 \i0 \ql \li0 \fs18 \intbl \cell \intbl 
{\ri0 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs18 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs18 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs18 \li0 
{\b0 \cf1 \f2 \i0 \fs18 
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
Food & Drug Admin., Artificial Intelligence and Machine Learning (AI/ML)-Enabled Medical Devices
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs18 \sa200 \sb0 
SS (Oct. 19, 2023), https://www.fda.gov/medical-devices/software-medical-device-samd/artificial-intelligence-and-machine-learning-aiml-enabled-medical-devices.
\par 
}
}
}
}
}\b0 \cf1 \f2 \ri0 \ul0 \strike0 \i0 \qj \li0 \fs18 \sa200 \sb0 \intbl \cell \row }
{\trowd \ltrrow \trleft0 
\clbrdrl \trql \clvertalt \clwWidth600 \cellx600 
\clpadb90 \clpadfb3 \clpadl90 \clpadfl3 \clbrdrr \trql \clwWidth9480 \cellx10080 
\intbl 
{\ri0 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \ql \fs18 \li0 
{\b0 \cf1 \f2 \i0 \fs18 
{\*\bkmkstart co_footnote_F49546934635_1}{\*\bkmkend co_footnote_F49546934635_1}
{\field {\*\fldinst HYPERLINK "#co_fnRef_F49546934635_ID0E5CAG_1" }{\fldrslt 
{\super \b0 \cf19 \f2 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
49
}\super \b0 \cf19 \f2 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 }}
\par 
}
}
}\b0 \cf1 \f2 \ri0 \i0 \ql \li0 \fs18 \intbl \cell \intbl 
{\ri0 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs18 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs18 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs18 \li0 
{\b0 \cf1 \f2 \i1 \fs18 
{\b0 \cf1 \f2 \ul0 \strike0 \i1 \fs18 \sa0 \sb0 
See id.
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
 The FDA maintains a database of AI/ML-enabled medical devices, which it periodically updates, to showcase the growing number of medical devices authorized by the agency; as of the most recent update, the FDA granted marketing authorization to 692 AI/ML-enabled medical devices.
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
 
}
{\b0 \cf1 \f2 \i1 \fs18 
{\b0 \cf1 \f2 \ul0 \strike0 \i1 \fs18 \sa200 \sb0 
Id.
\par 
}
}
}
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs18 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs18 \li0 
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
According to the FDA: \u8220\'3fThe year-over-year increase of AI/ML-enabled devices slowed in 2021 (15%) and 2022 (14%) after an increase of 39% in 2020 (compared to 2019). Based on projected volume in 2023, the increase of AI/ML-enabled devices (compared to 2022) is expected to reach 30+%.\u8221\'3f 
}
{\b0 \cf1 \f2 \i1 \fs18 
{\b0 \cf1 \f2 \ul0 \strike0 \i1 \fs18 \sa200 \sb0 
Id.
\par 
}
}
}
}
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs18 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs18 \li0 
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
\u8220\'3fThrough the end of July 2023, 79% of devices authorized in 2023 are in Radiology (85), 9% in Cardiovascular (10), 5% in Neurology (5), 4% in Gastroenterology/Urology (4), 2% in Anesthesiology (2), and 1% each in Ear, Nose and Throat (1), and Ophthalmic (1).\u8221\'3f 
}
{\b0 \cf1 \f2 \i1 \fs18 
{\b0 \cf1 \f2 \ul0 \strike0 \i1 \fs18 \sa0 \sb0 
Id.
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
 \u8220\'3f87% of devices on this list authorized in calendar year 2022 are in Radiology (122), followed by 7% in Cardiovascular (10) and 1% each in Neurology (2), Hematology (1), Gastroenterology/Urology (1), Ophthalmic (2), Clinical Chemistry (1) and Ear, Nose and Throat (1).\u8221\'3f 
}
{\b0 \cf1 \f2 \i1 \fs18 
{\b0 \cf1 \f2 \ul0 \strike0 \i1 \fs18 \sa200 \sb0 
Id.
\par 
}
}
}
}
}
}
}\b0 \cf1 \f2 \ri0 \ul0 \strike0 \i1 \qj \li0 \fs18 \sa200 \sb0 \intbl \cell \row }
{\trowd \ltrrow \trleft0 
\clbrdrl \trql \clvertalt \clwWidth600 \cellx600 
\clpadb90 \clpadfb3 \clpadl90 \clpadfl3 \clbrdrr \trql \clwWidth9480 \cellx10080 
\intbl 
{\ri0 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \ql \fs18 \li0 
{\b0 \cf1 \f2 \i0 \fs18 
{\*\bkmkstart co_footnote_F50546934635_1}{\*\bkmkend co_footnote_F50546934635_1}
{\field {\*\fldinst HYPERLINK "#co_fnRef_F50546934635_ID0EJDAG_1" }{\fldrslt 
{\super \b0 \cf19 \f2 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
50
}\super \b0 \cf19 \f2 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 }}
\par 
}
}
}\b0 \cf1 \f2 \ri0 \i0 \ql \li0 \fs18 \intbl \cell \intbl 
{\ri0 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs18 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs18 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs18 \li0 
{\b0 \cf1 \f2 \i1 \fs18 
{\b0 \cf1 \f2 \ul0 \strike0 \i1 \fs18 \sa0 \sb0 
See
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
 
}
{\b0 \cf1 \f2 \i0 \fs18 
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
Food & Drug Admin., Software as a Medical Device (SaMD)
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs18 \sa200 \sb0 
 (Dec. 4, 2018), https://www.fda.gov/medical-devices/digital-health-center-excellence/software-medical-device-samd.
\par 
}
}
}
}
}\b0 \cf1 \f2 \ri0 \ul0 \strike0 \i0 \qj \li0 \fs18 \sa200 \sb0 \intbl \cell \row }
{\trowd \ltrrow \trleft0 
\clbrdrl \trql \clvertalt \clwWidth600 \cellx600 
\clpadb90 \clpadfb3 \clpadl90 \clpadfl3 \clbrdrr \trql \clwWidth9480 \cellx10080 
\intbl 
{\ri0 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \ql \fs18 \li0 
{\b0 \cf1 \f2 \i0 \fs18 
{\*\bkmkstart co_footnote_F51546934635_1}{\*\bkmkend co_footnote_F51546934635_1}
{\field {\*\fldinst HYPERLINK "#co_fnRef_F51546934635_ID0ENDAG_1" }{\fldrslt 
{\super \b0 \cf19 \f2 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
51
}\super \b0 \cf19 \f2 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 }}
\par 
}
}
}\b0 \cf1 \f2 \ri0 \i0 \ql \li0 \fs18 \intbl \cell \intbl 
{\ri0 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs18 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs18 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs18 \li0 
{\b0 \cf1 \f2 \i1 \fs18 
{\b0 \cf1 \f2 \ul0 \strike0 \i1 \fs18 \sa0 \sb0 
See
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
 
}
{\b0 \cf1 \f2 \i0 \fs18 
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
Food & Drug Admin., Artificial Intelligence and Machine Learning in Software as a Medical Device
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
 (Sept. 22, 2021), https://www.fda.gov/medical-devices/software-medical-device-samd/artificial-intelligence-and-machine-learning-software-medical-device. The FDA\rquote s Center for Devices and Radiological Health (CDRH) Digital Health Center of Excellence is considering adopting lifecycle monitoring for adaptive AI/ML SaMD. 
}
{\b0 \cf1 \f2 \i1 \fs18 
{\b0 \cf1 \f2 \ul0 \strike0 \i1 \fs18 \sa200 \sb0 
Id.
\par 
}
}
}
}
}
}\b0 \cf1 \f2 \ri0 \ul0 \strike0 \i1 \qj \li0 \fs18 \sa200 \sb0 \intbl \cell \row }
{\trowd \ltrrow \trleft0 
\clbrdrl \trql \clvertalt \clwWidth600 \cellx600 
\clpadb90 \clpadfb3 \clpadl90 \clpadfl3 \clbrdrr \trql \clwWidth9480 \cellx10080 
\intbl 
{\ri0 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \ql \fs18 \li0 
{\b0 \cf1 \f2 \i0 \fs18 
{\*\bkmkstart co_footnote_F52546934635_1}{\*\bkmkend co_footnote_F52546934635_1}
{\field {\*\fldinst HYPERLINK "#co_fnRef_F52546934635_ID0E3DAG_1" }{\fldrslt 
{\super \b0 \cf19 \f2 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
52
}\super \b0 \cf19 \f2 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 }}
\par 
}
}
}\b0 \cf1 \f2 \ri0 \i0 \ql \li0 \fs18 \intbl \cell \intbl 
{\ri0 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs18 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs18 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs18 \li0 
{\b0 \cf1 \f2 \i1 \fs18 
{\b0 \cf1 \f2 \ul0 \strike0 \i1 \fs18 \sa0 \sb0 
See
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
 
}
{\b0 \cf1 \f2 \i0 \fs18 
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
Food & Drug Admin., Proposed Regulatory Framework for Modifications to Artificial Intelligence/Machine Learning (AI/ML)-Based Software as a Medical Device (SaMD) - Discussion Paper and Request for Feedback
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs18 \sa200 \sb0 
, FDA-2019-N-1185-0001 (Apr. 2, 2019), https://www.fda.gov/media/122535/download?attachment (recognizing that its \u8220\'3ftraditional paradigm of medical device regulation was not designed for adaptive AI/ML\u8221\'3f).
\par 
}
}
}
}
}\b0 \cf1 \f2 \ri0 \ul0 \strike0 \i0 \qj \li0 \fs18 \sa200 \sb0 \intbl \cell \row }
{\trowd \ltrrow \trleft0 
\clbrdrl \trql \clvertalt \clwWidth600 \cellx600 
\clpadb90 \clpadfb3 \clpadl90 \clpadfl3 \clbrdrr \trql \clwWidth9480 \cellx10080 
\intbl 
{\ri0 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \ql \fs18 \li0 
{\b0 \cf1 \f2 \i0 \fs18 
{\*\bkmkstart co_footnote_F53546934635_1}{\*\bkmkend co_footnote_F53546934635_1}
{\field {\*\fldinst HYPERLINK "#co_fnRef_F53546934635_ID0EBEAG_1" }{\fldrslt 
{\super \b0 \cf19 \f2 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
53
}\super \b0 \cf19 \f2 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 }}
\par 
}
}
}\b0 \cf1 \f2 \ri0 \i0 \ql \li0 \fs18 \intbl \cell \intbl 
{\ri0 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs18 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs18 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs18 \li0 
{\b0 \cf1 \f2 \i1 \fs18 
{\b0 \cf1 \f2 \ul0 \strike0 \i1 \fs18 \sa0 \sb0 
See
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
 
}
{\b0 \cf1 \f2 \i0 \fs18 
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
Food & Drug Admin., Marketing Submission Recommendations for a Predetermined Change Control Plan for Artificial Intelligence/Machine Learning (AI/ML)-Enabled Device Software Functions
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs18 \sa200 \sb0 
SS, FDA-2022-D-2628, 1-2 (Apr. 3, 2023), https://www.fda.gov/regulatory-information/search-fda-guidance-documents/marketing-submission-recommendations-predetermined-change-control-plan-artificial.
\par 
}
}
}
}
}\b0 \cf1 \f2 \ri0 \ul0 \strike0 \i0 \qj \li0 \fs18 \sa200 \sb0 \intbl \cell \row }
{\trowd \ltrrow \trleft0 
\clbrdrl \trql \clvertalt \clwWidth600 \cellx600 
\clpadb90 \clpadfb3 \clpadl90 \clpadfl3 \clbrdrr \trql \clwWidth9480 \cellx10080 
\intbl 
{\ri0 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \ql \fs18 \li0 
{\b0 \cf1 \f2 \i0 \fs18 
{\*\bkmkstart co_footnote_F54546934635_1}{\*\bkmkend co_footnote_F54546934635_1}
{\field {\*\fldinst HYPERLINK "#co_fnRef_F54546934635_ID0EPEAG_1" }{\fldrslt 
{\super \b0 \cf19 \f2 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
54
}\super \b0 \cf19 \f2 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 }}
\par 
}
}
}\b0 \cf1 \f2 \ri0 \i0 \ql \li0 \fs18 \intbl \cell \intbl 
{\ri0 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs18 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs18 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs18 \li0 
{\b0 \cf1 \f2 \i1 \fs18 
{\b0 \cf1 \f2 \ul0 \strike0 \i1 \fs18 \sa0 \sb0 
The Evolving FDA Regulatory Landscape of Artificial Intelligence
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
, 
}
{\b0 \cf1 \f2 \i0 \fs18 
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
JD Supra
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs18 \sa200 \sb0 
 (Mar. 29, 2023), https://www.jdsupra.com/legalnews/the-evolving-fda-regulatory-landscape-2823241/ [https://perma.cc/228R-5A5K].
\par 
}
}
}
}
}\b0 \cf1 \f2 \ri0 \ul0 \strike0 \i0 \qj \li0 \fs18 \sa200 \sb0 \intbl \cell \row }
{\trowd \ltrrow \trleft0 
\clbrdrl \trql \clvertalt \clwWidth600 \cellx600 
\clpadb90 \clpadfb3 \clpadl90 \clpadfl3 \clbrdrr \trql \clwWidth9480 \cellx10080 
\intbl 
{\ri0 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \ql \fs18 \li0 
{\b0 \cf1 \f2 \i0 \fs18 
{\*\bkmkstart co_footnote_F55546934635_1}{\*\bkmkend co_footnote_F55546934635_1}
{\field {\*\fldinst HYPERLINK "#co_fnRef_F55546934635_ID0ETFAG_1" }{\fldrslt 
{\super \b0 \cf19 \f2 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
55
}\super \b0 \cf19 \f2 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 }}
\par 
}
}
}\b0 \cf1 \f2 \ri0 \i0 \ql \li0 \fs18 \intbl \cell \intbl 
{\ri0 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs18 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs18 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs18 \li0 
{\b0 \cf1 \f2 \i1 \fs18 
{\b0 \cf1 \f2 \ul0 \strike0 \i1 \fs18 \sa0 \sb0 
See
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
 
}
{\b0 \cf1 \f2 \i0 \fs18 
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
Food & Drug Admin., Proposed Regulatory Framework for Modifications to Artificial Intelligence/Machine Learning (AI/ML)-Based Software as a Medical Device (SaMD) - Discussion Paper and Request for Feedback
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
, 
}
{\b0 \cf1 \f2 \i1 \fs18 
{\b0 \cf1 \f2 \ul0 \strike0 \i1 \fs18 \sa0 \sb0 
supra
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs18 \sa200 \sb0 
 note 52, at 4.
\par 
}
}
}
}
}\b0 \cf1 \f2 \ri0 \ul0 \strike0 \i0 \qj \li0 \fs18 \sa200 \sb0 \intbl \cell \row }
{\trowd \ltrrow \trleft0 
\clbrdrl \trql \clvertalt \clwWidth600 \cellx600 
\clpadb90 \clpadfb3 \clpadl90 \clpadfl3 \clbrdrr \trql \clwWidth9480 \cellx10080 
\intbl 
{\ri0 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \ql \fs18 \li0 
{\b0 \cf1 \f2 \i0 \fs18 
{\*\bkmkstart co_footnote_F56546934635_1}{\*\bkmkend co_footnote_F56546934635_1}
{\field {\*\fldinst HYPERLINK "#co_fnRef_F56546934635_ID0EZFAG_1" }{\fldrslt 
{\super \b0 \cf19 \f2 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
56
}\super \b0 \cf19 \f2 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 }}
\par 
}
}
}\b0 \cf1 \f2 \ri0 \i0 \ql \li0 \fs18 \intbl \cell \intbl 
{\ri0 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs18 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs18 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs18 \li0 
{\b0 \cf1 \f2 \i1 \fs18 
{\b0 \cf1 \f2 \ul0 \strike0 \i1 \fs18 \sa0 \sb0 
See
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
 Sharkey & Fodouop, 
}
{\b0 \cf1 \f2 \i1 \fs18 
{\b0 \cf1 \f2 \ul0 \strike0 \i1 \fs18 \sa0 \sb0 
supra
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs18 \sa200 \sb0 
 note 3, at 90-91, n.21.
\par 
}
}
}
}
}\b0 \cf1 \f2 \ri0 \ul0 \strike0 \i0 \qj \li0 \fs18 \sa200 \sb0 \intbl \cell \row }
{\trowd \ltrrow \trleft0 
\clbrdrl \trql \clvertalt \clwWidth600 \cellx600 
\clpadb90 \clpadfb3 \clpadl90 \clpadfl3 \clbrdrr \trql \clwWidth9480 \cellx10080 
\intbl 
{\ri0 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \ql \fs18 \li0 
{\b0 \cf1 \f2 \i0 \fs18 
{\*\bkmkstart co_footnote_F57546934635_1}{\*\bkmkend co_footnote_F57546934635_1}
{\field {\*\fldinst HYPERLINK "#co_fnRef_F57546934635_ID0EDGAG_1" }{\fldrslt 
{\super \b0 \cf19 \f2 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
57
}\super \b0 \cf19 \f2 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 }}
\par 
}
}
}\b0 \cf1 \f2 \ri0 \i0 \ql \li0 \fs18 \intbl \cell \intbl 
{\ri0 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs18 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs18 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs18 \li0 
{\b0 \cf1 \f2 \i1 \fs18 
{\b0 \cf1 \f2 \ul0 \strike0 \i1 \fs18 \sa0 \sb0 
See
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
 
}
{\b0 \cf1 \f2 \i0 \fs18 
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
Food & Drug Admin., Proposed Regulatory Framework for Modifications to Artificial Intelligence/Machine Learning (AI/ML)-Based Software as a Medical Device (SaMD) - Discussion Paper and Request for Feedback
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
, 
}
{\b0 \cf1 \f2 \i1 \fs18 
{\b0 \cf1 \f2 \ul0 \strike0 \i1 \fs18 \sa0 \sb0 
supra
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs18 \sa200 \sb0 
 note 52, at 3.
\par 
}
}
}
}
}\b0 \cf1 \f2 \ri0 \ul0 \strike0 \i0 \qj \li0 \fs18 \sa200 \sb0 \intbl \cell \row }
{\trowd \ltrrow \trleft0 
\clbrdrl \trql \clvertalt \clwWidth600 \cellx600 
\clpadb90 \clpadfb3 \clpadl90 \clpadfl3 \clbrdrr \trql \clwWidth9480 \cellx10080 
\intbl 
{\ri0 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \ql \fs18 \li0 
{\b0 \cf1 \f2 \i0 \fs18 
{\*\bkmkstart co_footnote_F58546934635_1}{\*\bkmkend co_footnote_F58546934635_1}
{\field {\*\fldinst HYPERLINK "#co_fnRef_F58546934635_ID0EIGAG_1" }{\fldrslt 
{\super \b0 \cf19 \f2 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
58
}\super \b0 \cf19 \f2 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 }}
\par 
}
}
}\b0 \cf1 \f2 \ri0 \i0 \ql \li0 \fs18 \intbl \cell \intbl 
{\ri0 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs18 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs18 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs18 \li0 
{\b0 \cf1 \f2 \i1 \fs18 
{\b0 \cf1 \f2 \ul0 \strike0 \i1 \fs18 \sa0 \sb0 
See The Evolving FDA Regulatory Landscape of Artificial Intelligence
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
, 
}
{\b0 \cf1 \f2 \i1 \fs18 
{\b0 \cf1 \f2 \ul0 \strike0 \i1 \fs18 \sa0 \sb0 
supra
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs18 \sa200 \sb0 
 note 54.
\par 
}
}
}
}
}\b0 \cf1 \f2 \ri0 \ul0 \strike0 \i0 \qj \li0 \fs18 \sa200 \sb0 \intbl \cell \row }
{\trowd \ltrrow \trleft0 
\clbrdrl \trql \clvertalt \clwWidth600 \cellx600 
\clpadb90 \clpadfb3 \clpadl90 \clpadfl3 \clbrdrr \trql \clwWidth9480 \cellx10080 
\intbl 
{\ri0 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \ql \fs18 \li0 
{\b0 \cf1 \f2 \i0 \fs18 
{\*\bkmkstart co_footnote_F59546934635_1}{\*\bkmkend co_footnote_F59546934635_1}
{\field {\*\fldinst HYPERLINK "#co_fnRef_F59546934635_ID0EMGAG_1" }{\fldrslt 
{\super \b0 \cf19 \f2 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
59
}\super \b0 \cf19 \f2 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 }}
\par 
}
}
}\b0 \cf1 \f2 \ri0 \i0 \ql \li0 \fs18 \intbl \cell \intbl 
{\ri0 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs18 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs18 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs18 \li0 
{\b0 \cf1 \f2 \i1 \fs18 
{\b0 \cf1 \f2 \ul0 \strike0 \i1 \fs18 \sa0 \sb0 
See
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
 
}
{\b0 \cf1 \f2 \i0 \fs18 
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
Food & Drug Admin., FDA Permits Marketing of Artificial Intelligence-Based Device to Detect Certain Diabetes-Related Eye Problems
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs18 \sa200 \sb0 
 (Apr. 12, 2018), https://www.fda.gov/news-events/press-announcements/fda-permits-marketing-artificial-intelligence-based-device-detect-certain-diabetes-related-eye.
\par 
}
}
}
}
}\b0 \cf1 \f2 \ri0 \ul0 \strike0 \i0 \qj \li0 \fs18 \sa200 \sb0 \intbl \cell \row }
{\trowd \ltrrow \trleft0 
\clbrdrl \trql \clvertalt \clwWidth600 \cellx600 
\clpadb90 \clpadfb3 \clpadl90 \clpadfl3 \clbrdrr \trql \clwWidth9480 \cellx10080 
\intbl 
{\ri0 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \ql \fs18 \li0 
{\b0 \cf1 \f2 \i0 \fs18 
{\*\bkmkstart co_footnote_F60546934635_1}{\*\bkmkend co_footnote_F60546934635_1}
{\field {\*\fldinst HYPERLINK "#co_fnRef_F60546934635_ID0E3GAG_1" }{\fldrslt 
{\super \b0 \cf19 \f2 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
60
}\super \b0 \cf19 \f2 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 }}
\par 
}
}
}\b0 \cf1 \f2 \ri0 \i0 \ql \li0 \fs18 \intbl \cell \intbl 
{\ri0 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs18 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs18 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs18 \li0 
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
While there has been a debate--especially active in recent years-- software has traditionally been classified as a service; moreover, the 
}
{\b0 \cf1 \f2 \i1 \fs18 
{\b0 \cf1 \f2 \ul0 \strike0 \i1 \fs18 \sa0 \sb0 
Restatement (Third) of Torts: Products Liability
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
 implicitly supports that view by defining products as \u8220\'3ftangible personal property.\u8221\'3f 
}
{\field {\*\fldinst HYPERLINK "https://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=0290692065&pubNum=0106659&originatingDoc=I434c460335f011ef8921fbef1a541940&refType=TS&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b0 \cf19 \f2 \i0 \fs18 
{\b0 \cf19 \f2 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
Restatement (Third) of Torts: Products Liability
}
}
{\b0 \cf19 \f2 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
 \u167\'3f 19
}\b0 \cf19 \f2 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 }}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
. But modern cases like 
}
{\b0 \cf1 \f2 \i1 \fs18 
{\b0 \cf1 \f2 \ul0 \strike0 \i1 \fs18 \sa0 \sb0 
Lemmon v. Snap
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
 and 
}
{\b0 \cf1 \f2 \i1 \fs18 
{\b0 \cf1 \f2 \ul0 \strike0 \i1 \fs18 \sa0 \sb0 
In re Social Media Adolescent Addiction
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
 suggest that software can at least sometimes be treated as a product. 
}
{\field {\*\fldinst HYPERLINK "https://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2053558932&pubNum=0000506&originatingDoc=I434c460335f011ef8921fbef1a541940&refType=RP&fi=co_pp_sp_506_1093&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)#co_pp_sp_506_1093" }{\fldrslt 
{\b0 \cf19 \f2 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
Lemmon v. Snap, Inc., 995 F.3d 1085, 1093 (9th Cir. 2021)
}\b0 \cf19 \f2 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 }}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
 (finding that Snap had a duty to design its in-app software to be a reasonably safe product); In re Soc. Media Adolescent Addiction/Pers. Inj. 
}
{\field {\*\fldinst HYPERLINK "https://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2077442454&pubNum=0000999&originatingDoc=I434c460335f011ef8921fbef1a541940&refType=RP&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b0 \cf19 \f2 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
Prod. Liab. Litig., No. 4:22-MD-03047-YGR, 2023 WL 7524912 (N.D. Cal. Nov. 14, 2023)
}\b0 \cf19 \f2 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 }}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs18 \sa200 \sb0 
 (holding that whether a functionality of an intangible platform is a product turns on whether that functionality is analogous to tangible personal property, and holding that functionalities such as parental controls, screen time limits, barriers to deletion, and failure to label filtered content are products).
\par 
}
}
}
}
}\b0 \cf1 \f2 \ri0 \ul0 \strike0 \i0 \qj \li0 \fs18 \sa200 \sb0 \intbl \cell \row }
{\trowd \ltrrow \trleft0 
\clbrdrl \trql \clvertalt \clwWidth600 \cellx600 
\clpadb90 \clpadfb3 \clpadl90 \clpadfl3 \clbrdrr \trql \clwWidth9480 \cellx10080 
\intbl 
{\ri0 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \ql \fs18 \li0 
{\b0 \cf1 \f2 \i0 \fs18 
{\*\bkmkstart co_footnote_F61546934635_1}{\*\bkmkend co_footnote_F61546934635_1}
{\field {\*\fldinst HYPERLINK "#co_fnRef_F61546934635_ID0EBHAG_1" }{\fldrslt 
{\super \b0 \cf19 \f2 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
61
}\super \b0 \cf19 \f2 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 }}
\par 
}
}
}\b0 \cf1 \f2 \ri0 \i0 \ql \li0 \fs18 \intbl \cell \intbl 
{\ri0 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs18 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs18 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs18 \li0 
{\b0 \cf1 \f2 \i1 \fs18 
{\b0 \cf1 \f2 \ul0 \strike0 \i1 \fs18 \sa0 \sb0 
See
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
 
}
{\b0 \cf1 \f2 \i0 \fs18 
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
Food & Drug Admin., Proposed Regulatory Framework for Modifications to Artificial Intelligence/Machine Learning (AI/ML)-Based Software as a Medical Device (SaMD) - Discussion Paper and Request for Feedback
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
, 
}
{\b0 \cf1 \f2 \i1 \fs18 
{\b0 \cf1 \f2 \ul0 \strike0 \i1 \fs18 \sa0 \sb0 
supra
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs18 \sa200 \sb0 
 note 52.
\par 
}
}
}
}
}\b0 \cf1 \f2 \ri0 \ul0 \strike0 \i0 \qj \li0 \fs18 \sa200 \sb0 \intbl \cell \row }
{\trowd \ltrrow \trleft0 
\clbrdrl \trql \clvertalt \clwWidth600 \cellx600 
\clpadb90 \clpadfb3 \clpadl90 \clpadfl3 \clbrdrr \trql \clwWidth9480 \cellx10080 
\intbl 
{\ri0 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \ql \fs18 \li0 
{\b0 \cf1 \f2 \i0 \fs18 
{\*\bkmkstart co_footnote_F62546934635_1}{\*\bkmkend co_footnote_F62546934635_1}
{\field {\*\fldinst HYPERLINK "#co_fnRef_F62546934635_ID0EPHAG_1" }{\fldrslt 
{\super \b0 \cf19 \f2 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
62
}\super \b0 \cf19 \f2 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 }}
\par 
}
}
}\b0 \cf1 \f2 \ri0 \i0 \ql \li0 \fs18 \intbl \cell \intbl 
{\ri0 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs18 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs18 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs18 \li0 
{\b0 \cf1 \f2 \i1 \fs18 
{\b0 \cf1 \f2 \ul0 \strike0 \i1 \fs18 \sa0 \sb0 
See
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
 
}
{\b0 \cf1 \f2 \i0 \fs18 
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
Food & Drug Admin., Artificial Intelligence/Machine Learning (AI/ML)-Based Software as a Medical Device (SaMD) Action Plan
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs18 \sa200 \sb0 
NN (Jan. 2021), https://www.fda.gov/media/145022/download.
\par 
}
}
}
}
}\b0 \cf1 \f2 \ri0 \ul0 \strike0 \i0 \qj \li0 \fs18 \sa200 \sb0 \intbl \cell \row }
{\trowd \ltrrow \trleft0 
\clbrdrl \trql \clvertalt \clwWidth600 \cellx600 
\clpadb90 \clpadfb3 \clpadl90 \clpadfl3 \clbrdrr \trql \clwWidth9480 \cellx10080 
\intbl 
{\ri0 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \ql \fs18 \li0 
{\b0 \cf1 \f2 \i0 \fs18 
{\*\bkmkstart co_footnote_F63546934635_1}{\*\bkmkend co_footnote_F63546934635_1}
{\field {\*\fldinst HYPERLINK "#co_fnRef_F63546934635_ID0EZHAG_1" }{\fldrslt 
{\super \b0 \cf19 \f2 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
63
}\super \b0 \cf19 \f2 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 }}
\par 
}
}
}\b0 \cf1 \f2 \ri0 \i0 \ql \li0 \fs18 \intbl \cell \intbl 
{\ri0 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs18 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs18 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs18 \li0 
{\b0 \cf1 \f2 \i1 \fs18 
{\b0 \cf1 \f2 \ul0 \strike0 \i1 \fs18 \sa0 \sb0 
See 
}
}
{\b0 \cf1 \f2 \i1 \fs18 
{\b0 \cf1 \f2 \ul0 \strike0 \i1 \fs18 \sa0 \sb0 
id.
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs18 \sa200 \sb0 
 at 3-6.
\par 
}
}
}
}
}\b0 \cf1 \f2 \ri0 \ul0 \strike0 \i0 \qj \li0 \fs18 \sa200 \sb0 \intbl \cell \row }
{\trowd \ltrrow \trleft0 
\clbrdrl \trql \clvertalt \clwWidth600 \cellx600 
\clpadb90 \clpadfb3 \clpadl90 \clpadfl3 \clbrdrr \trql \clwWidth9480 \cellx10080 
\intbl 
{\ri0 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \ql \fs18 \li0 
{\b0 \cf1 \f2 \i0 \fs18 
{\*\bkmkstart co_footnote_F64546934635_1}{\*\bkmkend co_footnote_F64546934635_1}
{\field {\*\fldinst HYPERLINK "#co_fnRef_F64546934635_ID0E4HAG_1" }{\fldrslt 
{\super \b0 \cf19 \f2 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
64
}\super \b0 \cf19 \f2 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 }}
\par 
}
}
}\b0 \cf1 \f2 \ri0 \i0 \ql \li0 \fs18 \intbl \cell \intbl 
{\ri0 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs18 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs18 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs18 \li0 
{\b0 \cf1 \f2 \i1 \fs18 
{\b0 \cf1 \f2 \ul0 \strike0 \i1 \fs18 \sa0 \sb0 
See
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
 
}
{\b0 \cf1 \f2 \i0 \fs18 
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
Food & Drug Admin., The Software Precertification (Pre-Cert) Pilot Program: Tailored Total Product Lifecycle Approaches and Key Findings
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs18 \sa200 \sb0 
 (Sept. 26, 2022), https://www.fda.gov/medical-devices/digital-health-center-excellence/digital-health-software-precertification-pre-cert-pilot-program [https://perma.cc/93KB-KKJA].
\par 
}
}
}
}
}\b0 \cf1 \f2 \ri0 \ul0 \strike0 \i0 \qj \li0 \fs18 \sa200 \sb0 \intbl \cell \row }
{\trowd \ltrrow \trleft0 
\clbrdrl \trql \clvertalt \clwWidth600 \cellx600 
\clpadb90 \clpadfb3 \clpadl90 \clpadfl3 \clbrdrr \trql \clwWidth9480 \cellx10080 
\intbl 
{\ri0 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \ql \fs18 \li0 
{\b0 \cf1 \f2 \i0 \fs18 
{\*\bkmkstart co_footnote_F65546934635_1}{\*\bkmkend co_footnote_F65546934635_1}
{\field {\*\fldinst HYPERLINK "#co_fnRef_F65546934635_ID0EVIAG_1" }{\fldrslt 
{\super \b0 \cf19 \f2 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
65
}\super \b0 \cf19 \f2 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 }}
\par 
}
}
}\b0 \cf1 \f2 \ri0 \i0 \ql \li0 \fs18 \intbl \cell \intbl 
{\ri0 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs18 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs18 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs18 \li0 
{\b0 \cf1 \f2 \i1 \fs18 
{\b0 \cf1 \f2 \ul0 \strike0 \i1 \fs18 \sa0 \sb0 
See
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
 
}
{\b0 \cf1 \f2 \i0 \fs18 
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
Food & Drug Admin., Marketing Submission Recommendations for a Predetermined Change Control Plan for Artificial Intelligence/Machine Learning (AI/ML)-Enabled Device Software Functions
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
SS, 
}
{\b0 \cf1 \f2 \i1 \fs18 
{\b0 \cf1 \f2 \ul0 \strike0 \i1 \fs18 \sa0 \sb0 
supra
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
 note 53. Note that there are additional elements, including cybersecurity guidelines, that are part of the FDA\rquote s overall plan but are not the focus here. 
}
{\b0 \cf1 \f2 \i1 \fs18 
{\b0 \cf1 \f2 \ul0 \strike0 \i1 \fs18 \sa0 \sb0 
See, e.g.
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
, Jennifer Korn, 
}
{\b0 \cf1 \f2 \i1 \fs18 
{\b0 \cf1 \f2 \ul0 \strike0 \i1 \fs18 \sa0 \sb0 
FDA Requires Medical Devices Be Secured Against Cyberattacks
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
, 
}
{\b0 \cf1 \f2 \i0 \fs18 
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
CNN Business
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs18 \sa200 \sb0 
 (Mar. 29, 2023), https://www.cnn.com/2023/03/29/tech/fda-medical-devices-secured-cyberattacks/index.html [https://perma.cc/P3KG-JEAL].
\par 
}
}
}
}
}\b0 \cf1 \f2 \ri0 \ul0 \strike0 \i0 \qj \li0 \fs18 \sa200 \sb0 \intbl \cell \row }
{\trowd \ltrrow \trleft0 
\clbrdrl \trql \clvertalt \clwWidth600 \cellx600 
\clpadb90 \clpadfb3 \clpadl90 \clpadfl3 \clbrdrr \trql \clwWidth9480 \cellx10080 
\intbl 
{\ri0 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \ql \fs18 \li0 
{\b0 \cf1 \f2 \i0 \fs18 
{\*\bkmkstart co_footnote_F66546934635_1}{\*\bkmkend co_footnote_F66546934635_1}
{\field {\*\fldinst HYPERLINK "#co_fnRef_F66546934635_ID0EDJAG_1" }{\fldrslt 
{\super \b0 \cf19 \f2 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
66
}\super \b0 \cf19 \f2 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 }}
\par 
}
}
}\b0 \cf1 \f2 \ri0 \i0 \ql \li0 \fs18 \intbl \cell \intbl 
{\ri0 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs18 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs18 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs18 \li0 
{\b0 \cf1 \f2 \i0 \fs18 
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
Food & Drug Admin., Marketing Submission Recommendations for a Predetermined Change Control Plan for Artificial Intelligence/Machine Learning (AI/ML)-Enabled Device Software Functions
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
SS, 
}
{\b0 \cf1 \f2 \i1 \fs18 
{\b0 \cf1 \f2 \ul0 \strike0 \i1 \fs18 \sa0 \sb0 
supra
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs18 \sa200 \sb0 
 note 53, at 6.
\par 
}
}
}
}
}\b0 \cf1 \f2 \ri0 \ul0 \strike0 \i0 \qj \li0 \fs18 \sa200 \sb0 \intbl \cell \row }
{\trowd \ltrrow \trleft0 
\clbrdrl \trql \clvertalt \clwWidth600 \cellx600 
\clpadb90 \clpadfb3 \clpadl90 \clpadfl3 \clbrdrr \trql \clwWidth9480 \cellx10080 
\intbl 
{\ri0 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \ql \fs18 \li0 
{\b0 \cf1 \f2 \i0 \fs18 
{\*\bkmkstart co_footnote_F67546934635_1}{\*\bkmkend co_footnote_F67546934635_1}
{\field {\*\fldinst HYPERLINK "#co_fnRef_F67546934635_ID0EYJAG_1" }{\fldrslt 
{\super \b0 \cf19 \f2 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
67
}\super \b0 \cf19 \f2 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 }}
\par 
}
}
}\b0 \cf1 \f2 \ri0 \i0 \ql \li0 \fs18 \intbl \cell \intbl 
{\ri0 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs18 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs18 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs18 \li0 
{\b0 \cf1 \f2 \i1 \fs18 
{\b0 \cf1 \f2 \ul0 \strike0 \i1 \fs18 \sa0 \sb0 
Id.
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs18 \sa200 \sb0 
 at 24.
\par 
}
}
}
}
}\b0 \cf1 \f2 \ri0 \ul0 \strike0 \i0 \qj \li0 \fs18 \sa200 \sb0 \intbl \cell \row }
{\trowd \ltrrow \trleft0 
\clbrdrl \trql \clvertalt \clwWidth600 \cellx600 
\clpadb90 \clpadfb3 \clpadl90 \clpadfl3 \clbrdrr \trql \clwWidth9480 \cellx10080 
\intbl 
{\ri0 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \ql \fs18 \li0 
{\b0 \cf1 \f2 \i0 \fs18 
{\*\bkmkstart co_footnote_F68546934635_1}{\*\bkmkend co_footnote_F68546934635_1}
{\field {\*\fldinst HYPERLINK "#co_fnRef_F68546934635_ID0EGLAG_1" }{\fldrslt 
{\super \b0 \cf19 \f2 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
68
}\super \b0 \cf19 \f2 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 }}
\par 
}
}
}\b0 \cf1 \f2 \ri0 \i0 \ql \li0 \fs18 \intbl \cell \intbl 
{\ri0 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs18 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs18 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs18 \li0 
{\b0 \cf1 \f2 \i1 \fs18 
{\b0 \cf1 \f2 \ul0 \strike0 \i1 \fs18 \sa0 \sb0 
See
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
 Sharkey & Fodouop, 
}
{\b0 \cf1 \f2 \i1 \fs18 
{\b0 \cf1 \f2 \ul0 \strike0 \i1 \fs18 \sa0 \sb0 
supra
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs18 \sa200 \sb0 
 note 3, at 87.
\par 
}
}
}
}
}\b0 \cf1 \f2 \ri0 \ul0 \strike0 \i0 \qj \li0 \fs18 \sa200 \sb0 \intbl \cell \row }
{\trowd \ltrrow \trleft0 
\clbrdrl \trql \clvertalt \clwWidth600 \cellx600 
\clpadb90 \clpadfb3 \clpadl90 \clpadfl3 \clbrdrr \trql \clwWidth9480 \cellx10080 
\intbl 
{\ri0 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \ql \fs18 \li0 
{\b0 \cf1 \f2 \i0 \fs18 
{\*\bkmkstart co_footnote_F69546934635_1}{\*\bkmkend co_footnote_F69546934635_1}
{\field {\*\fldinst HYPERLINK "#co_fnRef_F69546934635_ID0EPMAG_1" }{\fldrslt 
{\super \b0 \cf19 \f2 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
69
}\super \b0 \cf19 \f2 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 }}
\par 
}
}
}\b0 \cf1 \f2 \ri0 \i0 \ql \li0 \fs18 \intbl \cell \intbl 
{\ri0 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs18 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs18 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs18 \li0 
{\field {\*\fldinst HYPERLINK "https://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=2077292919&pubNum=0001043&originatingDoc=I434c460335f011ef8921fbef1a541940&refType=CA&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b0 \cf19 \f2 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
Exec. Order No. 14,110, 
}
{\b0 \cf19 \f2 \i1 \fs18 
{\b0 \cf19 \f2 \ul0 \strike0 \i1 \fs18 \sa0 \sb0 
supra
}
}
{\b0 \cf19 \f2 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
 note 1
}\b0 \cf19 \f2 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 }}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs18 \sa200 \sb0 
, at 75195.
\par 
}
}
}
}
}\b0 \cf1 \f2 \ri0 \ul0 \strike0 \i0 \qj \li0 \fs18 \sa200 \sb0 \intbl \cell \row }
{\trowd \ltrrow \trleft0 
\clbrdrl \trql \clvertalt \clwWidth600 \cellx600 
\clpadb90 \clpadfb3 \clpadl90 \clpadfl3 \clbrdrr \trql \clwWidth9480 \cellx10080 
\intbl 
{\ri0 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \ql \fs18 \li0 
{\b0 \cf1 \f2 \i0 \fs18 
{\*\bkmkstart co_footnote_F70546934635_1}{\*\bkmkend co_footnote_F70546934635_1}
{\field {\*\fldinst HYPERLINK "#co_fnRef_F70546934635_ID0E5MAG_1" }{\fldrslt 
{\super \b0 \cf19 \f2 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
70
}\super \b0 \cf19 \f2 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 }}
\par 
}
}
}\b0 \cf1 \f2 \ri0 \i0 \ql \li0 \fs18 \intbl \cell \intbl 
{\ri0 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs18 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs18 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs18 \li0 
{\b0 \cf1 \f2 \i1 \fs18 
{\b0 \cf1 \f2 \ul0 \strike0 \i1 \fs18 \sa0 \sb0 
See
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
 
}
{\b0 \cf1 \f2 \i0 \fs18 
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
Food & Drug Admin., Artificial Intelligence and Machine Learning (AI/ML)-Enabled Medical Devices
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
, 
}
{\b0 \cf1 \f2 \i1 \fs18 
{\b0 \cf1 \f2 \ul0 \strike0 \i1 \fs18 \sa0 \sb0 
supra
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs18 \sa200 \sb0 
 note 48.
\par 
}
}
}
}
}\b0 \cf1 \f2 \ri0 \ul0 \strike0 \i0 \qj \li0 \fs18 \sa200 \sb0 \intbl \cell \row }
{\trowd \ltrrow \trleft0 
\clbrdrl \trql \clvertalt \clwWidth600 \cellx600 
\clpadb90 \clpadfb3 \clpadl90 \clpadfl3 \clbrdrr \trql \clwWidth9480 \cellx10080 
\intbl 
{\ri0 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \ql \fs18 \li0 
{\b0 \cf1 \f2 \i0 \fs18 
{\*\bkmkstart co_footnote_F71546934635_1}{\*\bkmkend co_footnote_F71546934635_1}
{\field {\*\fldinst HYPERLINK "#co_fnRef_F71546934635_ID0E5NAG_1" }{\fldrslt 
{\super \b0 \cf19 \f2 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
71
}\super \b0 \cf19 \f2 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 }}
\par 
}
}
}\b0 \cf1 \f2 \ri0 \i0 \ql \li0 \fs18 \intbl \cell \intbl 
{\ri0 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs18 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs18 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs18 \li0 
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
Anupriya Ramraj, 
}
{\b0 \cf1 \f2 \i1 \fs18 
{\b0 \cf1 \f2 \ul0 \strike0 \i1 \fs18 \sa0 \sb0 
Transforming Healthcare with Generative AI
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
, 
}
{\b0 \cf1 \f2 \i0 \fs18 
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
Forbes
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs18 \sa200 \sb0 
 (June 27, 2023), https://www.forbes.com/sites/forbestechcouncil/2023/06/27/transforming-healthcare-with-generative-ai/ [https://perma.cc/W455-2LRV].
\par 
}
}
}
}
}\b0 \cf1 \f2 \ri0 \ul0 \strike0 \i0 \qj \li0 \fs18 \sa200 \sb0 \intbl \cell \row }
{\trowd \ltrrow \trleft0 
\clbrdrl \trql \clvertalt \clwWidth600 \cellx600 
\clpadb90 \clpadfb3 \clpadl90 \clpadfl3 \clbrdrr \trql \clwWidth9480 \cellx10080 
\intbl 
{\ri0 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \ql \fs18 \li0 
{\b0 \cf1 \f2 \i0 \fs18 
{\*\bkmkstart co_footnote_F72546934635_1}{\*\bkmkend co_footnote_F72546934635_1}
{\field {\*\fldinst HYPERLINK "#co_fnRef_F72546934635_ID0EDOAG_1" }{\fldrslt 
{\super \b0 \cf19 \f2 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
72
}\super \b0 \cf19 \f2 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 }}
\par 
}
}
}\b0 \cf1 \f2 \ri0 \i0 \ql \li0 \fs18 \intbl \cell \intbl 
{\ri0 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs18 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs18 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs18 \li0 
{\b0 \cf1 \f2 \i1 \fs18 
{\b0 \cf1 \f2 \ul0 \strike0 \i1 \fs18 \sa0 \sb0 
See id.
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
 (\u8220\'3f[Generative AI] can also predict the efficacy and safety of new drug candidates by analyzing large data on drug-target interactions. Generative AI identifies patient subgroups more likely to respond to a drug by analyzing clinical data patterns, helping personalize drug therapy and improve patient outcomes.\u8221\'3f); 
}
{\b0 \cf1 \f2 \i1 \fs18 
{\b0 \cf1 \f2 \ul0 \strike0 \i1 \fs18 \sa0 \sb0 
see also
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
 Kevin B. Johnson et al., 
}
{\b0 \cf1 \f2 \i1 \fs18 
{\b0 \cf1 \f2 \ul0 \strike0 \i1 \fs18 \sa0 \sb0 
Precision Medicine, AI, and the Future of Personalized Health Care
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
, 14 
}
{\b0 \cf1 \f2 \i0 \fs18 
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
Clinical & Translational Sci.
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs18 \sa200 \sb0 
 86 (2021).
\par 
}
}
}
}
}\b0 \cf1 \f2 \ri0 \ul0 \strike0 \i0 \qj \li0 \fs18 \sa200 \sb0 \intbl \cell \row }
{\trowd \ltrrow \trleft0 
\clbrdrl \trql \clvertalt \clwWidth600 \cellx600 
\clpadb90 \clpadfb3 \clpadl90 \clpadfl3 \clbrdrr \trql \clwWidth9480 \cellx10080 
\intbl 
{\ri0 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \ql \fs18 \li0 
{\b0 \cf1 \f2 \i0 \fs18 
{\*\bkmkstart co_footnote_F73546934635_1}{\*\bkmkend co_footnote_F73546934635_1}
{\field {\*\fldinst HYPERLINK "#co_fnRef_F73546934635_ID0EIOAG_1" }{\fldrslt 
{\super \b0 \cf19 \f2 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
73
}\super \b0 \cf19 \f2 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 }}
\par 
}
}
}\b0 \cf1 \f2 \ri0 \i0 \ql \li0 \fs18 \intbl \cell \intbl 
{\ri0 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs18 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs18 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs18 \li0 
{\b0 \cf1 \f2 \i1 \fs18 
{\b0 \cf1 \f2 \ul0 \strike0 \i1 \fs18 \sa0 \sb0 
See
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
 Salah S. Al-Zaiti et al., 
}
{\b0 \cf1 \f2 \i1 \fs18 
{\b0 \cf1 \f2 \ul0 \strike0 \i1 \fs18 \sa0 \sb0 
Machine Learning for ECG Diagnosis and Risk Stratification of Occlusion Myocardial Infarction
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
, 29 
}
{\b0 \cf1 \f2 \i0 \fs18 
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
Nature Med.
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs18 \sa200 \sb0 
 1804-13 (2023).
\par 
}
}
}
}
}\b0 \cf1 \f2 \ri0 \ul0 \strike0 \i0 \qj \li0 \fs18 \sa200 \sb0 \intbl \cell \row }
{\trowd \ltrrow \trleft0 
\clbrdrl \trql \clvertalt \clwWidth600 \cellx600 
\clpadb90 \clpadfb3 \clpadl90 \clpadfl3 \clbrdrr \trql \clwWidth9480 \cellx10080 
\intbl 
{\ri0 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \ql \fs18 \li0 
{\b0 \cf1 \f2 \i0 \fs18 
{\*\bkmkstart co_footnote_F74546934635_1}{\*\bkmkend co_footnote_F74546934635_1}
{\field {\*\fldinst HYPERLINK "#co_fnRef_F74546934635_ID0ELOAG_1" }{\fldrslt 
{\super \b0 \cf19 \f2 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
74
}\super \b0 \cf19 \f2 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 }}
\par 
}
}
}\b0 \cf1 \f2 \ri0 \i0 \ql \li0 \fs18 \intbl \cell \intbl 
{\ri0 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs18 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs18 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs18 \li0 
{\b0 \cf1 \f2 \i1 \fs18 
{\b0 \cf1 \f2 \ul0 \strike0 \i1 \fs18 \sa0 \sb0 
See
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
 Matthew Huddle et al., 
}
{\b0 \cf1 \f2 \i1 \fs18 
{\b0 \cf1 \f2 \ul0 \strike0 \i1 \fs18 \sa0 \sb0 
Generative AI Will Transform Health Care Sooner Than You Think
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs18 \sa200 \sb0 
, BCG (June 22, 2023), https://www.bcg.com/publications/2023/how-generative-ai-is-transforming-health-care-sooner-than-expected [https://perma.cc/M9SC-5ZZW].
\par 
}
}
}
}
}\b0 \cf1 \f2 \ri0 \ul0 \strike0 \i0 \qj \li0 \fs18 \sa200 \sb0 \intbl \cell \row }
{\trowd \ltrrow \trleft0 
\clbrdrl \trql \clvertalt \clwWidth600 \cellx600 
\clpadb90 \clpadfb3 \clpadl90 \clpadfl3 \clbrdrr \trql \clwWidth9480 \cellx10080 
\intbl 
{\ri0 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \ql \fs18 \li0 
{\b0 \cf1 \f2 \i0 \fs18 
{\*\bkmkstart co_footnote_F75546934635_1}{\*\bkmkend co_footnote_F75546934635_1}
{\field {\*\fldinst HYPERLINK "#co_fnRef_F75546934635_ID0EPOAG_1" }{\fldrslt 
{\super \b0 \cf19 \f2 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
75
}\super \b0 \cf19 \f2 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 }}
\par 
}
}
}\b0 \cf1 \f2 \ri0 \i0 \ql \li0 \fs18 \intbl \cell \intbl 
{\ri0 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs18 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs18 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs18 \li0 
{\b0 \cf1 \f2 \i1 \fs18 
{\b0 \cf1 \f2 \ul0 \strike0 \i1 \fs18 \sa0 \sb0 
See
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
 Sharkey et al., 
}
{\b0 \cf1 \f2 \i1 \fs18 
{\b0 \cf1 \f2 \ul0 \strike0 \i1 \fs18 \sa0 \sb0 
supra
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
 note 45, at 285-86; Sharkey, 
}
{\b0 \cf1 \f2 \i1 \fs18 
{\b0 \cf1 \f2 \ul0 \strike0 \i1 \fs18 \sa0 \sb0 
supra
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs18 \sa200 \sb0 
 note 46, at 370-71.
\par 
}
}
}
}
}\b0 \cf1 \f2 \ri0 \ul0 \strike0 \i0 \qj \li0 \fs18 \sa200 \sb0 \intbl \cell \row }
{\trowd \ltrrow \trleft0 
\clbrdrl \trql \clvertalt \clwWidth600 \cellx600 
\clpadb90 \clpadfb3 \clpadl90 \clpadfl3 \clbrdrr \trql \clwWidth9480 \cellx10080 
\intbl 
{\ri0 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \ql \fs18 \li0 
{\b0 \cf1 \f2 \i0 \fs18 
{\*\bkmkstart co_footnote_F76546934635_1}{\*\bkmkend co_footnote_F76546934635_1}
{\field {\*\fldinst HYPERLINK "#co_fnRef_F76546934635_ID0EXPAG_1" }{\fldrslt 
{\super \b0 \cf19 \f2 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
76
}\super \b0 \cf19 \f2 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 }}
\par 
}
}
}\b0 \cf1 \f2 \ri0 \i0 \ql \li0 \fs18 \intbl \cell \intbl 
{\ri0 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs18 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs18 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs18 \li0 
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
Baumann, 
}
{\b0 \cf1 \f2 \i1 \fs18 
{\b0 \cf1 \f2 \ul0 \strike0 \i1 \fs18 \sa0 \sb0 
supra
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs18 \sa200 \sb0 
 note 15 (quoting Alan Karthikesalingam, research lead at Google Health).
\par 
}
}
}
}
}\b0 \cf1 \f2 \ri0 \ul0 \strike0 \i0 \qj \li0 \fs18 \sa200 \sb0 \intbl \cell \row }
{\trowd \ltrrow \trleft0 
\clbrdrl \trql \clvertalt \clwWidth600 \cellx600 
\clpadb90 \clpadfb3 \clpadl90 \clpadfl3 \clbrdrr \trql \clwWidth9480 \cellx10080 
\intbl 
{\ri0 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \ql \fs18 \li0 
{\b0 \cf1 \f2 \i0 \fs18 
{\*\bkmkstart co_footnote_F77546934635_1}{\*\bkmkend co_footnote_F77546934635_1}
{\field {\*\fldinst HYPERLINK "#co_fnRef_F77546934635_ID0EOQAG_1" }{\fldrslt 
{\super \b0 \cf19 \f2 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
77
}\super \b0 \cf19 \f2 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 }}
\par 
}
}
}\b0 \cf1 \f2 \ri0 \i0 \ql \li0 \fs18 \intbl \cell \intbl 
{\ri0 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs18 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs18 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs18 \li0 
{\b0 \cf1 \f2 \i1 \fs18 
{\b0 \cf1 \f2 \ul0 \strike0 \i1 \fs18 \sa200 \sb0 
Id.
\par 
}
}
}
}
}
}\b0 \cf1 \f2 \ri0 \ul0 \strike0 \i1 \qj \li0 \fs18 \sa200 \sb0 \intbl \cell \row }
{\trowd \ltrrow \trleft0 
\clbrdrl \trql \clvertalt \clwWidth600 \cellx600 
\clpadb90 \clpadfb3 \clpadl90 \clpadfl3 \clbrdrr \trql \clwWidth9480 \cellx10080 
\intbl 
{\ri0 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \ql \fs18 \li0 
{\b0 \cf1 \f2 \i0 \fs18 
{\*\bkmkstart co_footnote_F78546934635_1}{\*\bkmkend co_footnote_F78546934635_1}
{\field {\*\fldinst HYPERLINK "#co_fnRef_F78546934635_ID0E5QAG_1" }{\fldrslt 
{\super \b0 \cf19 \f2 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
78
}\super \b0 \cf19 \f2 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 }}
\par 
}
}
}\b0 \cf1 \f2 \ri0 \i0 \ql \li0 \fs18 \intbl \cell \intbl 
{\ri0 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs18 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs18 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs18 \li0 
{\b0 \cf1 \f2 \i1 \fs18 
{\b0 \cf1 \f2 \ul0 \strike0 \i1 \fs18 \sa0 \sb0 
Id.
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs18 \sa200 \sb0 
 (quoting David Peloquin, health care attorney at Ropes & Gray LLP).
\par 
}
}
}
}
}\b0 \cf1 \f2 \ri0 \ul0 \strike0 \i0 \qj \li0 \fs18 \sa200 \sb0 \intbl \cell \row }
{\trowd \ltrrow \trleft0 
\clbrdrl \trql \clvertalt \clwWidth600 \cellx600 
\clpadb90 \clpadfb3 \clpadl90 \clpadfl3 \clbrdrr \trql \clwWidth9480 \cellx10080 
\intbl 
{\ri0 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \ql \fs18 \li0 
{\b0 \cf1 \f2 \i0 \fs18 
{\*\bkmkstart co_footnote_F79546934635_1}{\*\bkmkend co_footnote_F79546934635_1}
{\field {\*\fldinst HYPERLINK "#co_fnRef_F79546934635_ID0EWSAG_1" }{\fldrslt 
{\super \b0 \cf19 \f2 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
79
}\super \b0 \cf19 \f2 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 }}
\par 
}
}
}\b0 \cf1 \f2 \ri0 \i0 \ql \li0 \fs18 \intbl \cell \intbl 
{\ri0 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs18 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs18 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs18 \li0 
{\b0 \cf1 \f2 \i1 \fs18 
{\b0 \cf1 \f2 \ul0 \strike0 \i1 \fs18 \sa0 \sb0 
See
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
 Catherine M. Sharkey, 
}
{\b0 \cf1 \f2 \i1 \fs18 
{\b0 \cf1 \f2 \ul0 \strike0 \i1 \fs18 \sa0 \sb0 
What
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
 Riegel 
}
{\b0 \cf1 \f2 \i1 \fs18 
{\b0 \cf1 \f2 \ul0 \strike0 \i1 \fs18 \sa0 \sb0 
Portends for FDA Preemption
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
, 103 
}
{\b0 \cf1 \f2 \i0 \fs18 
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
Nw. U. L. Colloquy
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
 437, 445 (2009) (\u8220\'3f
}
{\b0 \cf1 \f2 \i1 \fs18 
{\b0 \cf1 \f2 \ul0 \strike0 \i1 \fs18 \sa0 \sb0 
Riegel
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs18 \sa200 \sb0 
 is rife with details from the FDA\rquote s regulatory review process--though their precise legal effect, given the Court\rquote s insistence on governing statutory text, is rather opaque. The Court drilled down to the details of the FDA\rquote s review process, repeatedly stressing the \u8216\'3frigorous\rquote  nature of its premarket approval (PMA) process for medical devices. This PMA process demands considerable resources and manpower hours, culminating in the FDA\rquote s determination of \u8216\'3freasonable assurance\u8217\'3f of the medical device\rquote s \u8216\'3fsafety and effectiveness.\u8221\'3f\u8217\'3f).
\par 
}
}
}
}
}\b0 \cf1 \f2 \ri0 \ul0 \strike0 \i0 \qj \li0 \fs18 \sa200 \sb0 \intbl \cell \row }
{\trowd \ltrrow \trleft0 
\clbrdrl \trql \clvertalt \clwWidth600 \cellx600 
\clpadb90 \clpadfb3 \clpadl90 \clpadfl3 \clbrdrr \trql \clwWidth9480 \cellx10080 
\intbl 
{\ri0 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \ql \fs18 \li0 
{\b0 \cf1 \f2 \i0 \fs18 
{\*\bkmkstart co_footnote_F80546934635_1}{\*\bkmkend co_footnote_F80546934635_1}
{\field {\*\fldinst HYPERLINK "#co_fnRef_F80546934635_ID0E6SAG_1" }{\fldrslt 
{\super \b0 \cf19 \f2 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
80
}\super \b0 \cf19 \f2 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 }}
\par 
}
}
}\b0 \cf1 \f2 \ri0 \i0 \ql \li0 \fs18 \intbl \cell \intbl 
{\ri0 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs18 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs18 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs18 \li0 
{\b0 \cf1 \f2 \i1 \fs18 
{\b0 \cf1 \f2 \ul0 \strike0 \i1 \fs18 \sa0 \sb0 
See id.
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs18 \sa200 \sb0 
 (\u8220\'3fPremarket notification is a streamlined process, which is completed in an average of 20 hours (as compared to the PMA\rquote s 1,200-hour average). So, measured by average manpower hours, this type of regulatory review is sixty times more lax. Even more germane is the distinction the Court drew between the FDA\rquote s premarket notification \u8216\'3fequivalence\u8217\'3f review, which essentially \u8216\'3fgrandfathers\rquote  devices that are equivalent to those existing on the market at the time of the MDA\rquote s enactment, and the full-blown PMA \u8216\'3fsafety\u8217\'3f review.\u8221\'3f).
\par 
}
}
}
}
}\b0 \cf1 \f2 \ri0 \ul0 \strike0 \i0 \qj \li0 \fs18 \sa200 \sb0 \intbl \cell \row }
{\trowd \ltrrow \trleft0 
\clbrdrl \trql \clvertalt \clwWidth600 \cellx600 
\clpadb90 \clpadfb3 \clpadl90 \clpadfl3 \clbrdrr \trql \clwWidth9480 \cellx10080 
\intbl 
{\ri0 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \ql \fs18 \li0 
{\b0 \cf1 \f2 \i0 \fs18 
{\*\bkmkstart co_footnote_F81546934635_1}{\*\bkmkend co_footnote_F81546934635_1}
{\field {\*\fldinst HYPERLINK "#co_fnRef_F81546934635_ID0EOTAG_1" }{\fldrslt 
{\super \b0 \cf19 \f2 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
81
}\super \b0 \cf19 \f2 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 }}
\par 
}
}
}\b0 \cf1 \f2 \ri0 \i0 \ql \li0 \fs18 \intbl \cell \intbl 
{\ri0 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs18 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs18 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs18 \li0 
{\b0 \cf1 \f2 \i1 \fs18 
{\b0 \cf1 \f2 \ul0 \strike0 \i1 \fs18 \sa200 \sb0 
See id.
\par 
}
}
}
}
}
}\b0 \cf1 \f2 \ri0 \ul0 \strike0 \i1 \qj \li0 \fs18 \sa200 \sb0 \intbl \cell \row }
{\trowd \ltrrow \trleft0 
\clbrdrl \trql \clvertalt \clwWidth600 \cellx600 
\clpadb90 \clpadfb3 \clpadl90 \clpadfl3 \clbrdrr \trql \clwWidth9480 \cellx10080 
\intbl 
{\ri0 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \ql \fs18 \li0 
{\b0 \cf1 \f2 \i0 \fs18 
{\*\bkmkstart co_footnote_F82546934635_1}{\*\bkmkend co_footnote_F82546934635_1}
{\field {\*\fldinst HYPERLINK "#co_fnRef_F82546934635_ID0ETTAG_1" }{\fldrslt 
{\super \b0 \cf19 \f2 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
82
}\super \b0 \cf19 \f2 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 }}
\par 
}
}
}\b0 \cf1 \f2 \ri0 \i0 \ql \li0 \fs18 \intbl \cell \intbl 
{\ri0 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs18 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs18 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs18 \li0 
{\b0 \cf1 \f2 \i1 \fs18 
{\b0 \cf1 \f2 \ul0 \strike0 \i1 \fs18 \sa0 \sb0 
See 
}
}
{\b0 \cf1 \f2 \i1 \fs18 
{\b0 \cf1 \f2 \ul0 \strike0 \i1 \fs18 \sa0 \sb0 
id.
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs18 \sa200 \sb0 
 at 441 (\u8220\'3fThe basic question at the core of implied conflict preemption inquiries is whether or not state common law actions are irreconcilable with, or would stand as an obstacle to, or frustrate, the command of federal regulatory directives and goals. To answer this question, courts need a fine-grained account of the precise regulatory review conducted by the agency and evidence as to its compatibility with state law tort claims. The agency reference model aims, as a general matter, to facilitate input from federal agencies on these issues.\u8221\'3f).
\par 
}
}
}
}
}\b0 \cf1 \f2 \ri0 \ul0 \strike0 \i0 \qj \li0 \fs18 \sa200 \sb0 \intbl \cell \row }
{\trowd \ltrrow \trleft0 
\clbrdrl \trql \clvertalt \clwWidth600 \cellx600 
\clpadb90 \clpadfb3 \clpadl90 \clpadfl3 \clbrdrr \trql \clwWidth9480 \cellx10080 
\intbl 
{\ri0 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \ql \fs18 \li0 
{\b0 \cf1 \f2 \i0 \fs18 
{\*\bkmkstart co_footnote_F83546934635_1}{\*\bkmkend co_footnote_F83546934635_1}
{\field {\*\fldinst HYPERLINK "#co_fnRef_F83546934635_ID0EQUAG_1" }{\fldrslt 
{\super \b0 \cf19 \f2 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
83
}\super \b0 \cf19 \f2 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 }}
\par 
}
}
}\b0 \cf1 \f2 \ri0 \i0 \ql \li0 \fs18 \intbl \cell \intbl 
{\ri0 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs18 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs18 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs18 \li0 
{\b0 \cf1 \f2 \i1 \fs18 
{\b0 \cf1 \f2 \ul0 \strike0 \i1 \fs18 \sa0 \sb0 
See supra
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs18 \sa200 \sb0 
 Part III.A.
\par 
}
}
}
}
}\b0 \cf1 \f2 \ri0 \ul0 \strike0 \i0 \qj \li0 \fs18 \sa200 \sb0 \intbl \cell \row }
{\trowd \ltrrow \trleft0 
\clbrdrl \trql \clvertalt \clwWidth600 \cellx600 
\clpadb90 \clpadfb3 \clpadl90 \clpadfl3 \clbrdrr \trql \clwWidth9480 \cellx10080 
\intbl 
{\ri0 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \ql \fs18 \li0 
{\b0 \cf1 \f2 \i0 \fs18 
{\*\bkmkstart co_footnote_F84546934635_1}{\*\bkmkend co_footnote_F84546934635_1}
{\field {\*\fldinst HYPERLINK "#co_fnRef_F84546934635_ID0EAWAG_1" }{\fldrslt 
{\super \b0 \cf19 \f2 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
84
}\super \b0 \cf19 \f2 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 }}
\par 
}
}
}\b0 \cf1 \f2 \ri0 \i0 \ql \li0 \fs18 \intbl \cell \intbl 
{\ri0 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs18 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs18 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs18 \li0 
{\b0 \cf1 \f2 \i1 \fs18 
{\b0 \cf1 \f2 \ul0 \strike0 \i1 \fs18 \sa0 \sb0 
See
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
 Kenneth S. Abraham & Catherine M. Sharkey, 
}
{\field {\*\fldinst HYPERLINK "https://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=0547946499&pubNum=0001292&originatingDoc=I434c460335f011ef8921fbef1a541940&refType=LR&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b0 \cf19 \f2 \i1 \fs18 
{\b0 \cf19 \f2 \ul0 \strike0 \i1 \fs18 \sa0 \sb0 
The Glaring Gap in Tort Theory
}
}
{\b0 \cf19 \f2 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
, 133 
}
{\b0 \cf19 \f2 \i0 \fs18 
{\b0 \cf19 \f2 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
Yale L.J.
}
}
{\b0 \cf19 \f2 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
 2165 (2024)
}\b0 \cf19 \f2 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 }}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs18 \sa200 \sb0 
, https://papers.ssrn.com/sol3/papers.cfm?abstract_id=4585790 [https://perma.cc/HK5W-SHKE].
\par 
}
}
}
}
}\b0 \cf1 \f2 \ri0 \ul0 \strike0 \i0 \qj \li0 \fs18 \sa200 \sb0 \intbl \cell \row }
{\trowd \ltrrow \trleft0 
\clbrdrl \trql \clvertalt \clwWidth600 \cellx600 
\clpadb90 \clpadfb3 \clpadl90 \clpadfl3 \clbrdrr \trql \clwWidth9480 \cellx10080 
\intbl 
{\ri0 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \ql \fs18 \li0 
{\b0 \cf1 \f2 \i0 \fs18 
{\*\bkmkstart co_footnote_F85546934635_1}{\*\bkmkend co_footnote_F85546934635_1}
{\field {\*\fldinst HYPERLINK "#co_fnRef_F85546934635_ID0EWWAG_1" }{\fldrslt 
{\super \b0 \cf19 \f2 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
85
}\super \b0 \cf19 \f2 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 }}
\par 
}
}
}\b0 \cf1 \f2 \ri0 \i0 \ql \li0 \fs18 \intbl \cell \intbl 
{\ri0 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs18 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs18 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs18 \li0 
{\b0 \cf1 \f2 \i1 \fs18 
{\b0 \cf1 \f2 \ul0 \strike0 \i1 \fs18 \sa0 \sb0 
See
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
 Peter Z. Grossman et al., 
}
{\b0 \cf1 \f2 \i1 \fs18 
{\b0 \cf1 \f2 \ul0 \strike0 \i1 \fs18 \sa0 \sb0 
Uncertainty, Insurance and the Learned Hand Formula
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
, 5 
}
{\b0 \cf1 \f2 \i0 \fs18 
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
L., Probability & Risk
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
 1, 1 (2005) (arguing how insurance provides necessary, aggregated guidance to courts and litigants regarding the danger of certain activities, optimal precautions to take, and therefore--under the Hand Formula--the threshold below which a lack of caution becomes legally cognizable negligence); 
}
{\b0 \cf1 \f2 \i1 \fs18 
{\b0 \cf1 \f2 \ul0 \strike0 \i1 \fs18 \sa0 \sb0 
see also
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
 
}
{\b0 \cf1 \f2 \i0 \fs18 
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
Omri Ben-Shahar & Ariel Porat, Personalized Law: Different Rules for Different People
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs18 \sa200 \sb0 
 32 (2020) (\u8220\'3fInsurance services are perhaps the pioneers in personalized treatments, which is not surprising given the wealth of personal data the industry has. Insurers \u8216\'3frate\u8217\'3f policyholders .... With the advent of digital data collection, the personalization has become more intensive, focusing on policyholders\rquote  conduct.\u8221\'3f).
\par 
}
}
}
}
}\b0 \cf1 \f2 \ri0 \ul0 \strike0 \i0 \qj \li0 \fs18 \sa200 \sb0 \intbl \cell \row }
{\trowd \ltrrow \trleft0 
\clbrdrl \trql \clvertalt \clwWidth600 \cellx600 
\clpadb90 \clpadfb3 \clpadl90 \clpadfl3 \clbrdrr \trql \clwWidth9480 \cellx10080 
\intbl 
{\ri0 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \ql \fs18 \li0 
{\b0 \cf1 \f2 \i0 \fs18 
{\*\bkmkstart co_footnote_F86546934635_1}{\*\bkmkend co_footnote_F86546934635_1}
{\field {\*\fldinst HYPERLINK "#co_fnRef_F86546934635_ID0EZWAG_1" }{\fldrslt 
{\super \b0 \cf19 \f2 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
86
}\super \b0 \cf19 \f2 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 }}
\par 
}
}
}\b0 \cf1 \f2 \ri0 \i0 \ql \li0 \fs18 \intbl \cell \intbl 
{\ri0 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs18 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs18 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs18 \li0 
{\b0 \cf1 \f2 \i1 \fs18 
{\b0 \cf1 \f2 \ul0 \strike0 \i1 \fs18 \sa0 \sb0 
See
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
 Abraham & Sharkey, 
}
{\b0 \cf1 \f2 \i1 \fs18 
{\b0 \cf1 \f2 \ul0 \strike0 \i1 \fs18 \sa0 \sb0 
supra
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs18 \sa200 \sb0 
 note 84.
\par 
}
}
}
}
}\b0 \cf1 \f2 \ri0 \ul0 \strike0 \i0 \qj \li0 \fs18 \sa200 \sb0 \intbl \cell \row }
{\trowd \ltrrow \trleft0 
\clbrdrl \trql \clvertalt \clwWidth600 \cellx600 
\clpadb90 \clpadfb3 \clpadl90 \clpadfl3 \clbrdrr \trql \clwWidth9480 \cellx10080 
\intbl 
{\ri0 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \ql \fs18 \li0 
{\b0 \cf1 \f2 \i0 \fs18 
{\*\bkmkstart co_footnote_F87546934635_1}{\*\bkmkend co_footnote_F87546934635_1}
{\field {\*\fldinst HYPERLINK "#co_fnRef_F87546934635_ID0E4WAG_1" }{\fldrslt 
{\super \b0 \cf19 \f2 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
87
}\super \b0 \cf19 \f2 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 }}
\par 
}
}
}\b0 \cf1 \f2 \ri0 \i0 \ql \li0 \fs18 \intbl \cell \intbl 
{\ri0 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs18 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs18 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs18 \li0 
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
The greater the threat of tort liability, the more cost-effective premium refinement and individualized coaching will be. 
}
{\b0 \cf1 \f2 \i1 \fs18 
{\b0 \cf1 \f2 \ul0 \strike0 \i1 \fs18 \sa200 \sb0 
Id.
\par 
}
}
}
}
}
}\b0 \cf1 \f2 \ri0 \ul0 \strike0 \i1 \qj \li0 \fs18 \sa200 \sb0 \intbl \cell \row }
{\trowd \ltrrow \trleft0 
\clbrdrl \trql \clvertalt \clwWidth600 \cellx600 
\clpadb90 \clpadfb3 \clpadl90 \clpadfl3 \clbrdrr \trql \clwWidth9480 \cellx10080 
\intbl 
{\ri0 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \ql \fs18 \li0 
{\b0 \cf1 \f2 \i0 \fs18 
{\*\bkmkstart co_footnote_F88546934635_1}{\*\bkmkend co_footnote_F88546934635_1}
{\field {\*\fldinst HYPERLINK "#co_fnRef_F88546934635_ID0EMXAG_1" }{\fldrslt 
{\super \b0 \cf19 \f2 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
88
}\super \b0 \cf19 \f2 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 }}
\par 
}
}
}\b0 \cf1 \f2 \ri0 \i0 \ql \li0 \fs18 \intbl \cell \intbl 
{\ri0 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs18 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs18 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs18 \li0 
{\b0 \cf1 \f2 \i1 \fs18 
{\b0 \cf1 \f2 \ul0 \strike0 \i1 \fs18 \sa0 \sb0 
See
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
 
}
{\b0 \cf1 \f2 \i0 \fs18 
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
Food & Drug Admin., FDA Permits Marketing of Artificial Intelligence-Based Device to Detect Certain Diabetes-Related Eye Problems
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
, 
}
{\b0 \cf1 \f2 \i1 \fs18 
{\b0 \cf1 \f2 \ul0 \strike0 \i1 \fs18 \sa0 \sb0 
supra
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs18 \sa200 \sb0 
 note 59 & accompanying text.
\par 
}
}
}
}
}\b0 \cf1 \f2 \ri0 \ul0 \strike0 \i0 \qj \li0 \fs18 \sa200 \sb0 \intbl \cell \row }
{\trowd \ltrrow \trleft0 
\clbrdrl \trql \clvertalt \clwWidth600 \cellx600 
\clpadb90 \clpadfb3 \clpadl90 \clpadfl3 \clbrdrr \trql \clwWidth9480 \cellx10080 
\intbl 
{\ri0 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \ql \fs18 \li0 
{\b0 \cf1 \f2 \i0 \fs18 
{\*\bkmkstart co_footnote_F89546934635_1}{\*\bkmkend co_footnote_F89546934635_1}
{\field {\*\fldinst HYPERLINK "#co_fnRef_F89546934635_ID0ERXAG_1" }{\fldrslt 
{\super \b0 \cf19 \f2 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
89
}\super \b0 \cf19 \f2 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 }}
\par 
}
}
}\b0 \cf1 \f2 \ri0 \i0 \ql \li0 \fs18 \intbl \cell \intbl 
{\ri0 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs18 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs18 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs18 \li0 
{\b0 \cf1 \f2 \i1 \fs18 
{\b0 \cf1 \f2 \ul0 \strike0 \i1 \fs18 \sa0 \sb0 
See
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
 W. Nicholson Price & Glenn Cohen, 
}
{\field {\*\fldinst HYPERLINK "https://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=0546087657&pubNum=0001126&originatingDoc=I434c460335f011ef8921fbef1a541940&refType=LR&fi=co_pp_sp_1126_342&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)#co_pp_sp_1126_342" }{\fldrslt 
{\b0 \cf19 \f2 \i1 \fs18 
{\b0 \cf19 \f2 \ul0 \strike0 \i1 \fs18 \sa0 \sb0 
Locating Liability for Medical AI
}
}
{\b0 \cf19 \f2 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
, 73 
}
{\b0 \cf19 \f2 \i0 \fs18 
{\b0 \cf19 \f2 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
DePaul L. Rev.
}
}
{\b0 \cf19 \f2 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
 339, 342 (2024)
}\b0 \cf19 \f2 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 }}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
; Michael D. Abramoff et al., 
}
{\b0 \cf1 \f2 \i1 \fs18 
{\b0 \cf1 \f2 \ul0 \strike0 \i1 \fs18 \sa0 \sb0 
Lessons Learned About Autonomous AI: Finding a Safe, Efficacious, and Ethical Path Through the Development Process
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
, 214 
}
{\b0 \cf1 \f2 \i0 \fs18 
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
Am. J. Ophthalmology
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs18 \sa200 \sb0 
 134, 139 (June 2020) (\u8220\'3fJust like a physician that would be held legally responsible for his or her diagnosis or other clinical decision, IDx, as creators of autonomous AI products, assume similar liability and have obtained medical malpractice insurance.\u8221\'3f).
\par 
}
}
}
}
}\b0 \cf1 \f2 \ri0 \ul0 \strike0 \i0 \qj \li0 \fs18 \sa200 \sb0 \intbl \cell \row }
{\trowd \ltrrow \trleft0 
\clbrdrl \trql \clvertalt \clwWidth600 \cellx600 
\clpadb90 \clpadfb3 \clpadl90 \clpadfl3 \clbrdrr \trql \clwWidth9480 \cellx10080 
\intbl 
{\ri0 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \ql \fs18 \li0 
{\b0 \cf1 \f2 \i0 \fs18 
{\*\bkmkstart co_footnote_F90546934635_1}{\*\bkmkend co_footnote_F90546934635_1}
{\field {\*\fldinst HYPERLINK "#co_fnRef_F90546934635_ID0EWXAG_1" }{\fldrslt 
{\super \b0 \cf19 \f2 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
90
}\super \b0 \cf19 \f2 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 }}
\par 
}
}
}\b0 \cf1 \f2 \ri0 \i0 \ql \li0 \fs18 \intbl \cell \intbl 
{\ri0 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs18 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs18 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs18 \li0 
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
Commercial general liability (\u8220\'3fCGL\u8221\'3f) policies cover liability for damages imposed because of bodily injury and property damage caused by anything that happens accidentally. 
}
{\b0 \cf1 \f2 \i1 \fs18 
{\b0 \cf1 \f2 \ul0 \strike0 \i1 \fs18 \sa0 \sb0 
See
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
 Abraham & Sharkey, 
}
{\b0 \cf1 \f2 \i1 \fs18 
{\b0 \cf1 \f2 \ul0 \strike0 \i1 \fs18 \sa0 \sb0 
supra
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
 note 84. Thus, when strict products liability was adopted in 1965 by the 
}
{\field {\*\fldinst HYPERLINK "https://www.westlaw.com/Link/Document/FullText?findType=Y&serNum=0290694188&pubNum=0101577&originatingDoc=I434c460335f011ef8921fbef1a541940&refType=TS&originationContext=document&vr=3.0&rs=cblt1.0&transitionType=DocumentItem&contextData=(sc.Search)" }{\fldrslt 
{\b0 \cf19 \f2 \i1 \fs18 
{\b0 \cf19 \f2 \ul0 \strike0 \i1 \fs18 \sa0 \sb0 
Restatement (Second) of Torts
}
}
{\b0 \cf19 \f2 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
 \u167\'3f 402A
}\b0 \cf19 \f2 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 }}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs18 \sa200 \sb0 
, CGL policies automatically covered it.
\par 
}
}
}
}
}\b0 \cf1 \f2 \ri0 \ul0 \strike0 \i0 \qj \li0 \fs18 \sa200 \sb0 \intbl \cell \row }
{\trowd \lastrow \trleft0 
\clbrdrb \clbrdrl \trql \clvertalt \clwWidth600 \cellx600 
\clpadb90 \clpadfb3 \clpadl90 \clpadfl3 \clbrdrb \clbrdrr \trql \clwWidth9480 \cellx10080 
\intbl 
{\ri0 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \ql \fs18 \li0 
{\b0 \cf1 \f2 \i0 \fs18 
{\*\bkmkstart co_footnote_F91546934635_1}{\*\bkmkend co_footnote_F91546934635_1}
{\field {\*\fldinst HYPERLINK "#co_fnRef_F91546934635_ID0EHYAG_1" }{\fldrslt 
{\super \b0 \cf19 \f2 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
91
}\super \b0 \cf19 \f2 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 }}
\par 
}
}
}\b0 \cf1 \f2 \ri0 \i0 \ql \li0 \fs18 \intbl \cell \intbl 
{\ri0 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs18 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs18 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs18 \li0 
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs18 \sa200 \sb0 
Cyber liability is a good example:
\par 
}
}
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs18 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs18 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs18 \li0 
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs18 \sa200 \sb0 
Initially, the demand for liability insurance was low because most defendants assumed they were protected from tort liability by the \u8220\'3fno duty\u8221\'3f economic loss rule. Some courts then began to impose duties to protect against security breaches. When this form of liability began to emerge, not all CGL policyholders wanted to purchase coverage against it. At first, an optional endorsement providing coverage was developed. But after a time, this approach became unsuitable and freestanding cyber insurance was developed and marketed. The process of developing such coverage is a major undertaking and requires that sufficient demand for the coverage exist or be anticipated in order to justify the investment, long before any premiums are earned. Cyber insurance premiums (typically for a combination of liability insurance and first-party coverage) grew 61% in 2021. But it remains to be seen whether such a thin sliver of new liability will satisfy this precondition.
\par 
}
}
}
}
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs18 \li0 
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs18 \li0 
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs18 \sa0 \sb0 
Abraham & Sharkey, 
}
{\b0 \cf1 \f2 \i1 \fs18 
{\b0 \cf1 \f2 \ul0 \strike0 \i1 \fs18 \sa0 \sb0 
supra
}
}
{\b0 \cf1 \f2 \ul0 \strike0 \i0 \fs18 \sa200 \sb0 
 note 84.
\par 
}
}
}
}
}
}\b0 \cf1 \f2 \ri0 \ul0 \strike0 \i0 \qj \li0 \fs18 \sa200 \sb0 \intbl \cell \row }}\par 
}
{\b0 \qc \cf1 \f3 \ri0 \i0 \fs20 \li0 
{\b0 \cf1 \f3 \ul0 \strike0 \i0 \fs20 \sa200 \sb0 
25 CLMSTLR 240
\par 
}
}
{\b0 \cf1 \f2 \ri0 \i0 \qj \fs20 \li0 {
{\trowd \lastrow \trleft0 
\clpadt24 \clpadft3 \clpadl100 \clpadfl3 \clpadr24 \clpadfr3 \clbrdrt \brdrcf23 \brdrw10 \brdrs \clbrdrb \clbrdrl \trql \clvertalt \clwWidth4320 \cellx4320 
\clpadt30 \clpadft3 \clpadl100 \clpadfl3 \clpadr30 \clpadfr3 \clbrdrt \brdrcf23 \brdrw10 \brdrs \clbrdrb \clbrdrr \trql \clvertalt \clwWidth5760 \cellx10080 
\intbl 
{\ri24 \li24 
{\b1 \cf23 \f2 \ri24 \i0 \ql \fs16 \li24 
{\b1 \cf23 \f2 \ul0 \strike0 \i0 \fs16 \sa0 \sb0 
End of Document
\par 
}
}
}\b1 \cf23 \f2 \ri24 \ul0 \strike0 \i0 \ql \li24 \fs16 \sa0 \sb0 \intbl \cell \intbl 
{\ri30 \li30 
{\qr \b0 \cf23 \f2 \ri30 \i0 \fs20 \li30 
{\b0 \cf23 \f2 \ul0 \strike0 \i0 \fs20 \sa0 \sb0 
\u169\'3f 2024 Thomson Reuters. No claim to original U.S. Government Works.
\par 
}
}
}\qr \b0 \cf23 \f2 \ri30 \ul0 \strike0 \i0 \li30 \fs20 \sa0 \sb0 \intbl \cell \row }}\par 
}
}\sect }